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Isolamento di metaboliti secondari di origine vegetale e loro utilizzo come modelli 
molecolari in nuove strategie sintetiche di sostanze bioattive. 
 
I metaboliti secondari prodotti dalle piante sono quei composti non direttamente essenziali per i 
meccanismi fotosintetici e respiratori della pianta. La loro funzione è normalmente di natura 
ecologica in quanto sono usati o come meccanismi di difesa contro predatori o per la 
competizione interspecifica o per facilitare i processi riproduttivi.  
L’ambiente con cui una specie vegetale si trova a comunicare per competizione, difesa o 
empatia è un ambiente complesso, caratterizzato da specie di natura diversa con le quali le 
piante instaurano una comunicazione di tipo chimico. Molti studi vengono condotti per 
comprendere l’origine, la funzione e il significato delle sostanze chimiche che mediano 
l’interazione tra organismi differenti. Meccanismi di interazione tra specie vegetali sono 
descritti con il termine allelopatia, che considera le interazioni positive o negative che una 
pianta esercita su di un’altra, mediante il rilascio di composti chimici nell’ambiente. Juglone, 
sulcotrione, scopoletina, 1,4-cineolo sono solo alcuni esempi di metaboliti fitotossici che, 
prodotti da una pianta le consentono il predominio vegetale del proprio habitat. Data l’elevata 
fitotossicità alcuni dei composti allelochimici isolati vengono impiegati in campo agronomico 
come erbicidi naturali (Duke et al., 2002).  
Erbicidi di origine naturale potenzialmente possiedono caratteristiche di biocompatibilità 
difficilmente riscontrabili in un erbicida di sintesi. A ciò si aggiunge la maggiore specificità dei 
metaboliti naturali, perfezionati dall’evoluzione per agire in maniera altamente selettiva su 
target di interesse.  
Inoltre, i prodotti di origine naturale rappresentano una notevole fonte di nuovi modelli 
molecolari con nuovi modi di agire che può essere utile per combattere la resistenza sviluppata 
da piante infestanti verso alcuni erbicidi di sintesi. 
In questa ottica il gruppo di ricerca presso il quale ho svolto il mio lavoro di tesi, ha negli anni 
studiato i metaboliti secondari prodotti da piante infestanti dell’area mediterranea (Cutillo et al., 
2003). In particolare nel corso del mio ciclo di dottorato ho condotto l’analisi sistematica dei 
metaboliti secondari delle specie Aptenia cordifolia e Oxalis pes-caprae, e intrapreso lo studio 
di Phillyrea angustifolia. 
Per ciascuna delle piante è stata realizzata l’estrazione dei metaboliti mediante infusione, 
seguita da un processo di frazionamento degli estratti mediante tecniche cromatografiche 
(cromatografia su colonna di silice, cromatografia liquido-liquido in controcorrente, TLC e 
HPLC in fase diretta e inversa). L’impiego di tali tecniche ha consentito la purificazione delle 
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frazioni e l’isolamento dei metaboliti. La caratterizzazione strutturale delle molecole isolate e’ 
stata realizzata con tecniche spettroscopiche, tra cui NMR mono e bidimensionale (1H-1H 
COSY, HMBC, HSQC, NOESY, ROESY), spettroscopia UV-VIS, dicroismo circolare e 
tecniche di spettrometria di massa (EI, ESI, MALDI). 
Aptenia cordifolia, appartenente alla famiglia delle Aizoaceae, è una pianta erbacea perenne 
caratterizzata da fusti di piccole dimensioni legnosi solo alla base e da foglie succulenti verde 
scuro. Viene comunemente usata come pianta ornamentale, anche in ambienti ostili in quanto è 
in grado di sopravvivere in uno ampio range di salinità del terreno e riesce a crescere in 
ambienti secchi e molto esposti al sole. E’ dotata di una notevole invasività ed in particolare 
quando ha a disposizione un’adeguata quantità di acqua riesce a sopraffare tutta la vegetazione 
circostante, crescendo su tutto ciò che incontra sul cammino. 
La pianta fresca è stata posta in infusione prima in una soluzione idroalcolica (10% 
CH3OH/H2O), poi in CH3OH ed, infine, AcOEt, a temperatura ambiente per sette giorni. 
Mediante i processi di purificazione sopra descritti dall’infuso idroalcolico di A. cordifolia 
sono stati isolati dodici composti con scheletro lignanico, di cui sei ossineolignani (DellaGreca 
et al., 2005) e due lignanammidi, tre ammidi cinnamiche (DellaGreca et al., 2006), cinque 
terpenoidi e diversi derivati fenolici (DellaGreca et al., 2007). 
Oxalis pes-caprae è una pianta erbacea perenne di origine sudafricana ma largamente 
naturalizzata lungo le coste mediterranee e del basso Atlantico europeo. Ha proprietà 
rinfrescanti, astringenti, depurative e per via esterna ha potere antinfiammatori e 
decongestionante. Dato l’alto contenuto di acido ossalico le foglie risultano tossiche se ingerite 
in quantità eccessive. 
Mediante i processi di estrazione e purificazione sopra descritti da Oxalis pes-caprae sono stati 
isolati sedici composti aromatici di natura esterea (DellaGreca et al., in press) due lignani e 
quattro flavoni. 
I metaboliti isolati sono stati sottoposti a saggi di fitotossicità sulla dicotiledone Lactuca sativa, 
specie test proposta come modello per le infestanti più comuni. I saggi sono stati condotti in 
accordo alla procedura ottimizzata da Macias et al. 
E’ stato valutato l’effetto che i metaboliti, a concentrazioni da 10-4 a 10-7 M, hanno sulla 
germinazione e sulla crescita dell’organismo vegetale testato. 
Phillyrea angustifolia è una specie tipica della macchia mediterranea, si ritrova soprattutto 
lungo la costa tirrenica, con un fronte altimetrico che raggiunge i 600 metri. Colonizza terreni 
difficili e siccitosi e viene favorita in climi miti e caldi.  
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La fillirea, come la maggior parte delle specie della macchia, attua un “pirofitismo attivo” 
come strategia di ripresa dopo il fuoco, ossia ricresce rapidamente dopo un incendio a partire 
da polloni e rizomi e generalmente i cespugli superano il metro di altezza già dopo un anno dal 
fuoco, formando insieme ad altre specie, intricati grovigli difficili da penetrare (Lopez-Soria et 
al. 1992). 
Dall’infuso idroalcolico della pianta sono stati finora isolati tre lignani e cinque secoiridoidi 
glucosilati, precedentemente già ritrovati in altre Oleaceae. Anche questi composti, insieme ad 
altri, saranno saggiati per valutarne una eventuale fitotossicità. 
Inoltre, durante un periodo trascorso presso il centro di ricerca americano USDA-ARS, mi 
sono occupata dello studio di due piante, Amyris madrensis e Swinglea glutinosa. Entrambe 
appartengono alla famiglia delle Rutaceae che è fonte di molte classi di composti 
biologicamente attivi. 
Amyris madrensis è una pianta sempreverde originaria dal Texas, molto resistente al caldo e 
alla siccità. Foglie secche della pianta sono state estratte per infusione con acetato di etile, una 
bioautografia dell’estratto mostrava la presenza di composti con attività fungicida. Ciò ci ha 
indotto alla successiva lavorazione dell’estratto mediante tecniche cromatografiche che hanno 
portato all’isolamento di diverse cumarine. 
Swinglea glutinosa è una pianta tropicale, usata come pianta ornamentale o per costruire 
barriere naturali nei giardini. Dall’estratto organico delle radici della pianta sono stati isolati tre 
cumarine e nove acridoni alcaloidi. Alcuni dei composti isolati mostravano una buona attività 
inibente la crescita della specie Oscillatoria peronata, un cianobatterio dannoso per le colture 
di pesci. 
L’ampio range di attività biologiche esibite dai lignani (MacRae et al. 1984) spiega l’enorme 
interesse verso l’isolamento e la sintesi di questi composti. Allo scopo di trovare un 
conveniente e blando metodo di preparazione di composti a struttura lignanica è stata studiato 
il comportamento dell’isoeugenolo e di altri propenil fenoli in reazioni fotoindotte (Della 
Greca et al. in press). In particolar modo sono state prese in considerazione la 
fotoossigenazione sensibilizzata da coloranti e la fotoossidazione mediata da t-butil perossido, 
entrambe reazioni estremamente semplici e di basso impatto ambientale. Lignani ciclici e 
aciclici si sono ottenuti a partire dall’isoeugenolo mentre meno reattivi si sono mostrati gli altri 
substrati utilizzati nelle condizioni di reazione adoperate.   
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1. INTRODUCTION 
 
Secondary metabolites are organic compounds that are not directly involved in the normal 
growth, development or reproduction of the organisms. They are often restricted to a narrow 
set of species witin a phylogenetic group. 
The function or importance of these compounds to the organism is usually of an ecological 
nature as they are used as defenses against predators, parasites and diseases, for interspecies 
competition, and to facilitate the reproductive processes (coloring agent, attractive smells).  
Plants compete with other plants not only for space, light, water and nutrients, but also defend 
themselves against microorganisms, insects, and herbivores. It will not be surprising that plants 
use more than thorns, hairy surfaces, and though skins to discourage predators from taking a 
bite, rather they wield an arsenal of chemicals to deter enemies, fend off pathogens, make 
nutrients more available and protect against cold and other physical hazards of environments. 
These secondary metabolites, beneficial or deterrent to the growth of receptor organisms, could 
be regarded as an evolutionary expression of a quiet antagonism of plant to its enemies. One 
important aspect of this quiet antagonism is allelopathy. Allelopathy is defined as any direct or 
indirect effect (stimulatory or inhibitory) by one plant, including microorganisms, on another 
through production of chemical compounds released into the environment.1  
Three criteria were proposed2 to establish evidence for allelopathy: 
1. The allegedly allelopathic plant must produce and release chemicals that modify the growth 
or function of other plants. 
2. The amount of inhibiting substances produced must be sufficient to affect vital processes of 
the sensitive plants, like nutrient and water uptake by roots or energy fixation. 
3. The observed field patterns of plant inhibition cannot be explained solely by physical or 
biotic factors. 
Demonstrating that a plant has the described criteria is not an easy task. The finding of 
phytotoxins in the rhizosphere, density-dependent experiments to distinguish allelopathy and 
resource competition effects,3 reduction of the negative power of one plant on the others by 
using substances with organic adsorptive capacity (activated carbon, gel filters)4 to alter the 
rhizosphere chemistry, are just some of the more persuasive experiments that provide a deeper 
insight into allelopathy. Inhibition zones around the plant, wide spontaneous monoculture area, 
and root segregation may of course develop from other mechanisms of interference (resource 
competition, nutrient immobilization, indirect effects of herbivores), but such patterns establish 
a realistic ecological features in which to investigate allelopathy.5  
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Allelochemical action is launched when the allelochemicals are released in the environment. 
This may happen through different processes, including foliar leaching, root exudation, residue 
decomposition, volatilisation and debris incorporation into soil.6 Once released, phytotoxins 
diffuse in the soil transported by water. It has also been demonstrated that allelopathic 
interaction can occur between organisms through root to root contact.6
Allelochemicals so far identified belong to different classes of chemical compounds, as 
terpenoids, quinones, saponins, coumarins, tannins, flavonoids, cinnamic and benzoic acids, 
alkaloids. 
Terpenoid class includes a wide range of mono-, di-, tri-, sesqui-, and tetraterpenoids. An 
impressive array of terpenoids from sunflower, responsible for inhibiting activity, have been 
described.7 
Mechanisms of action have been studied for some chemicals having a wellproved allelopathic 
activity, but no unique way of interaction with cells has been found for structural related 
compounds. 
One of the first mechanisms of action described for allelochemicals8 showed that the volatile 
1,8-cineole and camphor reduce cell division causing a shorter root cells elongation and the 
generation of cells with irregular nuclear and large internal globules. It was successively 
reported that these monoterpenes cause structural modifications of small cellular organelles 
and the disruption of the nuclear membrane and other internal membranes. 
 
O
                 
O
 
                                                                      1,8-cineole          1,4-cineole 
 
A natural analogue of 1,8-cineole is 1,4-cineole, which has been shown to be a potent inhibitor 
of asparigine synthetase, which is involved in nitrogen metabolism. The displacement of the 
oxygen bridge within the two monoterpenes described, deeply modifies the biological effects. 
Two significant examples of bioactive quinones are juglone and sorgoleone.9 They are 
described as having a role in black walnut and Sorghum allelopathy, respectively. They are 
both active at very low concentrations, several orders of magnitude lower than many 
allelochemicals from higher plants. It has been reported that both compounds affect plant 
energy metabolism, but it is still unclear what the target sites are. 
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Many bioactive coumarins were isolated from plants and their action mechanisms are broadly 
distributed, including an internal role in seed dormancy by retarding cellular development.10 
Coumarin and scopoletin both decrease mitosis, and an inhibiting action on indoleacetic acid 
oxidation by scopoletin has been demonstrated. Roots absorbed scopoletin was proved to be 
transferred to shoots, where it decreased the photosyntesis rate, probably by stomatal closure.11
 
 
O O O O
MeO
HO      
 Coumarin                                                        Scopoletin 
        
 
Cinnamic and benzoic acids production has been reported for many allelopathic plants. In their 
mode of action these compounds do not have a specific molecular target. Effects have been 
reported on several phytormone interactions, ion uptake and content, photosynthesis, 
respiration, chlorophyll maintenance, membrane structures and ATPases transport, patterns of 
carbon flow, and a variety of enzymes. All these effects are said to be caused by ferulic acid, 
one of the better studied phenolic acids, in higher plants.12 
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Secondary metabolites produced by plants and having biological activity have been broadly 
described in literature but only a small subset has been studied in connection with allelopahty, 
and their action mechanism is still far from being understood. Thus there is still a wide array of 
natural compounds to be investigated for a more complete view of allelopathy. 
Allelochemicals produced by a plant may act as phytotoxins on the plant itself. Two possible 
mechanisms might prevent a plant from poisoning itself: a) resistance at the molecular target 
site; b) processes that avoid the allelochemical to interact with the molecular target site. While 
there is no evidence for the first mechanism, the second one is supported by several examples. 
Phytotoxins are 
kept away from the molecular target through sequestration and chemical protection. 
Sequestration is realized by the compartmentalization of the toxic chemicals in cell areas which 
are not in contact with vital centres, as in vacuoles and trichomes. In some cases phytotoxins 
are modified by enzymatic processes that bond sugars or other moieties. In this way the 
modified phytotoxins can be 
transported to a vacuole. The modified compounds are usually less phytotoxic, and their 
negative activity is even weaker when they are stored within vacuoles. 
These compounds usually become phytotoxic only after they are released into the soil, where 
they are probably activated by the enzymatic removal of the function employed to ensure 
vacuole sequestration. 
Chemical modification of allelochemicals is sometimes performed by plants, according to a 
species selected process, in order to lessen the phytotoxic effects of other species. 
Detoxification processes include oxidation, carbohydrate or other chemical conjugation, and 
segregation in depository cell compartments before excretion. These kinds of plant reactions 
are also observed in response to 
herbicide treatments. 
Allelochemicals have received special attention due to the agricultural potential of these 
compounds as natural herbicides,13 both directly or after chemical modification that 
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implements physico-chemical properties. Widespread use of synthetic herbicides has resulted 
in herbiced-resistence weeds, and public concerns over the impact synthetic herbicides have on 
human health and the environment are increasing. These concerns are shifting attention to 
alternative weed control technologies based on natural products. Natural compounds often have 
a shorter environmental half life than synthetic compounds, thus reducing potential 
environmental impact. Herbicides designed by chemical synthesis have quite unspecific 
molecular target sites, usually aimed at undermining generic vital functions of the cell, causing 
drawbacks also to crops. Evolution, instead, selected a broad array of efficient and selective 
phytotoxins, which can be used as templates for new herbicides. Increasing the weeds 
resistance to common herbicides has aroused deep interest in the discovery of new molecular 
target sites for herbicides. 
The obstacle for industrial application of these compounds sometimes is constituted by their 
structural complexity that makes their synthesis cost prohibitive. Structural simplification of 
the lead compounds often results in significantly lower biological activity. For example, 
tentoxin,14 a cyclic tetrapeptide from the plant pathogen Alternaria alternate, has a really 
attractive soil behaviour. In fact, it shows high stability with good residual soil activity which 
is mainly exerted against an important spectrum of weed species. Several major crops are 
completely resistant to tentoxin toxicity. Unfortunately, much structure-activity research has 
not led to a simpler molecule with acceptable activity.14  
 
 
N
N
H
N
H
N
O
O
O
O
 
 
Tentoxin 
 
 
Many natural products are phytotoxic, but few have both the correct physicochemical 
properties or level of biological activity to be good herbicides. For example, sorgoleone, which 
is a plant produced quinone, structurally related to plastoquinone. Together with many of its 
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analogues, sorgoleone inhibits photosystem II of photosynthesis, apparently by preventing the 
binding of plastoquinone to the D-1 protein of PSII,15 but it is a relatively weak herbicide. 
Nevertheless there are many commercial herbicides deriving structurally from allelopathic 
compounds. An interesting example is provided by a herbicide widely used in Europe and 
Asia, cynmethylin. This herbicide is structurally similar to 1,4-cineole, a natural monoterpen, 
which acts on a target plant by inhibiting asparigine synthetase,16 a previously unexploited 
molecular action site. The inhibition of this enzyme causes an interruption of plant growth. It 
seems that Cynmethylin is a pro-herbicide that requires metabolic bioactivation in soil by 
cleavage of the benzyl-ether side chain, giving a molecule with a 1,4-cineole structure, 
responsible for the allelopathic activity.16
 
O
O
 
Cinmethylin 
 
For agricultural purposes different kinds of triketone herbicides structurally derived from the 
natural compound leptospermone are widely used. Two interesting examples are sulcotrione 
and mesotrione.17 These kinds of triketone herbicides act on the enzyme 
phydroxyphenylpyruvate dioxygenase, which is an enzyme involved in the biosynthesis of 
carotenoids and plastoquinone. The inhibition of its activity causes foliage bleaching in the 
treated plants, due to the loss of chlorophyll. 
 
O
O
O Cl
SO2Me          
O
O
O NO2
SO2Me  
 Sulcotrione Mesotrione 
 
The investigation of allelopathic compounds is just a small part of the studies of natural 
compounds. Nature still represents an infinite source of unknown molecules having new 
structures and functionalities that evolution refined for high specific biological roles. The 
functional-group diversity and architectural models of carbon skeletons designed by nature 
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continue to provide lessons for synthetic and medicinal chemists in their strategies for making 
biological active mimics. Biosynthetic pathways of natural compounds also provide interesting 
suggestions for monomer assembling and the tailoring of the growing product, which can be 
used to create new strategies for synthesising variants of natural products.18
My PhD project involved the study of two plants of the Mediterranean area, Aptenia cordifolia 
and Oxalis pes-caprea, in order to isolate and identify fitotoxic compounds. 
These plants have been chosen because of their characteristics of persistency and diffusion, 
which are promising features for plant allelopathy. 
The extraction of metabolites from these plants was realized by infusion in hydroalcoholic 
solution and then in methanol. Fractionation and purification of the extracts were realized by 
different chromatographic techniques (CC, HPLC, TLC), while pure compound identification 
was possible with spectroscopic techniques (1H and 13C NMR, UV-VIS, IR) and spectrometric 
techniques (ESI-MS, EI-MS, MALDI-MS). Characterized compounds have been tested on 
seeds of Lactuca sativa to detect their bioactivity, in accordance with a procedure defined by 
Macias et al.19
Furthermore, I have been concerned with the study of two Rutaceae species, Amyris madrensis 
and Swinglea glutinosa, at the USDA-ARS Natural Products Utilization Research Unit. In 
order to discover bioactive and environmentally safe compounds metabolites isolated from 
these plants have been evaluated for antifungal activity against the plant pathogen 
Colletotrichum fragariae, and for algicidal activity against Oscillatoria perornata, 
cianobacteria responsible for causing off-flavor in pond-cultured catfish. 
The bioassays were performed in accord with the Wedge20 and Schrader21 methods, 
respectively. 
Acetylcholinesterase inhibitory activity were also evaluated for these compounds. 
Finally, in order to find convenient and mild approaches to the preparation of lignan-like 
compounds, light-promoted oxidations of propenyl phenols have been examineted under 
various conditions. 
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2. MATERIALS AND METHODS 
 
2.1. General experimental procedures 
  
Nuclear magnetic resonance (NMR) spectra have been recorded at 500 MHz for 1H and 125 
MHz for 13C on a Varian 500 Fourier transform NMR spectrometer. Electronic Impact Mass 
Spectra (EI-MS) have been obtained with a HP 6890 spectrometer equipped with an MS 5973 
N detector. Matrix Assisted Laser Desorption Ionization Mass Spectra (MALDI-MS) were 
recorded using a Voyager-DE MALDI-TOF mass spectrometer. High Resolution ElettroSpray 
Ionization Mass Spectra (HRESI-MS) were obtained using an Agilent 1100 HPLC coupled to a 
JOEL AccuTOF (JMS-T100LC). UV/Vis spectra were recorded in ethanol on a Perkin-Elmer 
Lambda 7 spectrophotometer. The analytical HPLC apparatus consists of an Agilent 1100 
HPLC system equipped with a UV detector. The column is a 250 mm x 4.6 mm i.d., 5 µm 
Hibar LiChrosorb RP-18 (Merck). The preparative HPLC apparatus consists of a Shimadzu 
LC-10AD pump, a Shimadzu RID-10A refractive index detector, and a Shimadzu 
Chromatopac CR-6A recorder. Preparative HPLC was performed using a 250 mm x 10 mm 
i.d., reverse phase C-18 column (Phenomenex). Analytical TLC was made on Kieselgel 60 
F254 or RP-18 F254 plates with 0.2 mm layer thickness (Merck). Spots were visualized by UV 
light or by spraying with H2SO4 - AcOH - H2O (1:20:4). The plates were then heated for 5 min 
at 110 °C. Preparative TLC was performed on Kieselgel 60 F254 plates with 0.5 or 1 mm film 
thickness (Merck). Flash column chromatography was conducted on Kieselgel 60, 230-400 
mesh (Merck), at medium pressure. Column chromatography was performed on Kieselgel 60, 
70-240 mesh (Merck), or on Sephadex LH-20 (Pharmacia).  
The methylene blue-sensitized photooxygenations were performed in a 50-ml Pyrex flask, by 
irradiation with an external 650-W halogen lamp  (General Electric). A photoreactor (Helios 
Italquartz) equipped with a 500W high-pressure mercury lamp (through a Pyrex glass filter, 
λ >300 nm) was used for UV irradiation. 
 
 
2.2. Extraction and isolation of compounds from Aptenia cordifolia 
 
Plants of Aptenia cordifolia were collected in Campania, Italy, in August 2004, and identified 
by Prof. Antonino Pollio, Dipartimento di Biologia Vegetale, University Federico II, Naples, 
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Italy. A voucher specimen (HERBNAPY680) was deposited at the herbarium of the University 
Federico II. 
Leaves extract fractionation. 
Fresh leaves (12 kg) of A. cordifolia were powdered and extracted with H2O - CH3OH (9:1) at 
room temperature (25 °C) for 7 days. To an aqueous suspension (800 ml) of the hydroalcholic 
extract (450 g), cold (CH3)2CO (1.0 l) was added, and the mixture was placed on a stirring 
plate overnight at -18 °C. The (CH3)2CO addition led to heavy precipitation consisting mostly 
of proteinaceous material, which was removed by centrifugation. The solution was 
concentrated and successively chromatographed on Amberlite XAD-2, eluting with H2O, 
CH3OH, and (CH3)2CO. 
Fraction eluted with H2O was lyophilized (1.9 g), and the crude extract was subjected to silica 
gel flash column chromatography [CH2Cl2 - CH3OH - H2O (14:6:1)] to afford eight fractions. 
Fraction 1 was purified by reverse phase C-18 HPLC [CH3OH - H2O (9:1)] to give pure 35 (14 
mg). 
The fraction eluted with CH3OH (45.0 g) was rechromatographed on silica gel column with 
CH2Cl2 and increasing CH3OH. Fractions of 250 ml were collected and those with similar TLC 
profiles were combined to give thirteen fractions.  
Fraction 4 (13.5 g), eluted with CH2Cl2 - CH3OH (4:1), was purified by silica gel flash column 
chromatography (CH2Cl2 - CH3OH gradient) to give fractions A-F. Fraction A (20 mg), eluted 
with CH2Cl2, was purified by reverse phase C-18 HPLC [CH3OH - CH3CN - H2O (3:2:5)] to 
afford 19 (3 mg). Purification of fraction E (33 mg) by reverse phase C-18 HPLC [CH3OH - 
CH3CN - H2O (3:1:6)] gave 6 (10 mg) and 7 (3 mg). Fraction F (103 mg) was identified as 
pure 26 (103 mg).  
Fraction 5 (5.5 g), eluted with CH2Cl2 - CH3OH (7:3), was rechromatographed on silica gel 
flash column eluting with CH2Cl2 - AcOEt - CH3OH gradient to afford fractions A-I. Fraction 
A (91 mg) eluted with CH2Cl2  - AcOEt (4:1) was purified by preparative TLC [petrol ether - 
(CH3)2CO (3:1)], to give 22 (8 mg). Fraction B (210 mg), eluted with AcOEt - CH3OH (17:3), 
was purified by preparative TLC [CH2Cl2 - CH3OH (9:1)] to afford 4 (20 mg); fraction F (52 
mg), eluted with AcOEt - CH3OH (4:1), was purified by preparative TLC [CH2Cl2 - CH3OH 
(3:1)] to give 3 (6 mg).  
Fraction 13 (5.5 g), eluted with CH3OH, was repeatedly chromatographed on silica gel column 
with CH2Cl2 - CH3OH gradient to give crude 18 which was purified by reverse phase C-18 
HPLC [CH3OH - CH3CN - H2O (3:2:5)] (4 mg). 
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Fraction eluted with (CH3)2CO (50.0 g) was rechromatographed on silica gel column eluting 
with CH2Cl2 - (CH3)2CO - CH3OH gradient to give eleven fractions.  
Fraction 1 (2.0 g), eluted with CH2Cl2, was purified by silica gel flash column chromatography 
[CH2Cl2 - (CH3)2CO gradient)] to provide fractions A-M. Fraction M (45 mg), eluted with 
(CH3)2CO, was purified by preparative TLC [CH2Cl2 - (CH3)2CO (4:1)] to yield 16 (2 mg) and 
17 (3 mg).  
Fraction 2 (1.5 g), eluted with CH2Cl2 - (CH3)2CO (4:1), was purified by silica gel flash 
column chromatography [petrol ether - (CH3)2CO gradient)] to give fractions A-O. Fraction D 
(103 mg), eluted with petrol ether - (CH3)2CO (4:1), was purified by reverse phase C-18 HPLC 
[CH3OH - CH3CN - H2O (2:2:3)] to give 30 (2 mg) and 31 (4 mg). Fraction G (103 mg), eluted 
with petrol ether- (CH3)2CO (3:1) was purified by reverse phase C-18 HPLC [CH3OH - 
CH3CN - H2O (1:1:3)] to give 29 (8 mg) and 34 (7 mg).  
Fraction 3 (4.3 g), eluted with CH2Cl2 - (CH3)2CO (3:2), was rechromatographed on silica gel 
flash column eluting with CH2Cl2 - (CH3)2CO  gradient to afford fractions A-I. Fraction D (51 
mg), eluted with CH2Cl2 - (CH3)2CO (9:1), was purified by preparative TLC [CHCl3 - CH3OH 
(9:1)] and reverse phase C-18 HPLC [CH3OH - CH3CN - H2O (3:1:6)], to give 37 (8 mg). 
Fraction E (28 mg) eluted with CH2Cl2 - (CH3)2CO  (7:3) was purified by reverse phase C-18 
HPLC [CH3OH - CH3CN - H2O (6:3:11)], to give 36 (11 mg), 40 (2 mg), and 39 (3 mg) 
respectively. Fraction H (56 mg) was purified by preparative TLC [CH2Cl2 - (CH3)2CO (4:1)] 
affording pure 9 (28 mg). 
Fraction 6 (5.0 g) eluted with CH2Cl2 - CH3OH (1:1) was rechromatographed on silica gel flash 
column eluting with CH2Cl2 - (CH3)2CO - CH3OH gradient to afford fractions A-Q. Fraction L 
(498 mg) eluted with CH2Cl2 - CH3OH (4:1) was rechromatographed on silica gel flash column 
eluting with AcOEt - (CH3)2CO - CH3OH gradient to afford 11 fractions. Fraction eluted with 
AcOEt - (CH3)2CO (9:1) was purified by reverse phase C-18 HPLC [H2O - CH3OH (1:1)], to 
give 25 (4 mg). Fraction O (2.3 g) eluted with (CH3)2CO - CH3OH (1:1) was 
rechromatographed on silica gel flash column, eluting with CH2Cl2 - (CH3)2CO - CH3OH 
gradient to afford 9 subfractions. The first subfraction (23 mg), eluted with CH2Cl2, was 
purified by reverse phase C-18 HPLC [CH3OH - CH3CN - H2O - AcOH (1:5:4:0.1)] to afford 
28 (10 mg). The second subfraction  (13 mg), eluted with CH2Cl2 - (CH3)2CO (9:1), contained 
27 (13 mg). The third subfraction (46 mg) eluted with CH2Cl2 - (CH3)2CO (4:1) was purified 
by preparative TLC [petrol ether - (CH3)2CO (3:1)], to give 24 (4 mg) and 11 (15 mg). The 
forth subfraction (160 mg), eluted with CH2Cl2 - AcOEt (3:1), provided 10 (52 mg), 23 (9 mg), 
and 21 (11 mg) after purification by reverse phase C-18 HPLC [CH3OH - CH3CN - H2O 
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(3:1:6)]. The fifth subfraction (250 mg), eluted with CH2Cl2 - AcOEt (1:1), gave 12 (10 mg), 
13 (14 mg), and 14 (18 mg), after purification by reverse phase C-18 HPLC [CH3OH - CH3CN 
- H2O (3:2:5)].  
Fraction 8 (6.0 g) eluted with CH3OH was rechromatographed on silica gel flash column  
eluting with  (CH3)2CO - CH3OH gradient to afford fractions A-G. Fraction F (292 mg) eluted 
with (CH3)2CO - CH3OH (1:1) was rechromatographed on silica gel flash column eluting with 
(CH3)2CO - CH3OH (7:3) to afford fractions A-F. Fraction B (76 mg) was purified by 
preparative TLC [(CH3)2CO - CH3OH - H2O (35:14:1)], to give 20 (8 mg), and finally fraction 
D (20 mg) was purified by reverse phase C-18 HPLC column [H2O - CH3OH (1:1)], to give 38 
(5 mg). 
 
Twigs extract fractionation. 
Twigs of A. cordifolia (1.5 kg) were powdered and then extracted with H2O - CH3OH (9:1) at 
25 °C for 7 days. To an aqueous suspension (100 ml) of the crude extract (45.0 g), cold 
(CH3)2CO (100 ml) was added, and the mixture was placed on a stirring plate overnight at -18 
°C. Addition of (CH3)2CO led to the precipitation of mostly proteinaceous material, which was 
removed by centrifugation. The (CH3)2CO was removed by evaporation, and the resulting clear 
aqueous extract was reduced to a volume of 150 ml, and then separated by Amberlite XAD-2 
with  H2O, CH3OH, and (CH3)2CO. The fraction eluted with CH3OH (12.0 g) was purified by 
silica gel flash column chromatography to afford ten fractions. Fraction 1 (1.8 g), eluted with 
petrol ether - (CH3)2CO (3:1), was purified by silica gel flash column chromatography using 
CH2Cl2 - (CH3)2CO gradient to give fractions A-F. Fraction A (16 mg) was purified by reverse 
phase C-18 HPLC [CH3OH - CH3CN - H2O (2:1:2)] to afford 32 (2 mg), 2 (1 mg), and 33 (2 
mg). Fraction B (206 mg), eluted with CH2Cl2 - (CH3)2CO (4:1), was purified by silica gel 
flash column chromatography eluting with CH2Cl2 - ethyl ether gradient to give 5 subfractions. 
The third subfraction (35 mg) was purified by preparative TLC [CH2Cl2 - ethyl ether (4:1)] to 
provide 1 (8 mg) and 8 (3 mg). Fraction D (110 mg), eluted with CH2Cl2 - (CH3)2CO (7:3), 
was purified by silica gel flash column chromatography  eluting with CH2Cl2 - CH3OH (99:1) 
to afford six subfractions. The second subfraction (48 mg) was purified by preparative TLC 
[CH2Cl2 - CH3OH (19:1)] to give 5 (8 mg) and 15 (9 mg). 
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2.3. Extraction and isolation of compounds from Oxalis pes-caprae  
 
Leaves and twigs of Oxalis pes-caprae were collected in Bacoli-Naples, Italy, in April 2005, 
and identified by Prof. Antonino Pollio, Dipartimento di Biologia Vegetale of the University of 
Naples. A voucher specimen was deposited at the Botanical Gardens of the University Federico 
II of Naples, Italy. 
Fresh leaves and twigs (20 kg) were infused with EtOAc and, successively, with CH3OH for 7 
days at room temperature (25 °C).  
The EtOAc extract was concentrated by evaporation and fractionated into acidic and neutral 
fractions with aqueous NaOH 2M. The neutral fraction, washed with H2O and concentrated 
under vacuum (70 g), was chromatographed on silica gel column to give twenty-eight 
fractions. 
Fraction 3 (6.2 g), eluted with petrol ether - (CH3)2CO (17:3), was rechromatographed by silica 
gel column. The fraction eluted with petrol ether - EtOAc (4:1) contained compound 45, that 
was purified by silica gel flash column chromatography with petrol ether - (CH3)2CO (9:1), (10 
mg). 
Fraction 12 (2.2 g), eluted with petrol ether - (CH3)2CO (7:3), was rechromatographed on silica 
gel column. The fraction eluted with CH2Cl2 - (CH3)2CO (97:3) contained compounds 46 and 
54, that were purified by preparative TLC [petrol ether - (CH3)2CO (7:3), 11 and 4 mg]. 
Fraction 18 (7.3 g), eluted with CH2Cl2, was rechromatographed on silica gel column. The 
fraction eluted with CH2Cl2 - (CH3)2CO (19:1) containing compounds 44, 48, and 49, was 
purified by preparative TLC [CH2Cl2 - (CH3)2CO (9:1)], to obtain fractions A-D. Fraction A 
(22 mg), contained compound 44, that was purified by reverse phase C-18 HPLC [H2O - 
CH3OH - CH3CN (3:1:1), 3 mg]. Fraction B (15 mg) contained compound 48 that was purified 
by reverse phase C-18 HPLC [H2O - CH3OH - CH3CN (3:3:4), 2 mg]. Fraction C (15 mg) 
contained compound 49 that was purified by reverse phase C-18 HPLC [H2O - CH3OH - 
CH3CN (4:3:3), 2 mg].  
Fraction 20, eluted with CH2Cl2 - (CH3)2CO (23:2) contained compounds 57 and 59 that were 
purified by preparative TLC [CH2Cl2 - (CH3)2CO (23:2), 5 and 7 mg, respectively]. 
Fraction 22 (2.2 g), eluted with (CH3)2CO, was rechromatographed on silica gel column. The 
fraction eluted with CH2Cl2 - (CH3)2CO (17:3) contained compounds 56 and 58, that were 
purified by reverse phase C-18 HPLC [H2O - CH3OH - CH3CN (4:3:3), 3 and 5 mg, 
respectively]. 
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The MeOH extract was concentrated and partitioned between EtOAc and H2O. The crude 
EtOAc residue (37 g) was chromatographed on silica gel eluting with petrol ether, ethyl ether, 
CH2Cl2, EtOAc, (CH3)2CO, CH3OH, and H2O to give thirty-five fractions. 
Fraction 4 (480  mg), eluted with petrol ether - ethyl ether (19:1), was rechromatographed on 
silica gel eluting with petrol ether and (CH3)2CO to give fractions A-E. Fraction B (40 mg), 
eluted with petrol ether - (CH3)2CO (9:1), was subjected to TLC [petrol ether - (CH3)2CO 
(4:1)] to give resorcinol (1,3-dihydroxybenzene) 60 (4.5 mg) and  compound 53 (6.9 mg). 
Fraction 10 (5.8 g), eluted with petrol ether - ethyl ether (9:1), was rechromatographed on silica 
gel eluting with petrol ether, ethyl ether, EtOAc, and CH3OH to give fractions A-R. Fraction A 
(30 mg), eluted with petrol ether - ethyl ether (17:3), was subjected to TLC [petrol ether-
(CH3)2CO, (4:1)] to give methyl 4-hydroxycinnamate 64 (18.5 mg) and compound 41 (5 mg). 
Fraction 11 (850 mg), eluted with petrol ether - ethyl ether (4:1), was rechromatographed on 
silica gel eluting with petrol ether and ethyl ether to give fractions A-G. Fraction C (34 mg), 
eluted with petrol ether - ethyl ether (9:1), was subjected to TLC [petrol ether - (CH3)2CO, 
(3:1)] to give 4-hydroxybenzyl alcohol 61 (1.5 mg), 43 (4.1 mg), and 47 (3 mg).  
Fraction 12 (2.2 g), eluted with petrol ether - (CH3)2CO (17:3), was rechromatographed on 
silica gel eluting with petrol ether, ethyl ether, and (CH3)2CO to give fractions A-S. Fraction C 
(80 mg), eluted with ethyl ether - (CH3)2CO (4:1), was subjected to TLC [petrol ether - 
(CH3)2CO, (7:3)] to give 3-methoxy-4-hydroxybenzoic acid 62 (8.5 mg), 4-hydroxycinnamic 
acid 63 (4.5 mg), and compound 51 (4 mg). 
Fraction 14 (134 mg), eluted with petrol ether - (CH3)2CO (4:1), was rechromatographed on 
silica gel eluting with petrol ether, EtOAc, and (CH3)2CO to give fractions A-F. Fraction B (65 
mg), eluted with petrol ether - EtOAc (4:1), was subjected to Sep-Pak [CH3CN - CH3OH - 
H2O, (2:1:2)] to give compound 42 (4.0 mg). 
Fraction 20 (3.2 g), eluted with CH2Cl2 - EtOAc (4:1), was rechromatographed on silica gel 
eluting with CH2Cl2, (CH3)2CO, and CH3OH to give fractions A-Q. Fraction B (50 mg), eluted 
with CH2Cl2 - (CH3)2CO (19:1), was subjected to TLC [petrol ether - (CH3)2CO, (7:3)] to give 
sinapic acid 65 (28.5 mg) and compound 52 (11 mg). Fraction E (40 mg), eluted with CH2Cl2 - 
CH3OH (9:1), was subjected to TLC [CH2Cl2 - CH3OH (22:3)], to give caffeic acid 66 (16.5 
mg), 50 (5 mg), and 55 (5 mg). 
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2.4. Extraction and isolation of compounds from Swinlea glutinosa 
 
Dried roots (100 g) of Swinlea glutinosa were extracted at room temperature (25 °C) with 
EtOAc (1 l) twice for 12 h. After evaporation under reduced pressure at 40 oC, the extract was 
fractionated by silica gel flash column chromatography eluting with hexane and EtOAc starting 
from 10% of  EtOAc up to 100%, and finally with EtOAc - CH3OH (19:1). Fractions with 
similar TLC profiles were combined to yield sixteen fractions. 
Fractions 1 e 2 were combined and purified by silica gel column chromatography with  hexane 
- EtOAc  (19:1) to afford fractions A-F. Fraction B was determined to be pure 69 (125 mg). 
Fraction D was further purified by HPLC [hexane  - ethyl ether (4:1)] to give 68 (45 mg) and 
67 (40 mg). 
Fraction 4 was purified by crystallization from hexane and EtOAc to afford 77 (25 mg). 
Further purification of fraction 6, by silica gel column chromatography [(CH3)2CO - hexane 
(1:9)] and TLC plates [CH2Cl2 - ethyl ether (19:1)], gave pure 78 (14 mg), 76 (10 mg), 73 (6 
mg), 71 (17 mg), and 75 (21 mg). 
Fraction 10 was rechromatographed on silica gel column eluting with CH2Cl2 - ethyl ether 
(97:3) affording 74 (7 mg) and 72 (20 mg). 
Fraction 11 was rechromatographed on silica gel column eluting with  CH2Cl2 - ethyl ether 
(19:1) to give 11 subfractions. The ninth subfraction was purified by TLC [CH2Cl2 - (CH3)2CO 
(9:1)] to yield pure 70 (3 mg). 
 
 
2.5. Extraction and isolation of compounds from Amirys madrensis 
 
Dried leaves (400 g) of A. madrensis were ground in a blender. Ground plant material was 
extracted at room temperature with hexane (2 l) twice for 12 h. Following filtration through 
filter paper, the combined hexane extract was concentrated by evaporation under reduced 
pressure at 40o C to afford 13.3 g of extract. Dried material was subsequently extracted with 
EtOAc and CH3OH (4 l) providing 9.9 and 86 g of residue, respectively.  
The EtOAc extract was subjected to silica gel flash column chromatography using  hexane - 
EtOAc with increasing polarity. Fractions of 50 ml were collected and, on the basis of TLC 
similarities, were combined to produce twenty-seven fractions.  
Fraction 6 (430 mg) was rechromatographed on silica gel column eluting with hexane - EtOAc 
(19:1), to give 86 (120 mg) and 82 (35 mg). 
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Fraction 15 was an off-white residue, and this fraction was dissolved in EtOAc and precipitated 
with hexane to obtain a white powder that was further purified by crystallization to afford 
white crystals of 80 (160 mg). 
Fraction 19 (340 mg) was rechromatographed on silica gel column eluting with hexane - 
EtOAc 3:1 to afford fractions A-H. Fraction B was determined to be pure braylin 83 (35 mg). 
Fraction F (80 mg) was purified on silica gel column with CH2Cl2  - EtOAc  (19:1)  to provide 
84 (15 mg). 
Fraction 20 (610 mg) was rechromatographed on silica gel column eluting with hexane - 
(CH3)2CO (9:1) affording 85 (14 mg). 
Fraction 21 was dissolved in CH3OH and precipitated with EtOAc to obtain a white powder 
that was further purified by crystallization to afford white crystals of 81 (230 mg). The mother 
liquor (250 mg) was rechromatographed on silica gel column eluting with hexane - (CH3)2CO 
(9:1) to provide fractions A-G. Fractions E and F were combined (120 mg) and further purified 
using silica gel column chromatography with CH2Cl2  - EtOAc  (9:1) to afford 79 (21 mg). 
 
 
2.6. Bioassays 
 
Phytotoxic activity 
Pendimethalin, bioassayed as commercial mixture (Pendulum®) supplied by Ingegnoli Spa 
(Milano, Italy). Seed of Lactuca sativa L. (cv Cavolo di Napoli) were obtained from Ingegnoli 
Spa. All undersized or damaged seeds were discarded and the assay seeds were selected for 
uniformity. For the bioassays we used Petri dishes with one sheet of  Whatman No. 1 filter 
paper as support. In four replicate experiments, germination and growth were conducted in 
aqueous solutions at controlled pH. Test solutions (10-4
 
M) were prepared using MES (2-[N-
Morpholino]ethanesulfonic acid, 10 mM, pH 6) and the rest (10-5
 
- 10-7
 
M) were obtained by 
dilution. Parallel controls were performed. After adding 25 seeds and 2.5 ml of test solutions 
the Petri dishes were sealed with Parafilm® to ensure closed-system models. Seeds were 
placed in a KBW Binder 240 growth chamber at 25 °C in the dark. Germination percentage 
was determined daily for 5 days. After growth, the plants were frozen at -20 °C to avoid 
subsequent growth until the measurement process. Data are reported as percentage differences 
from control in the graphics. Thus, zero represents the control, positive values represent 
stimulation of the parameter studied and negative values represent inhibition.  
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Antifungal activity 
Bioautography on silica gel TLC plates with Colletotrichum fragariae was used to identify the 
antifungal activity according to the previously published method.20 Crude extracts and pure 
compounds from A. madrensis were applied to silica gel TLC plates and allowed to migrate in 
a suitable solvent. Each plate, dried, was subsequently sprayed with a spore suspension (105 
spores/ml) of the fungus of interest and was incubated in a moisture chamber for 3 days at 26 
°C with a 12 h photoperiod. The presence of antifungal constituents was indicated by clear 
zones of fungal growth inhibition on the TLC plates. 
 
Algicide activity 
Culture of the cyanobacterium O. perornata and of the green alga S. capricornutum were 
maintained separately in continuous, steady-state growth using the conditions outlined in 
Schrader et al.21 to provide a source of cells growing at fairly constant rate. Stock solutions 
(2.0, 20.0, 200.0, and 2000.0 μM) of pure compounds were micropipeted to the empty wells 
(10 μM/well) of a 96-well microplate. The solvent was allowed to evaporate completely before 
adding continuous culture sample material (200 μM/well). Final concentrations for each pure 
compounds were 0.1, 1.0, 10.0, and 100.0 μM. Control did not include any test material, only 
culture material. Three replications were used for each concentration of pure compounds and 
the control. Microplates were placed in a growth chamber held at 29-30 °C and were 
illuminated continuously by fluorescent lights (40W, cool white) at a photon flux density of 
21-27 μE m-2 s-1. Absorbance measurements of each well were measured at 650 nm at 24 h 
intervals for 4 days using a Packard model SpectraCount microplate photometer. Mean values 
and standard deviations of absorbance measurements were calculated and graphed to determine 
the lowest observed effect concentration (LOEC) and the lowest complete inhibition 
concentration (LCIC). 
 
Acetylcholinesterase inhibitory activity22
Acetylcholinesterase and galanthamine were purchased from Sigma, bovine serum albumin 
and 1-naphtyl acetate were obtained from Merk and Fast Blue B salt was from Fluka. 
Acetylcholinesterase was dissolved in 150 ml of Tris-hydrochloric acid buffer at pH 7.8, 
bovine serum albumin (150 mg) was added and the solution was kept at 4 °C. After migration 
of the samples in a suitable solvent, the TLC plates were dried, sprayed with the enzyme stock 
solution and dried again. The plates were incubated at 37 °C for 20 min in a humid atmosphere. 
10 ml of naphtyl acetate solution (prepared with 250 mg of naphtyl acetate in 100 ml of 
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ethanol) and 40 ml of the Fast Blue B salt solution (400 mg of Fast Blue B salt in 160 ml of 
distilled water) were mixed and sprayed onto the plates to give a purple coloration after 1-2 
min. 
 
 
2.7. Photooxidations 
 
Methylene blue (MB)-sensitized photooxygenation of isoeugenol 87a 
Each solution of 87a (100 mg, 0.61 mmol) was added of MB (22 mg, 0.06 mmol), and 
irradiated at 15 °C with a halogen lamp. During irradiation, dry oxygen was bubbled 
through the solution. Irradiation times, solvents, and concentrations are reported in Table 1. 
After solvent evaporation, chromatography of each residue on silica gel TLC [hexane - 
EtOAc (7:3)] followed by reverse phase C-18 HPLC column [H2O - MeOH - MeCN 
(4:3:3)] led to compounds 88a, 89, 90, 91, and 96, with the yields reported in Table 1. All 
products were spectroscopically characterized (IR, NMR, MS) and known compounds were 
identified by comparison of spectral data with those reported.  
 
          Table1. Methylene blue-sensitized photooxygenation of isoeugenol 87a, at 15 °C under different conditions 
  
Conc. 
(M) 
Solvent Time 
(h) 
Isolated Yield (%) 
   87a 88a 89 90 91 92 
0.36 CH2Cl2 30 3 30 15 - 3 trace 
0.1 CH2Cl2 12 50 20 10 - trace trace 
0.36 CH3CN 30 30 20 10 - trace trace 
0.1 CH3CN 12 50 15 15 - trace - 
0.1 H2O 12 50 4 5 20 trace 2 
0.1 H2O-CH3CN 
(2:1) 
12 40 22 8 8 4 - 
 
 
            
Irradiation of isoeugenol 87a with di-tert-butyl peroxide  
To a solution of 87a (100 mg, 0.61 mmol) in  CH3CN dry (0.05 M) 0.23 ml of di-tert-butyl 
peroxide (two equivalents) were added. The sample was bubbled with a slow stream of 
argon for 30 min before the UV irradiation. After 14 h of irradiation the residue was 
analyzed by 1H NMR. Chromatography purifications gave 88a (~20%) and trace of 
compounds 89 and 91.  
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 Irradiation of isoeugenol 87a with chloranil 
24.5 mg of chloranil were added to a solution of 87a (50 mg, 0.30 mmol) in  CH3CN dry 
(0.015 M). The sample was bubbled with a slow stream of argon for 30 min before the UV 
irradiation. After 8 h of irradiation the residue was analyzed by 1H NMR. Chromatography 
purifications gave 88a (~20%). 
 
Methylene blue-sensitized photooxygenation of coniferyl alcohol 87b and ferulic acid 87c  
Solutions of 87b (100 mg, 0.56 mmol) and 87c (100 mg, 0.52 mmol) in H2O - CH3CN (2:1) 
(0.1 M) were irradiated at 15 °C with a halogen lamp as above described for 87a. During 
irradiation oxygen was bubbled through the solutions.  
After 20 h 1H NMR analysis of the residue from 87b indicated the presence of compound 
89 as the only product. The 1H NMR spectrum of the residue from 87c showed the presence 
of starting 87c (80%) and its cis-isomer (20%). 
 
Irradiation of coniferyl alcohol 87b and ferulic acid 87c with di-tert-butyl peroxide 
To a solution of 87b (50 mg, 0.28 mmol) in  dry CH3CN (0.05 M) 0.11 ml of di-tert-butyl 
peroxide were added. The sample was bubbled with a slow stream of argon for 30 min 
before the UV irradiation. After 14 h of irradiation the residue was analyzed by 1H NMR. 
The mixture was purified by reverse phase C-18 HPLC column [H2O – MeOH - MeCN 
(5:3:2)], to give compounds 88b (30%) and 7 (10%).   
Acid 87c was treated similarly. After 14 h irradiation, the 1H NMR spectrum of the residue 
showed the presence of starting 87c (72%) and its cis-isomer (28%). 
 
  
 
 23
2.8. Spectroscopic data 
 
Compound 16. (-)-Pinoresinol (2 mg). [α]D25 = -10.0° (c 9.0, CHCl3). MS: m/z 358 [M]+. 1H 
NMR (CDCl3) δ: 6.82 (6H, m, H-6 and H-6’, H-5 and H-5’, H-2 and H-2’), 4.74 (2H, d, J=4.0 
Hz, H-7 and H-7’), 4.25 (2H, dd, J=9.0 and 7.0 Hz, H-9a and H-9’a), 3.88 (2H, dd, J=9.0 and 
4.0 Hz, H-9b and H-9’b), 3.10 (2H, m, H-8 and H-8’), 3.91 (6H, s, 3-OMe and 3’-OMe). 13C 
NMR (CD3OD) δ: 146.7 (C-3 and C-3’), 145.2 (C-4 and C-4’), 132.9 (C-1 and C-1’), 118.9 
(C-6 and C-6’), 114.3 (C-5 and C-5’), 108.6 (C-2 and C-2’), 85.8 (C-7 and C-7’), 71.6 (C-9 
and C-9’), 54.1 (C-8 and C-8’), 55.9 ( 3-OMe and 3’-OMe). 
 
Compound 17. (±)-Syringaresinol (3 mg). [α]D25 = 0° (c 3.5, CHCl3). MS: m/z 418 [M]+. 1H 
NMR (CDCl3) δ: 6.57 (4H, s, H-2, H-5, H-2’ and H-5’), 4.72 (2H, d, J=4.0 Hz, H-7 and H-7’), 
4.26 (2H, m, H-9a and H-9’a), 3.61 (2H, m, H-9b and H-9’b), 3.09 (2H, m, H-8 and H-8’), 
3.89 (12H, s, 3-OMe, 3’-OMe, 5-OMe, 5’-OMe). 
 
Compound 18. Di-erythro-syringylglycerol-β-O-4,4'-syringaresinol ether (4 mg).  [α]D25 = 
+3.1 (c = 0.05, CH2Cl2). MALDI-MS: m/z 893 [M + Na]+. 1H NMR (CDCl3) δ: 6.65 (4H, s, H-
2, H-6, H-2’ and H-6’), 6.58 (4H, s, H-2’’, H-6’’, H-2’’’ and H-6’’’), 4.99 (2H, d, J=4.0 Hz, H-
7’’ and H-7’’’), 4.79 (2H, d, J=2.8 Hz, H-7 and H-7’), 4.36 (2H, dd, J=7.6 and 14.8 Hz, H-9a 
and H-9’a), 4.13 (2H, m, H-8’’ and H-8’’’), 3.99 (2H, m, H-9b and H-9’b), 3.88 (2H, m, H-
9’’a and H-9’’’a), 3.50 (2H, dd, J=2.4 and 12.0 Hz, H-9’’b and H-9’’’b), 3.15 (2H, m, H-8 and 
H-8’), 3.90 (12H, s, 3-OMe, 3’-OMe, 5-OMe, 5’-OMe), 3.88 (12H, s, 3’’-OMe, 3’’’-OMe, 5’’-
OMe, 5’’’-OMe). 13C NMR (CDCl3) δ: 153.5 (C-3, C-3’, C-5 and C-5’), 147.1 (C-3’’, C-3’’’, 
C-5’’ and C-5’’’), 137.6 (C-4 and C-4’), 136.0 (C-4’’ and C-4’’’), 134.2 (C-1 and C-1’), 130.4 
(C-1’’ and C-1’’’), 102.9 (C-2, C-2’, C-6, and C-6’), 102.6 (C-2’’, C-2’’’, C-6’’, and C-6’’’), 
87.1 (C-7’’ and C-7’’’), 85.8 (C-7 and C-7’), 72.7 (C-8’’ and C-8’’’), 72.0 (C-9 and C-9’), 60.6 
(C-9’’ and C-9’’’), 54.5 (C-8 and C-8’), 56.4 and 56.3 (3-OMe, 3’-OMe, 3’’-OMe, 3’’’-OMe, 
5-OMe, 5’-OMe, 5’’-OMe, and  5’’’-OMe).  
 
Compound 19. 4-(4-Formylphenoxy)-3-methoxybenzaldehyde (3 mg). MS: m/z 256 [M]+. 1H 
NMR (CD3OD) δ: 9.75 (1H, s, H-7’), 9.72 (1H, s, H-7), 7.77 (2H, d, J=8.8 Hz, H-2’ and H-6’), 
7.43 (1H, s, H-2), 7.41 (1H, d, J=7.0 Hz, H-7), 6.91 (1H, d, J=7.0 Hz, H-5), 6.88 (2H, d, J=8.8 
Hz, H-3’ and H-5’), 3.92 (3H, s, 3-OMe). 13C NMR (CD3OD) δ: 193.3 (C-7 and C-7’), 164.6 
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(C-4’), 156.0 (C-4), 149.7 (C-3), 134.0 (C-2’), 131.1 (C-1’), 129.3 (C-1), 128.8 (C-6), 117.6 
(C-3’ and C-5’), 117.1 (C-5), 111.7 (C-2), 56.9 (3-OMe).  
 
 
Compound 20. 4,4′-Oxyneolign-9,9′-dioic acid (8 mg). UV λmax (CH3OH) nm: 278 (log ε 3.2). 
MALDI-MS: m/z 337 [M+Na]+. 1H NMR (CD3OD) δ: 6.92 (4H, d, J=8.5 Hz, H-2 and H-2’, H-
6 and H-6’), 6.63 (4H, d, J=8.5 Hz, H-3 and H-3’, H-5 and H-5’), 2.84 (4H, t, J=8.1 Hz, H-7 
and H-7’) 2.66 (4H, t, J=8.1 Hz, H-8 and H-8’). 13C NMR (CD3OD) δ: 180.6 (C-9 and C-9’), 
157.4 (C-4 and C-4’), 130.7 (C-2, C-2’, C-6, and C-6’) 129.6 (C-1 and C-1’), 116.6 (C-3, C-3’, 
C-5 and C-5’), 42.9 (C-8 and C-8’), 35.7 (C-7 and C-7’).  
 
Compound 21. 3-Methoxy-4,4′-oxyneolign-9,9′-dioic acid (11 mg). UV λmax (CH3OH) nm: 
280 (log ε 2.2). MALDI-MS: m/z 390 [M+2Na]+. 1H NMR (CD3OD) δ: 7.05 (2H, d, J=8.5 Hz, 
H-2’ and H-6’), 6.82 (1H, d, J=8.2 Hz, H-5), 6.74 (2H, d, J=8.5 Hz, H-3’ and H-5’), 6.72 (1H, 
d, J=1.5 Hz, H-2), 6.70 (1H, dd, J=1.5 and 8.2 Hz, H-6) 2.89 (4H, t, J=8.0 Hz, H-7 and H-7’) 
2.66 (4H, t, J=8.0 Hz, H-8 and H-8’), 3.86 (3H, s, 3-OMe). 13C NMR (CD3OD) δ: 178.9 (C-9 
and C-9’), 154.1 (C4’), 146.4 (C-3), 144.0 (C-4), 132.1 (C-1 and C-1’), 129.4 (C-2’ and C-6’), 
120.8 (C-6), 115.4 (C-3’ and C-5’), 114.4 (C-5), 111.0 (C-2), 55.8 (3-OMe), 35.8 (C-8 and C-
8’), 30.3 (C-7 and C-7’).  
 
Compound 22. Dimethyl 3-methoxy-4,4′-oxyneolign-9,9′-dioate (8 mg). UV λmax (CH3OH) 
nm: 280 (log ε 3.1). MALDI-MS: m/z 373 [M+H]+. 1H NMR (CDCl3) δ: 7.05 (2H, d, J=9.0 Hz, 
H-2’ and H-6’) 6.83 (1H, d, J=8.0 Hz, H-5), 6.75 (2H, d, J=9.0 Hz, H-3’ and H-5’), 6.70 (1H, 
d, J=1.5 Hz, H-2), 6.68 (1H, dd, J=1.5 and 8.0 Hz, H-6) 2.88 (4H, t, J=7.5 Hz, H-7 and H-7’) 
2.61 (4H, t, J=7.5 Hz, H-8 and H-8’), 3.87 (3H, s, 3-OMe), 3.67 (6H, s, 9-OMe and 9’-OMe). 
13C NMR (CDCl3) δ: 173.8 (C-9 and C-9’), 154.4 (C4’), 146.7 (C-3), 144.2 (C-4), 132.7 (C-1 
and C-1’), 129.6 (C-2’ and C-6’), 121.0 (C-6), 115.5 (C-3’ and C-5’), 114.6 (C-5), 110.2 (C-2), 
56.1 (3-OMe), 51.9 (9-OMe and 9’-OMe), 36.3 (C-8 and C-8’), 30.9 (C-7 and C-7’). 
 
Compound 23. 3,3′,5-Trimethoxy-4,4′-oxyneolign-9,9′-dioic acid (9 mg). UV λmax (CH3OH) 
nm: 321 (log ε 0.9), 280 (2.6), 242 (2.5). MALDI-MS: m/z 427 [M+Na]+. 1H NMR (CDCl3) δ: 
6.82 (1H, d, J=8.5 Hz, H-5’), 6.70 (1H, d, J=8.5 Hz, H-6’), 6.44 (2H, s, H-2 and H-6), 2.90 
(4H, t, J=7.5 Hz, H-7 and H-7’) 2.67 (4H, t, J=7.5 Hz, H-8 and H-8’), 3.87 (9H, s, 3-OMe, 3’-
OMe, and 5-OMe). 13C NMR (CDCl3) δ: 177.8 (C-9 and C-9’), 146.9 (C-3, C-3’, and C-5), 
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144.0 (C-4’), 133.1 (C-1), 131.9 (C-4), 131.2 (C-1’), 120.7 (C-6’), 114.3 (C-5’), 110.8 (C-2’), 
104.8 (C-2 and C-6), 55.7 (3’-OMe), 56.1 (3-OMe and 5-OMe), 35.7 (C-8 and C-8’), 30.7 (C-7 
and C-7’).  
 
Compound 24. 3,3′,5,5′-Tetramethoxy-4,4′-oxyneolign-9,9′-dioic acid (4 mg). UV λmax 
(CH3OH) nm: 322 (log ε 1.5), 279 (3.0), 244 (2.8). MALDI-MS: m/z 457 [M+Na]+. 1H NMR 
(CDCl3) δ: 6.42 (4H, s, H-2 and H-2’, H-6 and H-6’), 2.88 (4H, t, J=8.0 Hz, H-7 and H-7’), 
2.61 (4H, t, J=8.0 Hz, H-8 and H-8’), 3.88 (12H, s, 3-OMe and 3’-OMe, 5-OMe and 5’-OMe). 
13C NMR (CDCl3) δ: 178.4 (C-9 and C-9’), 147.0 (C-3 and C-3’, C-5 and C-5’), 145.2 (C-4 
and C-4’), 132.0 (C-1 and C-1’), 104.9 (C-2 and C-2’, C-6 and C-6’), 56.3 (3-OMe and 3’-
OMe, 5-OMe and 5’-OMe), 36.1 (C-8 and C-8’), 31.2 (C-7 and C-7’). 
 
Compound 25. 3′-Methoxy-2,4′-oxyneolign-9,9′-dioic acid (4 mg).  UV λmax (CH3OH) nm: 
280 (log ε 1.4). MALDI-MS: m/z 390 [M+2Na]+. 1H NMR (CD3OD) δ:  7.23 (1H, m, H-4), 
7.21 (2H, m, H-3 and H-6), 7.12 (1H, m, H-5),  6.82 (1H, d, J=2.0 Hz, H-2’), 6.67 (1H, d, J=8.0 
Hz, H-5’), 6.63 (1H, dd, J=2.0 and 8.0 Hz, H-6’), 2.89 (2H, t, J=7.6 Hz, H-7), 2.82 (2H, t, 
J=7.8 Hz, H-7’), 2.44 (2H, t, J=7.6 Hz, H-8), 2.41 (2H, t, J=7.8 Hz, H-8’), 3.87 (3H, s, 3’-
OMe). 13C NMR (CD3OD) δ: 182.2 (C-9 and C-9’), 148.6 (C-3), 145.8 (C-4), 144.2 (C-2’) 
135.7 (C-1) 129.2 (C-3’, C-4’, and C-6’), 127.1 (C-1’), 126.6 (C-5’), 122.0 (C-6), 116.4 (C-5), 
113.5 (C-2), 56.5 (3-OMe), 41.9 (C-8), 41.6 (C-8’), 34.4 (C-7’), 34.0 (C-7).  
 
Compound 26. (Dimethylamino)-1-phenylethanol (103 mg). [α]D25 = +1.1 (c = 0.08, CH2Cl2). 
EI-MS: m/z 165 [M]+, 150 [M-Me]+. 1H NMR (CDCl3) δ: 7.40 (2H, d, J=7.0 Hz, H-2' and H-
6'), 7.35 (2H, t, J=7.0 Hz, H-3' and C-5'), 7.28 (1H, t, J=7.0, H-4'), 4.86 (1H, dd, J=3.5 and 9.5 
Hz, H-1), 2.81 (1H, dd, J=9.5 and 12.8 Hz, H-2a), 2.66 (1H, dd, J=3.5 and 12.8 Hz, H-2b), 2.35 
(6H, s, 2×Me). 13C NMR (CDCl3) δ: 144.5 (C-1'), 130.0 (C-3' and C-5'), 129.3 (C-4'), 127.6 
(C-2' and C-6'), 71.8 (C-1), 67.9 (C-2), 45.9 (2×Me ).  
 
Compound 34. (3R,9R)-3,9-Dihydroxymegastigm-5-en-4-one (7 mg). [α]D25 = –76.0 (c = 0.1, 
CH2Cl2). EI-MS: m/z 226 [M] +. 1H NMR (CDCl3) δ: 4.30 (1H, dd, J=5.8 and 14.0 Hz, H-3), 
3.94-3.85 (1H, m, H-9), 2.54-2.45 (1H, m, H-7a), 2.34-226 (1H, m, H-7b), 2.15 (1H, dd, J=5.8 
and 12.5 Hz, H-2a), 1.83 (3H, s, 13-Me), 1.77 (1H, br t, J=13.0 Hz, H-2b), 1.66-1.59 (2H, m, 
H-8), 1.29 (3H, s, 12-Me), 1.28 (3H, d, J=6.4Hz), 1.23 (3H, s, 11-Me). 13C NMR (CDCl3) δ: 
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200.2 (C-4), 166.1 (C-6), 127.9 (C-5), 69.1 (C-3), 68.2 (C-9), 45.3 (C-2), 37.7 (C-8), 37.5 (C-
1), 29.8 (C-11), 27.1 (C-7), 25.6 (C-12), 23.8 (C-10), 11.9 (C-13). 
 
Compound 35.  3-O-Methyl-chiro-inositol [(1R,2R,3S,4R,5S,6R)-6-Methoxycyclohexane-
1,2,3,4,5-pentol] (14 mg). [α]25D = +56 (c = 0.3, CHCl3). ESI-MS: m/z 195 [M+H]+. 1H NMR 
(CDCl3) δ: 3.91 (1H, dd, J=2.0 and 9.5 Hz, H-2), 3.89 (1H, d, J=2.0, H-6), 3.73 (1H, dd, J=2.0 
and 9.5 Hz, H-1), 3.72 (1H, dd, J=2.0 and 9.5 Hz, H-5), 3.58 (1H, t, J=9.5 Hz, H-4), 3.35 (3H, 
s, 3-OMe), 3.25 (1H, d, J=9.0 and 9.5 Hz, H-3). 13C NMR (CDCl3) δ: 85.4 (C-3), 74.8 (C-4), 
74.2 (C-1), 74.0 (C-6), 73.0 (C-5), 72.5 (C-2), 61.2 (Me).  
 
Compound 36. (2S,E)-N-[2-Hydroxy-2-(4-hydroxyphenyl)ethyl] ferulamide (11 mg). 
Colourless oil. [α]25D = -3.0 (c 0.12, CH3OH). IR νmax (CH2Cl2) 3580, 3400, 2940, 1705, 1670, 
1592, 1424, 1334, 1019 cm-1. UV λmax (CH3OH) nm (log ε): 222 (3.9), 294 (2.5), 316 (2.4). EI-
MS: m/z 329 [M]+. 1H NMR (CD3OD) δ: 7.44 (1H, d, J=15.8 Hz, H-7), 7.22 (2H, d, J=8.9, H-
2' and H-6'), 7.12 (1H, d, J=1.9 Hz, H-2), 7.03 (1H, dd, J=1.9 and 8.8 Hz, H-6), 6.79 (1H, d, 
J=8.8 Hz, H-5), 6.77 (2H, d, J=8.9 Hz, H-3' and H-5'), 6.45 (1H, d, J=15.8 Hz, H-8), 4.72 (1H, 
dd, J=4.9 and 7.8 Hz, H-7'),  3.87 (3H, s, 3-OMe), 3.53 (1H, dd, J=4.9 and 13.7 Hz, H-8'a), 
3.44 (1H, dd, J=7.8 and 13.7 Hz, H-8'b). 13C NMR (CD3OD) δ: 169.6 (C-9), 158.1 (C-4’), 
149.9 (C-3), 149.3 (C-4), 142.3(C-7), 134.5(C-1’), 128.4 (C-2’ and C-6’), 123.3 (C-6), 118.7 
(C-8), 116.5 (C-3’ and C-5’), 116.1 (C-5), 111.7 (C-2), 73.5 (C-7’), 56.4 (3-OMe), 48.1 (C-8’). 
 
Compound 37. (E)-N-[2-Hydroxy-2-(4-hydroxy-3-methoxyphenyl)ethyl] ferulamide (8 mg). 
Colourless oil. [α]25D = 0.0 (c 0.10, CH3OH). IR νmax (CH2Cl2) 3676, 3433, 3046, 2940, 1663, 
1601, 1512, 1424, 1057 cm-1. UV λmax (CH3OH) nm (log ε): 226 (2.9), 298 (1.2), 320 (1.1). EI-
MS m/z: 359 [M]+. 1H NMR (CD3OD) δ: 7.45 (1H, d, J=16.0 Hz, H-7), 7.13 (1H, d, J=1.5 Hz, 
H-2), 7.03 (1H, dd, J=1.5 and 8.5 Hz, H-6), 7.00 (1H, d, J=1.5 Hz, H-2'), 6.83 (1H, dd, J=1.5 
and 8.6 Hz, H-6'), 6.80 (1H, d, J=8.5 Hz, H-5), 6.77 (1H, d, J=8.6 Hz, H-5'), 6.47 (1H, d, 
J=16.0 Hz, H-8), 4.73 (1H, dd, J=4.9 and 7.8 Hz, H-7'),  3.88 (3H, s, 3-OMe), 3.86 (3H, s, 3'-
OMe), 3.54 (1H, dd, J=4.8 and 13.6 Hz, H-8'a), 3.44 (1H, dd, J=7.9 and 13.6 Hz, H-8'b); 13C 
NMR (CD3OD) δ: 170.0 (C-9), 150.5 (C-4’), 149.8 (C-3), 149.5 (C-4), 147.6 (C-3’), 142.8 (C-
7), 128.7 (C-1), 123.8 (C-6), 120.5 (C-6’), 119.1 (C-8), 117.0 (C-5’), 116.5 (C-5), 112.0 (C-2), 
111.3 (C-2’), 74.1 (C-7’), 56.9 (3 and 3’-OMe), 48.8 (C-8’). 
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Compound 38. (E)-N-[2-(4-Hydroxyphenyl)-2-propoxyethyl] ferulamide (5 mg). Colourless 
oil.  [α]25D = -2.0 (c 0.08, CH3OH). IR νmax (CHCl3) 3625, 3522, 3400, 2943, 1705, 1673, 
1594, 1512, 1425, 1334, 1019 cm-1. UV λmax (CH3OH) nm (log ε): 280 (3.1). EI-MS: m/z 371 
[M]+. 1H NMR (CD3OD) δ: 7.46 (1H, d, J=19.5 Hz, H-7), 7.19 (2H, d, J=10.5, H-2' , H-6'), 
7.15 (1H, d, J=2.5 Hz, H-2), 7.05 (1H, dd, J=2.5 and 9.5 Hz, H-6), 6.82 (2H, d, J=10.5 Hz, H-3' 
and H-5'), 6.81 (1H, d, J=9.5 Hz, H-5), 6.49 (1H, d, J=19.5 Hz, H-8), 4.37 (1H, dd, J=5.3 and 
8.2 Hz, H-7'),  3.91 (3H, s, 3-OMe), 3.51 (1H, dd, J=5.3 and 14.0 Hz, H-8'a), 3.44 (1H, dd, 
J=8.2 and 14.0 Hz, H-8'b), 3.28 (2H, m, H-1′′), 1.58 (2H, ses, J=7.6 Hz, H-2′′), 0.92 (3H, t, 
J=7.6 Hz, H-3′′). 13C NMR  (CD3OD) δ: 169.7 (C-9), 158.8 (C-4’), 150.3 (C-3), 149.8 (C-4), 
142.7 (C-7), 132.7 (C-1’), 129.6 (C-2’ and C-6’), 128.8 (C-1), 123.8 (C-6), 119.2 (C-8), 117.0 
(C-5), 116.8 (C-3’ and C-5’), 112.2 (C-2), 81.5 (C-7’), 72.1 (C-1’’), 56.9 (3-OMe), 47.7 (C-8’), 
24.5 (C-2’’), 11.5 (C-3’’). 
 
Compound 39. (E,E)-N,N-Dityramin-4,4′-dihydroxy-3,5′-dimethoxy-β,3′-bicinnamamide (3 
mg).  
Amorphous powder. IR νmax (CHCl3) 3684, 3595, 2927, 2857, 1740, 1598, 1509, 1455, 1057 
cm-1. UV λmax (CH3OH) nm (log ε): 336 (0.9), 315 (2.6), 246 (3.2). MALDI-MS m/z: 623 [M-
H]-. 1H NMR (CD3OD) δ: 7.59 (1H, s, H-7), 7.40 (1H, d, J=16.0 Hz, H-7′), 7.19 (1H, d, J=2.0, 
H-2'), 7.04 (2H, d, J=8.0 Hz, H-2′′, H-6′′), 6.91 (2H, d, J=8.0 Hz, H-2′′′, H-6′′′), 6.83 (1H, d, 
J=2.0 Hz, H-6'), 6.74 (1H, dd, J=2.0 and 8.0 Hz, H-6), 6.70 (2H, d, J=8.0 Hz, H-3′′ and H-5′′), 
6.65 (1H, d, J=8.0 Hz, H-5), 6.62 (2H, d, J=8.0 Hz, H-3′′′ and H-5′′′), 6.52 (1H, d, J=2.0 Hz, 
H-2), 6.38 (1H, d, J=16.0, H-8'), 3.96 (3H, s, 3'-OMe), 3.47 (2H, t, J=6.8 Hz, H-8′′), 3.43 (2H, 
t, J=6.8 Hz, H-8′′'), 3.38 (3H, s, 3-OMe), 2.75 (2H, t, J=6.8 Hz, H-7′′), 2.65 (2H, t, J=6.8 Hz, 
H-7′′'). 13C NMR (CD3OD) δ: 170.4 (C-9), 169.5(C-9’), 157.3 (C-4’’ and C-4′′′), 150.6 (C-3), 
149.9 (C-3’), 149.3 (C-4), 148.7 (C-4’), 141.9 (C-7’), 139.1 (C-7), 131.8 (C-1’’), 131.6 (C-
1′′′), 131.2 (C-2’’, C-2′′′, C-6’’, and C-6′′′), 129.7(C-5’), 129.4 (C-8), 128.8 (C-1’), 127.0 (C-
1), 125.1 (C-6’), 120.2 (C-8’), 116.8 (C-3’’, C-3′′′, C-5’’, and C-5′′′), 116.4 (C-5), 113.6 (C-2), 
112.2 (C-2’), 57.2 (3’-OMe), 56.2 (3-OMe), 43.0 (C-8’’), 36.2 (C-7’’), 35.9 (C-7′′′). 
 
Compound 40. 7-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)-N2,N3-bis(4-hydroxyphenethyl)-6-
methoxy-1,2-dihydronaphthalene-2,3-dicarboxamide (2 mg). Amorphous powder.  [α]25D = 0.0 
(c 0.20, CH3OH). IR νmax (CHCl3) 3684, 3595, 3414, 3043, 2981, 1660, 1605, 1513, 1431, 
1308, 945 cm-1. UV λmax (CH3OH) nm (log ε): 223 (3.9), 284 (1.2), 333 (1.1). MALDI-MS 
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m/z: 623 [M-H]-. 1H NMR (CD3OD) δ: 7.21 (1H, s, H-7), 6.97 (2H, d, J=8.5 Hz, H-2′′ and H-
6′′), 6.88 (1H, s, H-2), 6.82 (2H, d, J=8.5 Hz, H-2′′′ and H-6′′′), 6.69 (1H, d, J=1.0 Hz, H-2′), 
6.68 (2H, d, J=8.5 Hz, H-3′′ and H-5′′), 6.66 (1H, d, J=8.0 Hz, H-5′), 6.65 (2H, d, J=8.5 Hz, H-
3′′′ and H-5′′′), 6.52 (1H, s, H-5), 6.41 (1H, dd, J=2.0 and 8.0 Hz, H-6′), 4.36 (1H, d, J=3.9 Hz, 
H-7′), 3.90 (3H, s, 3-OMe), 3.75 (3H, s, 3′-OMe), 3.70 (1H, d, J=3.9 Hz, H-8′), 3.42 (2H, t, 
J=6.8 Hz, H-8′'), 3.23 (2H, t, J=6.8 Hz, H-8′′′), 2.65 (2H, t, J=6.8 Hz, H-7′'), 2.50 (2H, t, J=6.8 
Hz, H-7′′′). 13C NMR (CD3OD) δ: 175.0 (C-9’), 170.0 (C-9), 157.4 (C-4’’ and C-4’’’), 150.1 
(C-3’), 148.7 (C-3), 147.2 (C-4), 146.0 (C-4’), 136.4 (C-1’), 135.1 (C-7), 133.0 (C-6), 131.9 
(C-1’’), 131.6 (C-1’’’), 131.3 (C-2’’ and C-6’’), 131.2 (C-2’’’ and C-6’’’), 128.0 (C-8), 125.3 
(C-1), 121.9 (C-6’), 117.7 (C-5), 116.7 (C-3’’, C-3’’’, C-5’’, and C-5’’’), 116.2 (C-5’), 113.7 
(C-2), 113.0 (C-2’), 57.1 (3-OMe), 56.8 (3’-OMe), 50.3 (C-8’), 48.1 (C-7’), 43.0 (C-8’’), 42.9 
(C-8’’’), 36.2 (C-7’’), 35.9 (C-7’’’). 
 
Compound 41. (E)-3-methoxyphenyl 3,4,5-trimethoxycinnamate (5 mg). Colourless oil. IR 
νmax (CHCl3) 2927, 1717, 1676, 1431 cm-1. UV (CH3OH) λmax (log ε) nm: 241, 308. HREI-
MS: m/z 344.1256 [M]+.  1H NMR (CDCl3) δ: 7.77 (1H, d, J=15.9 Hz, H-7), 7.30 (1H, t, J=8.2 
Hz, H-5'), 6.82 (2H, s, H-2 and H-6), 6.79 (1H, dd, J=2.0 and 8.0 Hz, H-4'), 6.77 (1H, dd, J=2.0 
and 8.0 Hz, H-6'), 6.73 (1H, t, J=2.2 Hz, H-2'), 6.53 (1H, d, J=15.9 Hz, H-8), 3.91 (9H, s, 3,4, 
and 5-OMe), 3.82 (3H, s, 3'-OMe). 13C NMR (CDCl3) δ: 165.3 (C-9), 160.6 (C-3'), 153.6 (C-3 
and C-5), 151.8 (C-1'), 146.6 (C-7), 146.3 (C-4), 129.9 (C-5'), 129.5 (C-1), 116.5 (C-8), 113.9 
(C-6'), 111.7 (C-4'), 107.7 (C-2'), 105.6 (C-2 and C-6), 61.0 (4-OMe), 56.2 (3 and 5-OMe), 
55.4 (3'- OMe).  
 
Compound 42. (E)-3-hydroxyphenyl 3,4,5-trimethoxycinnamate (4 mg). Colourless oil. IR 
νmax (CHCl3) 3585, 1715, 1650, 1580, 1510 cm-1. UV (CH3OH) λmax (log ε) nm: 219, 231, 290, 
319. HREI-MS: m/z 330.1100 [M]+. 1H NMR (CDCl3) δ: 7.78 (1H, d, J=16.0 Hz, H-7), 7.25 
(1H, t, J=8.5 Hz, H-5’), 6.82 (2H, s, H-2 and H-6), 6.74 (1H, dd, J=2.0 and 8.5 Hz, H-4'), 6.72 
(1H, dd, J=2.0 and 8.5 Hz, H-6'), 6.68 (1H, t, J=2.0 Hz, H-2'), 6.53 (1H, d, J=16.0 Hz, H-8), 
3.91 (9H, s, 3, 4, and 5-OCH3). 13C-NMR (CDCl3) δ: 165.4 (C-9), 156.6 (C-3'), 153.5 (C-3 and 
C-5), 152.1 (C-1'), 146.7 (C-7), 140.8 (C-4), 130.1 (C-5'), 129.6 (C-1), 116.3 (C-8), 113.8 (C-
6'), 113.0 (C-4'), 109.3 (C-2'), 105.5 (C-2 and C-6), 61.0 (4-OMe), 56.2 (3 and 5-OMe),  
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Compound 43. (E)-3-hydroxyphenyl sinapate (4.1 mg). Colourless oil. IR νmax (CHCl3) 3330, 
3047, 1726, 1682, 1515 cm-1. UV (CH3OH) λmax (log ε) nm: 310. HREI-MS: m/z 316.0943 
[M]+. 1H NMR (CDCl3) δ: 7.77 (1H, d, J=16.2 Hz, H-7), 7.22 (1H, t, J=8.4 Hz, H-5'), 6.82 (2H, 
s, H-2 and H-6), 6.70 (2H, d, J=8.4 Hz, H-4’ and H-6’), 6.66 (1H, d, J=2.1 Hz, H-2'), 6.47 (1H, 
d, J=16.2 Hz, H-8), 3.92 (6H, s, 3 and 5-OMe). 13C NMR (CDCl3) δ: 166.0 (C-9), 156.9 (C-3'), 
151.6 (C-3 and C-5), 147.3 (C-7 and C-1'), 137.6 (C-4), 130.0 (C-1 and C-5'), 114.7 (C-8), 
113.4 (C-6'), 113.2 (C-4'), 109.3 (C-2'), 105.4 (C-2 and C-6), 56.3 (3 and 5-OMe). 
 
Compound 44. (E)-3-methoxyphenyl sinapate (3 mg). IR νmax (CHCl3) 2927, 1719, 1676, 
1431 cm-1. UV (CH3OH) λmax (log ε) nm: 241, 308. EI-MS: m/z 270 [M]+ (8), 253 [M-OH]+ 
(16), 147 [M-C7H7O2]+ (48), 123 [M-C9H7O2]+ (25). 1H NMR (CDCl3) δ: 7.79 (1H, d, J=15.9 
Hz, H-7), 7.29 (1H, t, J=7.2 Hz, H-5’), 6.83 (2H, s, H-2 and H-6), 6.82 (1H, dd, J=2.2 and 7.2 
Hz, H-6’), 6.68 (1H, dd, J=2.2 and 7.2 Hz, H-4'), 6.63 (1H, t, J=2.2 Hz, H-2’), 6.52 (1H, d, 
J=15.9 Hz, H-8), 3.92 (6H, s, 3 and 5-OMe), 3.91 (3H, s, 3’-OMe). 13C-NMR (CDCl3) δ: 167.6 
(C-9), 162.0 (C-4), 161.7 (C-1'), 153.4 (C-3'), 148.3 (C-7), 131.5 (C-2 and C-6), 130.8 (C-5'), 
127.0 (C-1), 116.9 (C-3 and C-5), 114.9 (C-8), 114.2 (C-4'), 113.9 (C-6'), 108.5 (C-2'), 56.3 (3 
and 5-OMe), 56.0 (3'-OMe). 
 
Compound 45. 2’-methoxyphenyl dihydrocinnamate (10 mg). IR νmax (CHCl3) 3330, 3047, 
1726, 1682, 1515 cm-1. UV (CH3OH) λmax (log ε) nm: 310. EI-MS: m/z 256 [M]+ (3), 225 [M-
OCH3]+ (14), 207 [M-C6H5O2]+ (29), 109 [M-C11H11O4]+ (54). 1H NMR (CDCl3) δ: 7.29 (4H, 
m, H-2, H-3, H-5 e H-6), 7.20 (2H, m, H-4 and H-6’), 7.05 (1H, d, J=9,0 Hz, H-3’), 6.92 (2H, 
m, H-4’ and H-5’), 3.76 (3H, s, OMe), 3.04 (2H, t, J=6,4 Hz, H-7), 2.92 (2H, t, J=6,4 Hz, H-8). 
13C NMR (CDCl3) δ: 172.0 (C-9), 157.1 (C-2'), 148.8 (C-1’), 132.1 (C-1), 128.7 (C-3 and C-
5), 127.7 (C-2 and C-6), 126.0 (C-4), 124.0 (C-4'), 122.0 (C-5'), 118.2 (C-6'), 115.5 (C-3'), 58.2 
(2’-OMe), 36.0 (C-8), 31.0 (C-7).  
 
Compound 46. (E)-4’-acetylphenyl 4-hydroxycinnamate (11 mg). Colourless oil. IR νmax 
(CHCl3) 3350, 3010, 1725, 1720, 1599 cm-1. UV (CH3OH) λmax (log ε) nm: 312. EI-MS: m/z 
282 [M]+ (3), 265 [M-OH]+ (14), 239 [M-CH3CO]+ (48), 147 [M-C8H7O2]+ (29), 135 [M- 
C9H7O2]+ (54). 1H NMR (CDCl3) δ: 8.03 (2H, d, J=9.0 Hz, H-3’ and H-5’), 7.84 (1H, d, J=15.5 
Hz, H-7), 7.51 (2H, d, J=8.5 Hz, H-2 and H-6), 7.28 (2H, d, J=9.0 Hz, H-2’ and H-6’), 6.88 
(2H, d, J=8.5 Hz, H-3 and H-5), 6.49 (1H, d, J=15.5 Hz, H-8), 2.62 (3H, s, Me). 13C-NMR 
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(CDCl3) δ: 197.8 (C-7’), 165.5 (C-9), 158.0 (C-4), 155.0 (C-1’), 147.2 (C-7), 134.5 (C-4’), 
130.7 (C-2 and C-6), 130.2 (C-3’ and C-5’), 127.5 (C-1), 122.1 (C-2' and C-6’), 116.3 (C-3 and 
C-5), 114.4 (C-8), 26.8 (Me).  
 
Compound 47. (E)-3’-acethylphenyl 3,4,5-trimethoxycinnamate (3 mg). Colourless oil. IR 
νmax (CHCl3) 3300, 1650, 1580, 1510 cm-1. UV (CH3OH) λmax (log ε) nm: 219, 231, 290, 319. 
EI-MS: m/z 356 [M]+ (5), 325 [M-OCH3]+ (15), 221 [M-C8H7O2]+ (51), 135 [M-C12H13O4]+ 
(20). 1H-NMR (CDCl3) δ: 7.84 (1H, d, J=7.5 Hz, H-4’), 7.80 (1H, d, J=16.0 Hz, H-7), 7.75 
(1H, d, J=1.5 Hz, H-2’), 7.51(1H, t, J=7.5 Hz, H-5’), 7.38 (1H, dd, J=1.5 and 7.5 Hz, H-6’), 
6.82 (2H, s, H-2 and H-6),  6.54 (1H, d, J=16.0 Hz, H-8), 3.90 (9H, s, 3, 4, and 5-OMe), 2.61 
(3H, s, Me). 13C NMR (CDCl3) δ: 196.9 (C-7’), 165.0 (C-9), 153.5 (C-3 and C-5), 151.0 (C-
1’), 147.0 (C-7), 140.6 (C-4), 138.5 (C-3’), 129.6 (C-5’), 129.4 (C-1), 126.4 (C-6’), 125.6 (C-
4’), 121.4 (C-2'), 115.9 (C-8), 105.5 (C-2 and C-6), 60.9 (4-OMe), 56.1 (3 and 5-OMe), 26.6 
(Me).  
 
Compound 48. (E)-4’-acethylphenyl sinapate (2 mg). Colourless oil. IR νmax (CHCl3) 3330, 
3047, 1726, 1682, 1515 cm-1. UV (CH3OH) λmax (log ε) nm: 310. EI-MS: m/z 342 [M]+ (3), 
325 [M-OH]+ (14), 311 [M-OCH3]+ (48), 207 [M-C8H7O2]+ (29), 135 [M-C11H11O4]+ (54). 1H 
NMR (CDCl3) δ: 8.02 (2H, d, J=8.8 Hz, H-3’ and H-5’), 7.80 (1H, d, J=15.8 Hz, H-7), 7.27 
(2H, d, J=8.8 Hz, H-2’ and H-6’), 6.84 (2H, s, H-2 and H-6), 6.48 (1H, d, J=15.8 Hz, H-8), 
3.94 (6H, s, 3 and 5-OMe), 2.61 (3H, s, Me). 13C NMR (CDCl3) δ: 195.8 (C-7’), 165.0 (C-9), 
154.7 (C-3 and C-5), 154.6 (C-1’),  147.3 (C-4), 147.6 (C-7), 134.7 (C-4’), 134.6 (C-1), 130.0 
(C-2' and C-6’), 121.8 (C-3’ and C-5’) 114.4 (C-8), 105.5 (C-2 and C-6), 56.4 (3 and 5-OMe), 
26.6 (Me). 
 
Compound 49. (E)-4’-acethylphenyl 3,4,5-trimethoxycinnamate (2 mg). Colourless oil. IR 
νmax (CHCl3) 2927, 1727, 1676, 1431 cm-1. UV (CH3OH) λmax (log ε) nm: 245, 318. EI-MS: 
m/z 356 [M]+ (3), 325 [M-OCH3]+ (16), 221 [M-C8H7O2]+ (48), 135 [M-C12H13O4]+ (25). 1H-
NMR (CDCl3) δ: 8.01 (2H, d, J=8.0 Hz, H-3’ and H-5’), 7.80 (1H, d, J=15.6 Hz, H-7), 7.26 
(2H, d, J=8.0 Hz, H-2’ and H-6’), 6.83 (2H, s, H-2 and H-6), 6.53 (1H, d, J=15.6 Hz, H-8), 
3.89 (9H, s, 3, 4, and 5-OMe), 2.59 (3H, s, Me). 13C-NMR (CDCl3) δ: 196.0 (C-7’), 164.8 (C-
9), 154.6 (C-1’), 153.5 (C-3 and C-5), 147.3 (C-7), 140.3 (C-4), 134.7 (C-4’), 130.0 (C-2' and 
C-6’), 129.4 (C-1), 121.8 (C-3’ and C-5’), 115.9 (C-8), 105.6 (C-2 and C-6), 61.1 (4-OMe), 
56.2 (3 and 5-OMe), 26.6 (Me).  
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Compound 50. (E)-3’-(1-hydroxyethyl)-phenyl 3,4,5-trimethoxycinnamate (5 mg). Colourless 
oil. IR νmax (CHCl3) 3250, 1580, 1510 cm-1. UV (CH3OH) λmax (log ε) nm: 219, 319. EI-MS: 
m/z 358 [M]+ (3), 341 [M-OH]+ (14), 327 [M-OCH3]+ (48), 301 [M-C2H5CO]+ (29), 221 [M-
C8H9O2]+, 137 [M-C12H13O4]+ (54). 1H NMR (CDCl3) δ: 7.81 (1H, d, J=16.0 Hz, H-7), 7.37 
(1H, t, J=7.6 Hz, H-5’), 7.25 (1H, d, J=7.6 Hz, H-4’), 7.18 (1H, t, J=2.0 Hz, H-2’), 7.03 (1H, 
dd, J=2.0 and 7.6 Hz, H-6’),  7.00 (2H, s, H-2 and H-6), 6.69 (1H, d, J=16.0 Hz, H-8), 4.85 
(1H, d, J=6.4 Hz, H-7’), 3.88 (6H, s, 3 and 5-OMe), 3.81 (3H, s, 4-OMe), 1.44 (3H, d, J=6.4 
Hz, Me). 13C NMR (CDCl3) δ: 167.7 (C-9), 155.4 (C-3 and C-5), 152.9 (C-1’), 148.6 (C-7), 
142.0 (C-4), 131.9 (C-1), 131.8 (C-3’), 130.8 (C-5’) 124.4 (C-4’), 121.8 (C-6’), 120.3 (C-2'), 
118.0 (C-8), 107.6 (C-2 and C-6), 70.8 (C-7’), 61.7 (4-OMe), 57.3 (3 and 5-OMe), 26.1 (Me). 
 
Compound 51. (E)-2-hydroxyethyl 3,4,5-trimethoxycinnamate (4 mg). Colourless oil. IR νmax 
(CHCl3)  3350, 3010, 1725, 1599 cm-1. UV (CH3OH) λmax (log ε) nm: 312. HREI-MS: m/z 
282.1100 [M]+. 1H NMR (CDCl3) δ: 7.63 (1H, d, J=16.0 Hz, H-7), 6.75 (2H, s,  H-2 and H-6), 
6.38 (1H, d, J=16.0 Hz, H-8), 4.35 (2H, m, H-1'), 3.90 (2H, m, H-2'), 3.88 (9H, s, 3, 4, and 5-
OMe). 13C NMR (CDCl3) δ: 167.2 (C-9), 153.4 (C-3 and C-5), 145.4 (C-7), 141.8 (C-4), 129.7 
(C-1), 116.8 (C-8), 105.3 (C-2 and C-6), 66.2 (C-1'), 61.4 (C-2'), 60.9 (4-OMe), 56.1 (3 and 5-
OMe).  
 
Compound 52. 2-hydroxyethyl senapate (11 mg). Colourless oil. IR νmax (CHCl3) 3540, 1718, 
1580, 1510 cm-1 . UV (CH3OH) λmax (log ε) nm: 219, 319. HREI-MS: m/z 268.0950 [M]+. 1H-
NMR (CDCl3) δ: 7.64 (1H, d, J=15.6 Hz, H-7), 6.78 (2H, s, H-2 and H-6), 6.35 (1H, d, J=15.6 
Hz, H-8), 4.36 (3H, m, H-1'), 3.92 (6H, s, 3 and 5-OMe),  3.82 (3H, m, H-2'). 13C NMR 
(CDCl3) δ: 167.4 (C-9), 147.2 (C-3 and C-5), 145.7 (C-7), 138.8 (C-4), 129.7 (C-1), 115.3 (C-
8), 105.1 (C-2 and C-6), 66.1 (C-1’), 61.5 (C-2'), 56.3 (3 and 5-OMe). 
 
Compound 53. (E)-2-acetoxyethy 3,4,5-trimethoxycinnamate (7 mg). Colourless oil. IR νmax 
(CHCl3) 3606, 3317, 1721, 1715, 1580, 1510 cm-1. UV (CH3OH) λmax (log ε) nm: 219, 319. 
HREI-MS: m/z 324.1205 [M]+. 1H NMR (CDCl3) δ: 7.64 (1H, d, J=16.0 Hz, H-7), 6.77 (2H, s, 
H-2 and H-6), 6.38 (1H, d, J=16.0 Hz, H-8), 4.42 (2H, m, H-1'), 4.36 (2H, m, H-2'), 3.90 (9H, 
s, 3,4, and 5-OMe), 2.11 (3H, s, COMe).13C NMR (CDCl3) δ: 170.8 (COMe), 166.7 (C-9), 
153.5 (C-3 and C-5), 145.5 (C-7), 142.0 (C-4), 129.8 (C-1), 116.7 (C-8), 105.4 (C-2 and C-6), 
62.3 (C-1' and C-2'), 61.0 (4-OMe), 56.2 (3 and 5-OMe), 20.9 (2-COMe).  
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Compound 54. 2-hydroxyethyl caffeate (4 mg). Colourless oil. IR νmax (CHCl3) 3600, 3307, 
1718, 1550, 1510 cm-1. UV (CH3OH) λmax (log ε) nm: 219, 319. HREI-MS: m/z 224.0688 
[M]+. 1H NMR (CDCl3) δ: 7.58 (1H, d, J=16.5 Hz, H-7), 7.04 (1H, d, J= 2.0 H-2), 6.95 (1H, 
dd, J=2.0 and 7.5 Hz, H-6), 6.77 (1H, d, J=7.5 Hz, H-5), 6.29 (1H, d, J=16.5 Hz, H-8), 4.23 
(2H, m, H-1'), 3.78 (2H, m, H-2'). 13C NMR (CDCl3) δ: 169.8 (C-9), 150.1 (C-3), 147.6 (C-7), 
147.3 (C-4), 128.2 (C-1), 123.4 (C-6), 117.0 (C-8), 115.6 (C-5), 115.5 (C-2), 67.4 (C-1'), 61.7 
(C-2').  
 
Compound 55. (E)-4-(4-(2-carboxyvinyl)phenoxy)benzoic acid (5 mg). MALDI-MS: m/z 285 
[M+H]+. 1H NMR (CD3OD) δ: 8.05 (2H, d, J=8.4 Hz, H-2’ and H-6’), 7.45 (1H, d, J=15.6 Hz, 
H-7), 7.24 (2H, d, J=8.1 Hz, H-2 and H-6), 7.12 (2H, d, J=8.4 Hz, H-3’ and H-5’), 6.81 (2H, d, 
J=8.1 Hz, H-3 and H-5), 7.24 (1H, d, J=15.6 Hz, H-8). 13C NMR (CD3OD) δ: 171.3 (C-9), 
170.6 (C-7’), 162.2 (C-4’), 156.2 (C-4) 148.0 (C-7), 130.0 (C-2’ and C-6’), 128.3 (C-1), 126.1 
(C-2 and C-6), 123.4 (C-1’), 117.4 (C-3, C-3’, C-5, and C-5’), 115.6 (C-8).  
 
Compound 56. 5,6,7,8,4’-pentamethoxyflavone (3 mg). EI-MS: m/z 372 [M]+ (34), 357 [M- 
CH3]+ (56), 341 [M-OCH3]+ (100). 1H NMR (CDCl3) δ: 7.88 (2H, d, J=9.0 Hz, H-2’ and H-6’), 
7.02 (2H, d, J=9.0 Hz, H-3’ and H-5’), 6.60 (1H, s, H-3), 4.10 (3H, s, 5-OMe), 4.02 (3H, s, 8-
OMe), 3.95 (6H, s, 6 and 7-OMe), 3.89 (3H, s, 4’-OMe). 13C NMR (CDCl3) δ: 177.3 (C-4), 
162.2 (C-2), 161.1 (C-4’), 151.3 (C-7), 148.4 (C-8), 147.7 (C-9), 144.0 (C-5), 138.1 (C-6), 
127.8 (C-2’ and C-6’), 123.8 (C-1'), 114.8 (C-10), 114.4 (C-3’ and C-5’), 106.7 (C-3), 62.3 (5-
OMe), 62.1 (6-OMe), 61.9 (7-OMe), 61.7 (8-OMe), 55.5 (4’-OMe). 
 
Compound 57. 5,6,7,8,3’,4’-esamethoxyflavone (5 mg). EI-MS: m/z 402 [M]+ (26), 387 [M- 
CH3]+ (58), 371 [M-OCH3]+ (100). 1H NMR (CDCl3) δ: 7.57 (1H, dd, J=2.1 and 9.1 Hz, H-6’), 
7.41 (1H, d, J=2.1 Hz, H-2’), 6.99 (1H, d, J=9,0 Hz, H-5’), 6.62 (1H, s, H-3), 4.11 (3H, s, 5-
OMe), 4.03 (3H, s, 8-OMe), 3.98 (3H, s, 6-OMe), 3.97 (3H, s, 7-OMe), 3.96 (6H, s, 3’ and 4’-
OMe). 13C NMR (CDCl3) δ: 177.4 (C-4), 161.0 (C-2), 151.9 (C-4’), 151.4 (C-7), 149.3 (C-3’), 
147.7 (C-9), 144.0 (C-5), 138.0 (C-6 and C-8), 124.0 (C-1'), 119.6 (C-6’), 114.8 (C-10), 111.0 
(C-5’), 108.7 (C-2’), 106.7 (C-3), 62.3 (5-OMe), 62.0 (6-OMe), 61.8 (7-OMe), 61.7 (8-OMe), 
56.1 (3’-OMe) 56.0 (4’-OMe). 
 
Compound 58. 5-hydroxy-6,7,8,3’, 4’-pentamethoxyflavone (5 mg). EI-MS: m/z 388 [M]+ 
(100), 373 [M-CH3]+ (96), 357 [M-OCH3]+ (55), 343 [M-CH3-OCH3]+ (6,4). UV (CH3OH) 
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λmax (log ε) nm: 205, 251, 280, 337. 1H NMR (CDCl3) δ: 7.58 (1H, dd, J=2.1 and 9.0 Hz, H-
6’), 7.42 (1H, d, J=2.1 Hz, H-2’), 6.99 (1H, d, J=9.0 Hz, H-5’), 6.61 (1H, s, H-3), 4.12 (3H, s, 
8-OMe), 3.99 (6H, s, 3’ and 4’-OMe), 3.97 (3H, s, 7-OMe), 3.96 (3H, s, 6-OMe). 13C NMR 
(CDCl3) δ: 179.3 (C-4), 158.8, (C-2), 152.9 (C-7), 149.1 (C-5), 149.0 (C-4’), 145.6 (C-3’), 
142.9 (C-9), 136.2 (C-6), 132.9 (C-8), 123.7 (C-1'), 121.6 (C-6’), 114.6 (C-2’), 110.5 (C-5’), 
107.5 (C-10), 106.5 (C-3), 62.1 (6-OMe), 61.7 (7-OMe), 61.2 (8-OMe), 56.1 (3’-OMe), 56.0 
(4’-OMe). 
 
Compound 59. 4’-hydroxy-5,6,7,8,3’-pentamethoxyflavone (7 mg). EI-MS: m/z 388 [M]+ (14), 
373 [M-CH3]+ (100), 357 [M-OCH3]+ (10). UV (CH3OH) λmax (log ε) nm: 248, 268, 272, 340. 
1H NMR (CDCl3) δ: 7.52 (1H, dd, J=1.5 and 9.0 Hz, H-6’), 7.39 (1H, d, J=1.5 Hz, H-2’), 7.04 
(1H, d, J=9.0 Hz, H-5’), 6.60 (1H, s, H-3), 4.04 (3H, s, 8-OMe), 4.02 (3H, s, 5-OMe), 3.99 
(3H, s, 3’-OMe), 3.96 (6H, s, 6 and 7-OMe). 13C NMR (CDCl3) δ: 177.4 (C-4), 161.0, (C-2), 
151.9 (C-4’), 151.4 (C-7), 149.3 (C-3’), 147.7 (C-9), 144.0 (C-5), 106.7 (C-3), 138.0 (C-6 and 
C-8), 124.0 (C-1'), 119.6 (C-6’), 114.8 (C-10), 111.0 (C-5’), 108.7 (C-2’), 62.3 (5-OMe), 62.0 
(6-OMe), 61.8(7-OMe), 61.7 (8-OMe), 56.1, (3’-OMe). 
 
Compound 67. Seselin (40 mg). EI-MS: m/z 228 [M]+. 1H NMR (CDCl3) δ: 7.54 (1H, d, J=9.0 
Hz, H-4), 7.15 (1H, d, J=8.4 Hz, H-5), 6.81 (1H, d, J=9.6 Hz, H-1’), 6.65 (1H, d, J=8.4 Hz, H-
6), 6.15 (1H, d, J=9.6 Hz, H-3), 5.67 (1H, d, J=9.6 Hz, H-2’), 1.41 (6H, s, H-4’ and H-5’). 13C 
NMR (CDCl3) δ: 161.1, (C-2), 156.5 (C-8a), 150.3 (C-7), 144.1 (C-4), 130.9 (C-2’), 128.0 (C-
5), 115.1 (C-6 and C-4’), 113.7 (C-4a), 112.7 (C-3), 109.4 (C-8), 77.8 (C-3’), 28.3 (C-4’ and 
C-5’). 
 
Compound 68. 5-methoxyseselin (45 mg). EI-MS: m/z 258 [M]+. 1H NMR (CDCl3) δ: 7.91 
(1H, d, J=9.4 Hz, H-4), 6.75 (1H, d, J=10.0 Hz, H-1’), 6.20 (1H, s, H-6), 6.09 (1H, d, J=9.4 Hz, 
H-3), 5.54 (1H, d, J=10.0 Hz, H-2’), 3.84 (3H, s, 5-OMe), 1.42 (6H, s, H-4’ and H-5’). 13C 
NMR (CDCl3) δ: 161.5 (C-2), 157.6 (C-7), 156.7 (C-5), 151.2 (C-8a), 139.2 (C-4), 127.7 (C-
2’), 115.1 (C-1’), 110.6 (C-3), 103.9 (C-4a), 102.8 (C-8), 95.5 (C-6), 78.2 (C-3’), 56.2 (5-
OMe), 28.3 (C-4’ and C-5’). 
 
Compound 69. 6-(3,3-dimethylallyl)seselin (125 mg). HRESI-MS : m/z 297.1491 [M+H]+. 1H 
NMR (CDCl3) δ: 7.54 (1H, d, J=9.6 Hz, H-4), 7.02 (1H, s, H-5), 6.84 (1H, d, J=10.2 Hz, H-
1’’), 6.16 (1H, d, J=9.6 Hz, H-3), 5.68 (1H, d, J=10.2 Hz, H-2’’), 5.22 (1H, t, J=7.2 Hz, H-2’), 
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3.24 (2H, d, J=7.2 Hz, H-1’), 1.72 (3H, s, H-5’), 1.70 (3H, s, H-4’), 1.43 (6H, s, H-4’’ and H-
5’’).  13C NMR (CDCl3) δ: 161.5 (C-2), 154.2 (C-7), 148.9 (C-8a), 144.3 (C-4), 133.2 (C-3’), 
130.6 C-2’’), 127.3 (C-5 and C-4a), 126.7 (C-6), 121.9 (C-2’), 115.6 (C-1’’), 112.6 (C-3), 
109.1 (C-8), 79.0 (C-3’’), 28.3 (C-4’’ and C-5’’), 28.0 (C-1’), 26.0 (C-5’), 18.1 (C-4’). 
 
Compound 70. 4,9-dihydroxy-2-(2-hydroxypropan-2-yl)-11-methoxy-10-methyl-2,3-
dihydrofuro[3,2-b]acridin-5(10H)-one. (3 mg).  HRESI-MS: m/z 370.1291 [M-H]-. 1H NMR 
(CD6CO) δ: 7.79 (1H, dd, J=1.6 and 8.0  Hz, H-8), 7.27 (1H, dd, J=1.6 and 8.0 Hz, H-6), 7.15 
(1H, t, J=8.0 Hz, H-7), 4.87 ( 1H, dd, J=8.0 and 9.2 Hz, H-2’), 3.85 (3H, s, 4-OMe), 3.82 (3H, 
s, N-Me), 3.20 (2H, m, H-1’a,b), 1.33 (3H, s, H-4’), 1.29 (3H, s, H-5’).  13C NMR (CD6CO) δ: 
182.3 (C-9), 159.8 (C-3), 154.2 (C-1), 147.8 (C-5), 143.1 (C-4a), 137.3 (C-10a), 125.7 (C-4), 
124.8 (C-8a), 122.9 (C-7), 119.7 (C-6), 116.8 (C-8), 107.5 (C-2), 107.3 (C-9a), 92.4 (C-2’), 
72.0 (C-3’), 60.6 (4-OMe), 46.5 (N-Me), 27.5 (C-1’), 25.5 (C-5’), 24.2 (C-4’).  
 
Compound 71. Glycocitrine IV (17 mg). HRESI-MS: m/z 354.0598 [M-H]-. 1H NMR (CDCl3) 
δ: 7.79 (1H, d, J=7.8 Hz, H-8), 7.06 (1H, d, J=7.8 Hz, H-6), 7.01 (1H, t, J=7.8 Hz, H-7), 5.29 
(1H, t, J=7.2 Hz, H-2’), 3.76 (3H, s, 4-OMe), 3.75 (3H, s, N-Me), 3.39 (2H, d, J=7.2 Hz, H-1’), 
1.78 (3H, s, H-5’), 1.66 (3H, s, H-4’). 13C NMR (CDCl3) δ: 182.9 (C-9), 157.8 (C-1), 155.2 (C-
3), 147.7 (C-5), 139.4 (C-4a), 136.9 (C-10a), 132.3 (C-3’), 128.0 (C-4), 124.8 (C-8a), 122.8 
(C-7), 122.3 (C-2’), 119.7 (C-6), 117.1 (C-8), 108.9 (C-2), 106.3 (C-9a), 60.2 (4-OMe), 45.1 
(N-Me), 25.9 (C-5’), 21.9 (C-1’), 18.0 (C-4’),  
 
Compound 72. Citrusinine II (20 mg). HRESI-MS: m/z 288.0335 [M+H] +. 1H NMR 
(CD3OD) δ: 7.51 (1H, d, J=7.8 Hz, H-8), 6.93 (1H, d, J=7.8 Hz, H-6), 6.86 (1H, t, J=7.8 Hz, H-
7), 6.01 (1H, s, H-2), 3.59 (3H, s, 4-OMe), 3.52 (3H, s, N-Me). 13C NMR (CD3OD) δ: 182.2 
(C-9), 159.4 (C-1), 158.0 (C-3), 148.1 (C-5), 142.4 (C-4a), 137.1 (C-10a), 128.9 (C-4), 124.5 
(C-8a), 122.9 (C-7), 119.7 (C-6), 116.1 (C-8), 106.3 (C-9a), 97.0 (C-2), 59.8 (4-OMe), 45.6 
(N-Me). 
 
Compound 73. Citbrasine (6 mg). HRESI-MS: m/z 300.0124 [M-H] -. 1H NMR (CD3OD) δ: 
7.87 (1H, d, J=7.8 Hz, H-8), 7.17 (1H, d, J=7.8 Hz, H-6), 7.10 (1H, t, J=7.8 Hz, H-7), 4.12 
(3H, s, 2-OMe), 3.94 (3H, s, 3-OMe), 3.83 (3H, s, 4-OMe), 3.80 (3H, s, N-Me). 13C NMR 
(CD3OD) δ: 183.1 (C-9), 154.7 (C-1), 152.1 (C-2), 147.0 (C-5), 138.9 (C-3), 137.6 (C-10a), 
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134.5 (C-4), 124.6 (C-8a), 122.9 (C-7), 120.5 (C-6), 118.0 (C-8), 108.3 (C-9a), 61.9 (4-OMe), 
61.3 (3-OMe), 61.0 (2-OMe), 46.6 (N-Me). 
 
Compound 74. Junosine (7 mg). HRESI-MS: m/z 324.0471 [M-H]-. 1H NMR (CD3OD) δ: 
7.77 (1H, d, J=7.8 Hz, H-8), 7.09 (1H, d, J=7.8 Hz, H-6), 7.03 (1H, t, J=7.8 Hz, H-7), 6.32 
(1H, s, H-4), 5.24 (1H, t, J=7.2 Hz, H-2’), 3.97 (3H, s, N-Me), 3.29 (2H, d, J=7.2 Hz, H-1’), 
1.78 (3H, s, H-5’), 1.65 (3H, s, H-4’). 13C NMR (CD3OD) δ: 180.3 (C-9), 163.2 (C-1), 161.2 
(C-3), 147.2 (C-5), 145.8 (C-10a), 133.8 (C-3’), 130.4 (C-4a), 124.8 (C-8a), 122.8 (C-7), 121.8 
(C-2’), 119.2 (C-6), 116.3 (C-8), 108.4 (C-2), 104.5 (C-9a), 90.2 (C-4), 40.1 (N-Me), 24.8 (C-
4’), 21.0 (C-1’), 16.7 (C-5’).  
 
Compound 75. Oriciacridone (21 mg). HRESI-MS: m/z 324.0219 [M-H]-. 1H NMR (CD3OD) 
δ: 7.62 (1H, d, J=7.6 Hz, H-8), 7.08 (1H, d, J=7.6 Hz, H-6), 7.04 (1H, t, J=7.8 Hz, H-7), 6.17 
(1H, s, H-2), 5.30 (1H, m, H-2’), 3.56 (3H, s, N-Me), 3.41 (2H, d, J=7.8 Hz, H-1’), 1.73 (3H, s, 
H-5’), 1.66 (3H, s, H-4’). 13C NMR (CD3OD) δ: 182.5 (C-9), 164.3 (C-3), 162.1 (C-1), 151.1 
(C-4a), 148.7 (C-5), 138.2 (C-10a), 131.0 (C-3’), 124.6 (C-8a), 124.8 (C-2’), 122.7 (C-7), 
119.2 (C-6), 115.7 (C-8), 107.9 (C-4), 106.7 (C-9a), 96.7 (C-2), 46.5 (N-Me), 25.9 (C-1’), 24.7 
(C-5’), 17.0 (C-4’).  
 
Compound 76. Citrusinine I (10 mg). HRESI-MS: m/z 288.0122 [M-H] -. 1H NMR (CD3OD) 
δ: 7.74 (1H, d, J=7.8 Hz, H-8), 7.06 (1H, d, J=7.8 Hz, H-6), 7.03 (1H, t, J=7.8 Hz, H-7), 6.29 
(1H, s, H-2), 3.85 (3H, s, 4-OMe), 3.75 (3H, s, 3-OMe), 3.71 (3H, s, N-Me). 13C NMR 
(CD3OD) δ: 182.7 (C-9), 160.0 (C-1), 159.4 (C-3), 148.0 (C-5), 141.1 (C-4a), 137.6 (C-10a), 
128.9 (C-4), 124.7 (C-8a), 122.9 (C-7), 120.1 (C-6), 116.7 (C-8), 106.5 (C-9a), 93.7 (C-2), 
60.5 (4-OMe),  56.3 (3-OMe), 46.3 (N-Me). 
 
Compound 77. Atalaphyllidine (25 mg). HRESI-MS: m/z 322.1025 [M-H] -. 1H NMR 
(CD6CO) δ: 7.77 (1H, d, J=7.6 Hz, H-8), 7.33 (1H, d, J=7.6 Hz, H-6), 7.19 (1H, t, J=7.8 Hz, H-
7), 6.75 (1H, d, J=9.6 Hz, H-1’), 6.11 (1H, s, H-2), 5.66 (1H, d, J=9.6 Hz, H-2’), 3.84 (3H, s, 
N-Me), 1.50 (6H, s, H-4’ and H-5’). 13C NMR (CD6CO) δ: 182.2 (C-9), 164.4 (C-3), 161.3 (C-
1), 148.9 (C-4a), 148.1 (C-5), 137.3 (C-10a), 125.2 (C-8a), 124.0 (C-2’), 123.6 (C-7), 121.1 
(C-1’), 120.2 (C-6), 116.2 (C-8), 106.9 (C-4), 102.5 (C-9a), 97.4 (C-2), 76.8 (C-3’), 26.6 (C-4’ 
and C-5’), 48.5 (N-Me). 
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Compound 78. Pyranofoline (14 mg). HRESI-MS: m/z 352.1142 [M-H] -. 1H NMR (CD6CO) 
δ: 7.79 (1H, d, J=7.6 Hz, H-8), 7.31 (1H, d, J=7.6 Hz, H-6), 7.16 (1H, t, J=7.8 Hz, H-7), 6.72 
(1H, d, J=9.6 Hz, H-1’), 5.71 (1H, d, J=9.6 Hz, H-2’), 1.52 (6H, s, H-4’ and H-5’), 3.85 (3H, s, 
4-OMe), 3.84 (3H, s, N-Me). 13C NMR (CD6CO) δ: 182.2 (C-9), 154.6 (C-3), 153.8 (C-1), 
142.9 (C-4a), 148.1 (C-5), 137.2 (C-10a), 124.2 (C-8a), 124.0 (C-2’), 123.1 (C-7), 116.1 (C-
1’), 120.2 (C-6), 116.2 (C-8), 129.3 (C-4), 106.5 (C-9a), 103.4 (C-2), 78.1 (C-3’), 27.8 (C-4’ 
and C-5’), 60.1 (4-OMe), 46.5 (N-Me). 
 
Compound 79. 8-hydroxy-2’-acetoxydihydroxanthyletin (21 mg). HRESI-MS: m/z 305.1009 
[M+H]+. 1H NMR (CDCl3) δ: 7.59 (1H, d, J=9.6 Hz, H-4), 6.82 (1H, s, H-5), 6.20 (1H, d, 
J=9.6 Hz, H-3), 5.12 (1H, m, H-2’), 3.25 (2H, m, H-1’), 1.96 (3H, s, COMe), 1.57 (3H, s, H-
4’), 1.52 (3H, s, H-5’). 13C NMR (CDCl3) δ: 170.5 (COMe), 160.7 (C-2), 150.1 (C-7), 144.5 
(C-4), 143.3 (C-8a), 128.1 (C-8), 125.3 (C-6), 114.5 (C-5), 113.4 (C-4a), 112.3 (C-3), 89.4 (C-
2’), 82.3 (C-3’), 30.6 (C-1’), 22.5 (C-4’), 22.4 (C-5’), 21.3 (COMe). 
 
Compound 80. Dehydrogeijerin (160 mg). HRESI-MS: m/z 259.0937 [M+H]+. 1H NMR 
(CDCl3) δ: 7.65 (1H, s, H-5), 7.60 (1H, d, J=9.4 Hz, H-4), 6.76 (1H, s, H-8), 6.54 (1H, s, H-2’),  
6.21 (1H, d, J=9.4 Hz, H-3), 3.88 (3H, s, 7-OMe), 2.17 (3H, s, H-4’), 1.92 (3H, s, H-5’). 13C 
NMR (CDCl3) δ: 190.7 (C-1’), 160.6 (C-7), 157.5 (C-2), 156.9 (C-8a), 143.6 (C-4), 133.8 (C-
3’), 130.6 (C-5), 128.4 (C-6), 125.0 (C-2’), 114.0 (C-3), 112.3 (C-4a), 99.8 (C-8), 56.5 (7-
OMe), 28.3 (C-4’), 21.6 (C-5’). 
 
Compound 81. Hopeyhopin (230 mg). HRESI-MS: m/z 275.0915 [M+H]+. 1H NMR (CDCl3) 
δ: 7.99 (1H, s, H-5), 7.68 (1H, d, J=9.5 Hz, H-4), 6.86 (1H, s, H-8), 6.27 (1H, d, J=9.5 Hz, H-
3), 4.00 (3H, s, 7-OMe), 4.01 (1H, s, H-2’), 1.50 (3H, s, H-4’), 1.21 (3H, s, H-5’). 13C NMR 
(CDCl3) δ: 193.6 (C-1’), 162.3 (C-7), 160.1 (C-2), 158.9 (C-8a), 143.5 (C-4), 131.5 (C-5), 
123.4 (C-6), 114.7 (C-3), 112.9 (C-4a), 100.1 (C-8), 68.1 (C-2’), 62.1 (C-3’), 57.0 (7-OMe), 
24.5 (C-4’), 18.5 (C-5’). 
 
Compound 82. 2H-1-Benzopyran-2-one, 6-[(acetyloxy)(3,3-dimethyloxiranyl)methyl]-7-
methoxy- (9CI) (35 mg). HRESI-MS: m/z 319.0835 [M+H]+. 1H NMR (CDCl3) δ: 7.62 (1H, d, 
J=9.5 Hz, H-4), 7.43 (1H, s, H-5), 6.77 (1H, s, H-8), 6.21 (1H, d, J=9.5 Hz, H-3), 5.92 (1H, d, 
J=8.8 Hz, H-1’), 3.87 (3H, s, 7-OMe), 3.07 (1H, d, J=8.8 Hz, H-2’), 2.07 (3H, s, COMe), 1.34 
(3H, s, H-4’), 1.22 (3H, s, H-5’). 13C NMR (CDCl3) δ: 169.9 (COMe), 160.9 (C-2), 159.9 (C-
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7), 156.0 (C-8a), 143.5 (C-4), 127.3 (C-5), 123.8 (C-6), 113.8 (C-3), 112.6 (C-4a), 99.6 (C-8), 
69.9 (C-2’), 65.1(C-2’), 59.9 (C-3’), 56.3 (7-OMe), 24.5 (C-4’), 21.3 (COMe), 19.8 (C-5’). 
 
Compound 83. Braylin (35 mg). HRESI-MS: m/z 259.1025 [M+H]+. 1H NMR (CDCl3) δ: 7.54 
(1H, d, J=9.4 Hz, H-4), 6.80 (1H, d, J=10.0 Hz, H-1’), 6.72 (1H, s, H-5), 6.20 (1H, d, J=9.4 Hz, 
H-3), 5.68 (1H, d, J=10.0 Hz, H-2’), 3.83 (3H, s, 5-OMe), 1.46 (6H, s, H-4’ and H-5’). 13C 
NMR (CDCl3) δ: 161.3 (C-2), 146.0 (C-7), 145.8 (C-6), 144.5 (C-8a), 143.9 (C-4), 130.9 (C-
2’), 115.2 (C-1’), 113.2 (C-3), 111.5 (C-4a), 110.3 (C-8), 108.7 (C-5), 77.2 (C-3’), 56.6 (6-
OMe), 28.1 (C-4’ and C-5’). 
 
Compound 84. Heraclenin (15 mg). HRESI-MS: m/z 287.0841 [M+H]+ . 1H NMR (CDCl3) δ: 
7.76 (1H, d, J=9.6 Hz, H-4), 7.67 (1H, d, J=2.4 Hz, H-2’), 7.38 (1H, s, H-5), 6.80 (1H, d, J=2.4 
Hz, H-1’), 6.35 (1H, d, J=9.6 Hz, H-3), 4.56 (2H, m, H-1’’), 3.29 (2H, m, H-2’’), 1.31 (3H, s, 
H-4’), 1.25 (3H, s, H-5’). 13C NMR (CDCl3) δ: 160.5 (C-2), 148.5 (C-7), 147.0 (C-2’), 144.5 
(C-4), 143.8 (C-8a), 131.6 (C-8), 126.1 (C-6), 116.7 (C-4a), 114.9 (C-3), 114.0 (C-5), 107.0 
(C-1’), 72.6 (C-1’’), 61.5 (C-2’’), 58.3 (C-3’’), 24.7 (C-4’’), 19.0 (C-1’’). 
 
Compound 85. 6,7,8-trimethoxycoumarin (14 mg). EI-MS: m/z 214 [M]+. 1H NMR (CDCl3) δ: 
7.59 (1H, d, J=9.6 Hz, H-4), 6.64 (1H, s, H-5), 6.24 (1H, d, J=9.6 Hz, H-3), 3.99 (3H, s, 6-
OMe), 3.93 (3H, s, 8-OMe), 3.89 (3H, s, 7-OMe). 13C NMR (CDCl3) δ: 160.6 (C-2), 150.2 (C-
6), 146.0 (C-8), 143.7 (C-4), 143.1 (C-7), 141.2 (C-8a), 115.2 (C-3), 114.5 (C-4a), 110.3, 103.8 
(C-5), 61.9 (6-OMe), 61.6 (8-OMe), 56.4 (7-OMe). 
 
Compound 86. Methyleugenol (120 mg). EI-MS: m/z 178 [M]+. 1H NMR (CDCl3) δ: 6.78 
(1H, d, J=8.4 Hz, H-5), 6.71 (1H, d, J=1.6 Hz, H-2), 6.70 (1H, dd, J=1.6 and 8.4 Hz, H-6), 
5.95 (1H, m, H-8), 5.05 (2H, m, H-9), 3.84 (3H, s, 3-OMe), 3.82 (3H, s, 4-OMe), 3.31 (2H, 
d, J=6.7 Hz, H-7). 13C NMR (CDCl3) δ: 148.8 (C-3), 147.3 (C-4), 137.6 (C-8), 132.5 (C-1), 
120.5 (C-6), 115.5 (C-5), 111.8 (C-2), 111.2 (C-9), 55.7(3 and 4-OMe), 39.7 (C-7). 
 
Compound 88a. (±)-Dehydroisoeugenol. EI-MS: m/z 326 [M]+. IR νmax cm-1: 3370. 1H NMR 
δ: 7.10-6.50 (5H, m, H-2, H-2’, H-5, H-6, and H-6’), 6.36 (1H, d, J=15.7 Hz, H-7’), 6.10 (1H, 
dq, J=6.5 and 15.7 Hz, H-8’), 5.64 (1H, s, OH), 5.10 (1H, d, J=9.4 Hz, H-7), 3.89 (3H, s, 
OCH3), 3.87 (3H, s, OCH3), 3.45 (1H, m, H-8), 1.86 (3H, d, J=6.5 Hz, H-9’), 1.37 (3H, d, 
J=6.7 Hz, H-9). 13C NMR δ: 146.7 (C-3’), 146.6 (C-3), 145.8 (C-4’), 144.1 (C-4), 133.3 (C-1), 
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132.2 (C-5’), 132.1 (C-1’), 130.9 (C-1), 123.4 (C-6), 119.4 (C-8’), 114.1 (C-2’), 113.3 (C-2), 
109.3 (C-5), 108.9 (C-6’), 93.7 (C-7), 55.9 (2×OMe), 45.6 (C-8), 18.3 (C-9’), 17.6 (C-9). 
 
Compound 88b. (±)-Dehydrodiconiferyl alcohol. EI-MS: m/z 358 [M]+. 1H NMR (CD3OD) δ: 
6.93 (2H, m, H-2’ and H-6’), 6.82 (1H, dd, J=1.8 and 8.1 Hz, H-6), 6.79 (1H, d, J=1.8 Hz, H-
2), 6.75 (1H, d, J=8.1 Hz, H-5), 6.55 (1H, d, J=15.8 Hz, H-7’), 6.18 (1H, dt, J=6.0 and 15.8 Hz, 
H-8’), 5.58 (1H, d, J=7.2 Hz, H-7), (2H, d, J=6.0 Hz, H-9’), 3.85 (6H, s, 3-OMe and 3’-OMe), 
3.79 (2H, m, H-9), 3.50 (1H, m, H-8). 13C NMR (CD3OD) δ: 147.3 (C-3’), 149.3 (C-3), 141.4 
(C-4’), 140.2 (C-4), 127.6 (C-7’), 126.5 (C-8’), 116.2 (C-6’), 132.4 (C-1), 127.2 (C-1’), 122.0 
(C-6), 135.3 (C-5’), 116.8 (C-5), 115.3 (C-2), 109.6 (C-2’), 88.2 (C-7), 65.6 (C-9’), 63.2 (C-9), 
56.3 (3-OMe and 3’-OMe), 50.4 (C-8). 
 
Compound 90. (±)-Erythro-guaiacylpropan-1,2-diol-β-O-4'-isoeugenylether. 1H NMR 
(CDCl3) δ: 6.98-6.81 (6H, m, H-2, H-2', H-5, H-5’, H-6, and H-6’), 6.38 (1H, d, J=15.7 Hz, H-
7’), 6.17 (1H, dq, J=6.6 and 15.7 Hz, H-8’), 4.84 (1H, d, J=2.8 Hz, H-7),  4.31 (1H, m, H-8), 
3.90 (6H, s, 2×OMe), 1.83 (3H, d, J=6.6 Hz, H-9’), 1.10 (3H, d, J=6.4, H-9). (±)-Threo-
guaiacylpropan-1,2-diol-β-O-4'-isoeugenylether: 1H-NMR (CDCl3) δ: 6.98-6.91 (6H, m, H-2, 
H-2', H-5, H-5’, H-6, and H-6’), 6.38 (1H, d, J=15.5 Hz, H-7’), 6.17 (1H, dq, J=6.6 and 15.5 
Hz, H-8’), 4.74 (1H, d, J=8.8 Hz, H-7), 4.26 (1H, m, H-8), 3.88 (6H, s, 2×OMe), 1.83 (3H, d, 
J=6.6 Hz, H-9’), 1.04 (3H, d, J=6.3, H-9). 
 
Compound 91. (±)-Threo-guaiacylpropan-1,2-diol-α-O-4'-isoeugenylether. HREI-MS: m/z 
344.1620 [M]+. 1H NMR (CDCl3) δ: 6.75-6.95 (4H, m, H-2, H-6, H-2', H-5'), 6.66 (1H, d, 
J=7.0 Hz, H-5), 6.58 (1H, d, J=9.0 Hz, H-6'), 6.29 (1H, d, J=15.5 Hz, H-7'), 6.08 (1H, dt, 
J=6.5 and 15.5 Hz, H-8'), 4.43 (1H, d, J=7.8 Hz, H-7), 4.07 (1H, m, H-8), , 1.84 (3H, d, 
J=6.5 Hz, H-9'), 1.01 (3H, d, J=6.0 Hz, H-9), 3.90 (3H, s, 3-OMe), 3.89 (3H, s, 3’-OMe). 
13C NMR (CDCl3) δ: 150.6 (C-3), 147.9 (C-3’), 147.1 (C-4), 145.1 (C-4’), 133.6 (C-1'), 
131.0 (C-1), 130.2 (C-7'), 125.6 (C-8'), 120.9 (C-6), 119.1 (C-6'), 118.8 (C-5), 114.5 (C-5'), 
109.8 (C-2'), 109.3 (C-2), 91.0 (C-7), 71.3 (C-8), 57.5 (3 and 3’-OMe), 18.9 (C-9’), 18.0 
(C-9).  
 
Compound 92. 4-formyl-2-methoxyphenyl 4-hydroxy-3-methoxybenzoate. HREI-MS: m/z 
302.0785 [M]+.  1H NMR (CDCl3) δ: 9.98 (1H, s, H-7’), 7.84 (1H, dd, J=2.0 and 8.4 Hz, H-6), 
7.67 (1H, d, J=2.0 Hz, H-2), 7.54 (1H, d, J=1.6 Hz, H-2’), 7.52 (1H, dd, J=1.6 and 8.0 Hz, H-
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6'), 7.33 (1H, d, J=8.0 Hz, H-5’), 7.02 (1H, d, J=8.4 Hz, H-5), 3.99 (3H, s, 3-OMe), 3.89 (3H, 
s, 3’-OMe). 13C NMR (CDCl3) δ: 192.2 (C-7’), 165.7 (C-7), 152.4 (C-3’), 151.2 (C-4), 146.7 
(C-3), 146.1 (C-4’), 125.8 (C-6), 125.0 (C-5’ and C-6’), 114.8 (C-5), 113.8 (C-2), 111.2 (C-2’), 
57.0 (3 and 3’-OMe).  
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3. RESULTS AND DISCUSSION 
 
Two spontaneous plants of the Mediterranean area, Aptenia cordifolia and Oxalis pes-caprae, 
besides two Rutaceous plants, Swinglea glutinosa and Amyris madrensis, have been 
investigated in order to study the metabolites they produce and to determine whether or not 
they possess biological activity.  
All pure compounds were isolated by chromatographic techniques (CC, TLC, HPLC) and 
identified by using Mass Spectrometry (EI-MS, ESI-MS, MALDI-MS), NMR spectroscopy on 
1H and 13C by one-dimensional and two-dimensional experiments, IR, and UV. For each plant 
the isolated compounds are described and the investigation modalities that allowed their 
structural elucidation are reported. Biological assays results are also illustrated. 
 
3.1. Aptenia cordifolia 
 
Aptenia cordifolia, belonging to the Aizoaceae family, is native of South Africa and now 
largely diffused in the United States (California, Florida, Oregon) and along the southern coast 
of Europe. It is a perennial herb, spreading over ground and neighbouring vegetation, with 
small, heart-shaped, dark green succulent leaves interspersed with small, purple flowers that 
open only in spring and summer. The most commonly grown plant, usually grown under the 
cultivar name of 'Red Apple', has brighter red flowers and is considered by some botanists to 
be actually a hybrid between Aptenia cordifolia and the closely related Platythyra Aptenia 
haeckeliana.23
 
 
 
Fig. 1- Aptenia cordifolia 
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It is planted in parking lot planters, parkways, home gardens, in the urban interface near parks 
and preserves. It can tolerate some soil salinity and grows well in frost-free or almost frost free 
areas in full sun. When watered, red apple overwhelms all neighbouring vegetation, climbing 
over anything in its path, this invasiveness has recently become a serious problem. It has been 
used in landscaping adjacent to riparian areas within the urban interface, so it can easily spread 
into and dominate more natural riparian and wetland areas.  
Fresh leaves and twigs of A. cordifolia were powdered and then extracted with H2O - CH3OH 
(9:1) at 25 °C for 7 days.  
The hydroalcoholic extract of A. cordifolia leaves was reduced in volume and precipitated with 
(CH3)2CO. The (CH3)2CO/H2O soluble part was fractionated by Amberlite XAD-2 column 
chromatography and fractions were purified by silica gel chromatography and HPLC yielding 
compounds 3, 4, 6, 7, 9-14, 16-31, 34-40.24, 25, 26  
Repeated column chromatographies and preparative TLC of the hydroalcoholic extract of twigs 
of the plants, after acetone precipitation, afforded compounds 1, 2, 5, 8, 15, 32, 33.26 The 
structures of  all the compounds were elucidated by their spectral data.  
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Phenols 1-5 were identified as 3,4,5-trimethoxyphenol, 4-hydroxybenzoic acid, methyl 2,5-
dihydroxybenzoate, 4-(hydroxylmethyl)phenol, and 4-(hydroxymethyl)-2,6-dimethoxyphenol, 
respectively; metabolites 6-9 were identified as ferulic acid, methyl ferulate, sinapic acid, and 
3,4,5-trimethoxycinnamic acid, respectively. Compounds 10-15 were identified as 
dihydrocinnamic acid, 4-hydroxy-dihydrocinnamic acid, dihydroferulic acid, 3,4-dimethoxy-
dihydrocinnamic acid, and the corresponding Me and Et esters, respectively. All these 
compounds were identified by comparison of their spectroscopic data with those of authentic 
samples.  
Compounds 16-25 were determined to have a lignan skeleton.  
Lignans, widely distributed in the plant kingdom, are constituted by phenylpropanoid (C6C3) 
units linked by the central carbons of their side chains. Naturally occurring dimers that exhibit 
linkage other than this C8-C8’ type linkage are known as neolignans, or oxyneolignans if the 
C6C3 units are linked by an oxygen atom. 
Biogenetically they derive from the oxidative coupling of phenylpropanoid units, 
biosynthesized from the shikimic acid pathway, through radical processes. 
Repeating units of lignans generate lignins, which are involved in the lignification of plants 
cell walls to generate solid structures and watering conduction system in trees. Many lignans 
exhibit interesting antimicrobic, antiviral, herbicidal, or antifeedant activities that are thought 
to participate in plant defence mechanisms against biotic stresses.27 Cancer protective effects of 
dietary lignans have been also demonstrated.28
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Compound 16 was identified as (-)-pinoresinol by analysing the spectroscopic data and 
comparing them to literature.29 It has a molecular formula C20H22O6 as deduced from the 
molecular ion peak [M]+ m/z 358 in the EI mass spectrum and NMR data. The 13C NMR 
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spectrum showed ten signals, that from a DEPT experiment were deduced to be three methines 
(δ 108.6, 114.3, and 118.9) and three quaternary carbons (δ 132.9, 145.2, and 146.7), in the 
aromatic region. At higher fields the signals of a methylenic carbon at δ 71.6, a benzylic 
methine at δ 85.8, an aliphatic methine carbon at δ 54.1, and a methylic carbon at δ 55.9 were 
present. These data were in agreement with a dioxabicyclic system, having two condensed 
furanic rings symmetrically substituted by phenylic rings. According to this hypothesis, 1H 
NMR spectrum showed three aromatic protons of a 1,2,4-trisubstituted system, a benzylic 
proton bonded to an oxygen atom at 4.74 (d, J=4.0 Hz), two double doublets due to the two 
diastereotopic protons of the methylenic group at δ 4.25 (J=7.0 and 9.0 Hz), and δ 3.88 (J=4.0 
and 9.0 Hz), a multiplet at δ 3.10 of a methinic proton, and the signal of two methoxyls at 
δ 3.91. Chemical shift values and couplings of the protons H-7 and H-9 defined the relative 
configuration of the compound. The absolute configuration was assigned by the measure of the 
optical rotation ([α]D25= -10°) and comparing it to literature value.29
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Compound 17 had the molecular ion peak [M]+ at m/z 418 in the EI mass spectrum. The 1H 
NMR spectrum showed the signals of a tetrasubstituted aromatic ring and of a C3 side chain. In 
a 1H-1H COSY experiment a doublet at δ 4.72 coupled to a multiplet at δ 3.09, which, in turn, 
was correlated to two different multiplets at δ 4.26 and 3.61. These chemical shifts data are 
typical of a dioxabicyclic system. A singlet integrated for twelve protons appeared at δ 3.89. 
Comparison with literature30 data univocally defined compound 17 as (±)-syringaresinol. 
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Spectral data suggested the molecular formula C44H54O18 for the new compound 18. It had a 
pseudo-molecular ion peak [M+Na]+ at m/z 893  in the MALDI mass spectrum. In the 13C 
NMR (DEPT) spectrum of 18 only sixteen signals were present, indicating a highly symmetric 
molecule. The 1H NMR and 1H-1H COSY spectra revealed the connectivities of four H-atoms 
characteristic of one 3,7-dioxabicyclo[3.3.0]octane and two propane-1,2,3-triol moieties. The 
1H and 13C NMR spectra of 18 showed the presence of four aromatic rings, each one with two 
H-atoms in meta position relative to each other. The COSY spectrum enabled us to define the 
two glycerol moieties as C-7'', C-8'', C-9'' [δ(H): 4.99 (d, J=4.0 Hz); 4.13 (m), 3.88 (obscured), 
3.50 (dd, J=2.4 and 12.0 Hz)]. The coupling constant of 4.0 Hz between H–7'' and H–8'' 
indicated an erythro relative configuration. The 13C NMR and DEPT spectra of 18 showed two 
methyls, two methylenes, and five methines, as well as six quaternary carbons, which were 
connected by HMQC analysis. The functional groups were attached to the main skeleton with 
the aid of HMBC correlations. In the HMBC spectrum, H–7 correlated to C-2/C-6, C-8, and C-
9. The doublet at δ 4.99 was attributed to H-7'', with HMBC correlations with C-1'', C-2''/C-6'', 
and C-9''. Finally, NOEs between the methyl groups at δ 3.90 and 3.88 with H-2/H-6 and H-
2''/H-6'', respectively, defined the positions of the methoxyl groups. From these data, the 
structure of the new dilignan 18 was elucidated as di-erythro-syringylglycerol-β-O-4,4'-
syringaresinol ether. 
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Compound 19 showed the molecular ion peak [M]+ at m/z 256 in the EI mass spectrum that, 
along with NMR data, suggested a molecular formula C15H12O4. The UV spectrum revealed an 
absorption maximum at 276 nm, and the IR spectrum showed bands typical of carbonyl (1687 
cm-1) and phenyl (1604 cm-1) groups.  
The 1H NMR spectrum of 19 indicated the presence of four ortho-coupled H-atoms, two 
doublets, and one singlet in the aromatic region, as well a singlet integrated for three protons 
and two singlets due to formyl groups. In the 13C NMR (DEPT) spectrum, twelve resonances 
were evident, including one methyl and seven aromatic methines. An HMQC experiment 
allowed the assignment of all H-atoms, with key HMBC cross-peaks of both H-2 and H-5 to C-
3 and C-4, and of H-6 to C-1 and C-7. Furthermore H-2'/H-6' coupled with C-4' and C-7', H-7 
showed a cross-peaks with C-1 and C-2/C-6, and H-7' interacted with C-1' and C-2'/C-6'. 
Finally, the methoxyl group was placed at C-3, based on an NOE between C-3 and H-2. From 
these data, the structure of 19 was derived as 4-(4-formylphenoxy)-3-methoxybenzaldehyde. 
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Compound 20 showed a pseudo-molecular ion peak [M+Na]+ at m/z 337 in the MALDI 
spectrum. The UV spectrum revealed a band at 278 nm. The 1H and 13C NMR spectra indicated 
a highly symmetric molecule. In the 1H NMR spectrum eight aromatic protons were present as 
two ortho coupled protons and eight methylene protons as two triplets in aliphatic region. The 
13C NMR spectrum showed only seven carbon signals that were assigned by a DEPT 
experiment as two methylenes and two methines. According to the structure in the HMBC 
spectrum both the H-7/H-7′ and H-8/H-8′ protons were correlated to the C-9/C-9′ at δ 180.6 
and C-1/C-1′ at δ 129.6; furthermore the H-3/H-3′ protons were correlated to C-1/C-1′ and C-
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4/C-4′ carbons at δ 157.4. From these data compound 20 was determined to be 4,4’-
oxyneolign-9,9’-dioic acid. 
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Compound 21 was identified as 3-methoxy-4,4’-oxyneolign-9,9’-dioic acid. The pseudo-
molecular ion peak at m/z 390 [M+2Na]+ in the MALDI spectrum, along with 13C NMR 
spectrum, defined the molecular formula C19H20O6. The 1H NMR spectrum indicated the 
presence of four ortho coupled protons, two doublet protons, and one double doublet proton in 
the aromatic region; a methyl singlet of a methoxyl group and two triplets in the aliphatic 
region. In the 13C NMR spectrum fourteen carbons were evident. The DEPT spectrum 
indicated the presence of a methyl, three methylenes, and five methines. The HMQC 
experiment allowed the assignment of the protons to the corresponding carbons. The HMBC 
spectrum showed cross-peaks of both the H-2 and H-5 protons with the C-3 and C-4 carbons 
and the H-6 with the C-1 and C-7. Furthermore the H-2′/H-6′ protons gave cross peaks with the 
C-4′ and C-7′ carbons, the H-7′ and the H-8′ protons gave cross peaks with the C-1′ and C-9′ 
carbons. These data led to the structure 21 as depicted. The assignment of the methoxyl at C-3 
was confirmed by NOE between the methoxyl and the H-2 proton. 
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Compound 22 had a pseudo-molecular ion peak [M+H]+ at m/z 373 in the MALDI mass 
spectrum. Its NMR spectrum closely resembled those of 21, except for an additional signal at δ 
3.67, due to two methoxyl groups. These data suggested that compound 22 is dimethyl 3-
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methoxy-4,4’-oxyneolign-9,9’-dioate. The structure was also deduced from the NOE observed 
between the methoxyls and the H-8/H-8′ protons in the NOESY experiment. Compound 22 
was also obtained by treatment of apteniol 21 with ethereal CH2N2. 
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Compound 23 was deduced to be 3,3’,5-trimethoxy-4,4’-oxyneolign-9,9’-dioic acid. It had the 
molecular formula C21H24O8, as established by a pseudo-molecular peak at m/z 427 [M+Na]+ in 
the MALDI mass spectrum and spectroscopic data. The 1H NMR spectrum showed the 
presence of one aromatic ring with three coupled protons in a ABX system, an aromatic ring 
with two protons meta coupled, two methylenes as triplets and a methyl singlet of three 
methoxyls. In the 13C NMR spectrum fifteen carbon signals were present, and the DEPT 
experiment evidenced two methyls, two methylenes, and four methines. The 1H and 13C 
resonances were assigned by combination of COSY, DEPT, HMQC, and HMBC experiments. 
The HMBC spectrum of compound 23 showed cross-peaks of both the H-2 and H-6 with C-4 
and C-7, and both the H-2′ and the H-5′ protons with the C-1′ and C-4′ carbons. NOEs between 
the signal at δ 3.87 and the H-2, H-6 and H-2′ protons allowed to assign  the methoxyls at C-3, 
C-5, and C-5′ positions.  
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Compound 24 was defined as 3,3’,5,5’-tetramethoxy-4,4’-oxyneolign-9.9’-dioic. The UV 
spectrum revealed bands at 322, 279, and 244 nm. The 1H NMR spectrum showed only one 
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singlet aromatic signal, two triplets in aliphatic region, and a methyl signal. In the 13C NMR 
spectrum only eight carbon signals were present indicating a highly symmetric molecule. The 
1H and 13C resonances of 24 were assigned by combination of COSY, DEPT, HMQC, and 
HMBC experiments. The DEPT spectrum showed one methyl, two methylenes, and one 
methine. According to the structure in the HMBC spectrum both the H-7/H-7′ and the H-8/H-8′ 
protons were correlated to the C-9/C-9′ at δ 178.4 and the C-1/C-1′ at δ 132.0; furthermore the 
H-2, H-6/H-2′, H-6′ protons were correlated to the C-1/C-1′ and C-4/C-4′ carbons. The NOE of 
the signal at δ 3.88 with H-2/H-6 and H-2′/H-6′ allowed assignment of the methoxyls at the C-
3, C-3′, C-5, and C-5′ positions. 
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Compound 25 was determined to be 3’-methoxy-2,4’-oxyneolign-9,9’-dioic acid. The 1H NMR 
spectrum showed the presence of one aromatic ring with three coupled protons in a ABX 
system, an aromatic ring with four adjacent protons, two methylenes as triplets and a methyl 
singlet of a methoxyl group. In the 13C NMR spectrum sixteen carbon signals were present, and 
the DEPT experiment showed one methyl, four methylenes, and five methines. The HMQC 
experiment allowed the assignment of the protons to the corresponding carbons. The HMBC 
spectrum of compound 25 showed cross-peaks of H-7 with C-2, C-6, and C-9; H-8 with C-1, 
and both the H-2′ and the H-5′ protons with the C-1′ and C-4′ carbons. NOEs between the 
signal at δ 3.87 and H-2′, allowed assignment of the methoxyl at the C-3′ position.  
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      Table 2.  1H NMR Data of 20 - 25 (CD3OD)a at 500 MHz  
Position 20 21 22b 23b 24b 25 
2 6.92 d (8.5) 6.72 d (1.5) 6.70 d (1.5) 6.44 s 6.42 s  
3 6.63 d (8.5)     7.21c)
4      7.23c)
5 6.63 d (8.5) 6.82 d (8.2) 6.83 d (8.0)   7.12 m 
6 6.92 d (8.5) 6.70 dd (8.2, 
1.5) 
6.68 dd (8.0, 
1.5) 
6.44 s 6.42 s 7.21c)
7 2.84 t (8.1) 2.89 t (8.0) 2.88 t (7.5) 2.90 t (7.5) 2.88 t (8.0) 2.89 t (7.6) 
8 2.66 t (8.1) 2.66 t (8.0) 2.59 t (7.5) 2.67 t (7.5) 2.61 t (8.0) 2.44 t (7.6) 
2′ 6.92 d (8.5) 7.05 d (8.5) 7.05 d (9.0) 6.72 s 6.42 s 6.82 d (2.0) 
3′ 6.63 d (8.5) 6.74 d (8.5) 6.75 d (9.0)    
5′ 6.63 d (8.5) 6.74 d (8.5) 6.75 d (9.0) 6.82 d (8.5)  6.67 d (8.0) 
6′ 6.92 d (8.5) 7.05 d (8.5) 7.05 d (9.0) 6.70 d (8.5) 6.42 s 6.63 dd (8.0, 
2.0) 
7′ 2.84 t (8.1) 2.89 t (8.0) 2.88 t (7.5) 2.90 t (7.5) 2.88 t (8.0) 2.82 t (7.8) 
8′ 2.66 t (8.1) 2.66 t (8.0) 2.61 t (7.5) 2.67 t (7.5) 2.61 t (8.0) 2.41 t (7.8) 
3-OMe  3.86 s 3.87 s 3.87 s 3.88 s  
5-OMe    3.87 s 3.88 s  
3′-OMe    3.87 s 3.88 s 3.87 s 
5′-OMe     3.88 s  
9-OMe   3.67 s    
9′-OMe   3.67 s    
a J values (in Hz) in parentheses; b recorded in CDCl3500 MHz; c multiplicity was not determined due to 
overlapping. 
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Table 3. 13C NMR Data of 20-25 (CD3OD) at 125 MHz     
 Position 20  21 22a 23a 24a 25 
1 129.6 132.1 132.7 133.1 132.0 135.7
2 130.7 111.0 110.2 104.8 104.9 113.5
3 116.6 146.4 146.7 146.9 147.0 148.6
4 157.4 144.0 144.2 131.9 145.2 145.8
5 116.6 114.4 114.6 146.9 147.0 116.4
6 130.7 120.8 121.0 104.8 104.9 122.0
7 35.7 30.3 30.9 30.7 31.2 34.0 
8 42.9 35.9 36.3 35.7 36.1 41.9 
9 180.6 178.9 173.8 177.8 178.4 182.2
1′ 129.6 132.1 130.0 131.2 132.0 127.1
2′ 130.7 129.4 129.6 110.8 104.9 144.2
3′ 116.6 115.4 115.5 146.9 147.0 129.2
4′ 157.4 154.1 154.4 144.0 145.2 129.2
5′ 116.6 115.4 115.5 114.3 147.0 126.6
6′ 130.7 129.4 129.6 120.7 104.9 129.2
7′ 35.7 30.3 30.9 30.2 31.2 34.4 
8′ 42.9 35.8 36.3 35.7 36.1 41.6 
9′ 180.6 178.9 173.8 177.8 178.4 182.2
3-OMe  55.8 56.1 56.1 56.3 56.5 
5-OMe    56.1 56.3  
3′-OMe    55.7 56.3  
5′-OMe     56.3  
9-OMe   51.9    
9′-OMe   51.9    
a recorded in CDCl3. 
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Compound 26 was identified as 2-(dimethylamino)-1-phenylethanol. The EI mass spectrum 
showed the molecular ion peak [M]+ at m/z 165, with a prominent fragment [M-Me]+ at m/z 
150. The structure of 26 was established by means of 1H and 13C NMR (DEPT) as well as 2D 
NMR analyses, including COSY, HMQC, and HMBC experiments. The 1H NMR spectrum 
indicated the presence of five aromatic protons at δ 7.40 (2Η, d, J=7.0 Hz), 
7.35 (2Η, t, J=7.0 Hz), and 7.28 (1Η, d, J=7.0 Hz); three double doublets at δ 4.86 (J=3.5 and 
9.5 Hz), 2.81 (J=2.8 and 9.5 Hz ), and 2.66 (J=3.5 and 12.8 Hz), and two methyl singlets at δ 
2.35. In the 13C NMR (DEPT) spectrum, seven resonances were evident due to one methyl, one 
methylene, and four methines. An HMQC experiment allowed the assignment of the protons to 
the corresponding carbons, and the HMBC spectrum showed cross-peaks of both H-1 and H-2 
to C-1', and of H-2'/H-6' to C-1 and C-3'/C-5'. These data confirmed the structure of 26, which 
had been isolated before from Dolichothele uberiformis as the corresponding hydrochloride31, 
exhibiting an [α]D25 value of -74°. Compound 26 isolated from A. cordifolia had [α]D25 value 
of +1.1°. 
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Compounds 27 and 28 were identified as 3-(1H-indol-3-yl)propanoic acid and its Me ester, 
respectively. 
Compounds 29-34 were identified as C13 norisoprenoids. These molecules are generally found 
as aroma compounds in fruits and vegetables, but also in many leaf products such as tea or 
tobacco. C13 norisoprenoids are supposed to be structurally derived from higher molecular 
weight terpenoids such as carotenoids, through degradation processes.  
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Compound 29 was determined to be 3-hydroxy-7,8-dihydro-β-ionone, and has been previously 
isolated from the fruits of Prunus species.32 Compounds 30 and 31 had spectroscopic data 
corresponding to (9R)-9-hydroxymegastigm-4-ene-3-one and megastigm-4-ene-3,9-dione, in 
agreement with those isolated from Chenopodium album.33 Compound 32 was identified as 
dehydrololiolide, previously isolated from Vitis vinifera.34 Finally, the structure of 4-oxo-7,8-
dihydro-β-ionone (33) was determined by spectroscopic comparison with a synthetic 
intermediate previously obtained during the preparation of canthaxanthin.35
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Compound 34 was identified as (3R,9R)-3,9-dihydroxymegastigm-5-en-4-one, previously 
identified in the metabolism of astaxanthin, a carotenoid non-provitamin A.36 The molecular 
ion peak [M]+ at m/z 226 in the EI mass spectrum and the 13C NMR spectrum were in 
agreement with the molecular formula C13H22O3. In the 1H NMR spectrum of 34 there were 
three methyl singlets at δ 1.23, 1.29, and 1.83, one methyl doublet at δ 1.28, three methylenes 
groups at δ 2.15/1.77 (H-2), 2.50/2.30 (H-7), and 1.60 (H-8), a double doublet at δ 4.30 (H-3) 
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and a multiplet at δ 3.89 (H-9) due to two oxygenated methines. The 13C NMR (DEPT) 
spectrum showed thirteen signals, including four methyls, three methylenes, two methines, and 
four quaternary carbons, which were assigned on the basis of HMQC experiments. 
1H-1H COSY experiments with 34 showed a correlation series beginning with δ 3.89 (H-9), 
which was coupled to the methyl doublet at δ 1.28 (H-10) and to H-8 at δ 1.60. The latter, in 
turn, was correlated with H-7 at δ 2.50/2.30. The signal at δ 4.30 was correlated to the 
methylene at δ 2.15/1.77. The C=O group was placed in 4-position, and the OH groups were 
attached to C-3 and C-9, respectively, on the basis of HMBC experiments. HMBC correlations 
of H-2 and H-13 with C-4, of H-2 with C-3, and of H-8 and H-10 with C-9 confirmed the 
above assignments. In the NOESY spectrum of 34, spatial interactions between the CH3 groups 
at δ 1.23 and H-3, and between the CH3 at δ 1.29 and H-2 were observed, which allowed us to 
differentiate between H-11 and H-12 methyls. 
The absolute configuration of 34 was established by Mosher’s method37 upon conversion of 34 
into the diastereoisomeric Mosher diesters. 1H-1H COSY experiments allowed us to identify 
the signals for H-2 and H-8 of the two diastereoisotopic diesters. Comparison of the chemical 
shifts of these protons in both the (R)- and the (S)-Mosher derivatives, and calculation of the 
corresponding shift differences, expressed as Δδ = δ(R) – δ(S), were in agreement with an (R)-
configuration at both C-9 and C-3, as further confirmed by a positive Δδ value for CH3-13, and 
negative ones for CH3-11 and CH3-12.38
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Compound 35 was identified as 3-O-methyl-chiro-inositol. The ESI mass spectrum showed the 
pseudo-molecular ion peak [M+H]+ at m/z 195. The 1H NMR spectrum showed a methoxyl 
group at δ 3.35, and six methines at δ  3.91, 3.89, 3.73, 3.62, 3.58, and 3.25. The 13C NMR 
(DEPT) spectrum showed signals due to seven carbons, including one methyl and six methine 
groups. Analysis of the 1H-1H COSY and HSQC spectra of 35 suggested the presence of a 
sequence of six consecutive methine groups, and their 1H NMR coupling constants were in 
good agreement with those previously reported.39 The methoxyl group was positioned at C-3, 
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on the basis of HMBC correlations between C-3 and H-1, H-2, H-4, H-5, and the Me, 
respectively. 
Furthermore, three cinnamic acid amides (36-38) and two lignanamides (39-40) were isolated 
from A. cordifolia leaves. Cinnamic acid amides are constituted of a cinnamic acid unit linked 
to a tyramine derivative. Hydrocinnamic acid amides have been observed in the leaves of 
virus-infected tobacco and the authors40 suggested that they have antiviral effect. Several 
amides and lignanamides have been found in Cannabis sativa and Procelia macrocarpa,41 
some of them proved to have biological activities. 
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36 
 
The molecular formula of compound 36 was deduced to be C18H19NO5 as the EIMS spectrum 
showed the molecular ion peak [M]+ at m/z 329. The UV spectrum revealed bands at 222, 294, 
and 316 nm. Signals at δ 7.44 (1H, d, J=15.8 Hz, H-7) and 6.45 (1H, d, J=15.8 Hz, H-8), in the 
1H NMR spectrum, indicated the presence of a trans-substituted double bond. Signals at δ 7.12 
(1H, d, J=1.9 Hz, H-2), 6.79 (1H, d, J=8.8 Hz, H-5), and 7.03 (1H, dd, J=1.9 and 8.8 Hz, H-6) 
in the 1H NMR spectrum suggested the presence of a 1,2,4-trisubstituted aromatic ring, as did 
signals at δ 111.7 (C-2), 116.1 (C-5), and 123.3 (C-6) in the 13C NMR (DEPT) spectrum. In the 
HMBC spectrum, long-range correlations from the H-7 olefinic proton to the carbonyl carbon 
C-9 (δ 169.6) and the methine carbons C-2 and C-6 were observed, indicating the presence of a 
feruloyl group. Signals at δ 7.22 (2H, d, J=8.9 Hz, H-2’, H-6’) and 6.77 (2H, d, J=8.9 Hz, H-3’, 
H-5’) in the 1H NMR spectrum, and signals at δ 128.4 (C-2’ and C-6’) and 116.5 (C-3' and 
C5'), in the 13C NMR (DEPT) spectrum, suggested the presence of a p-substituted aromatic 
ring. In the 1H NMR spectrum, the signals at δ 4.72 (1H, dd, J=4.9 and 7.8 Hz, H-7’), 3.53 
(1H, dd, J= 4.9 and 13.7 Hz, H-8a'), 3.44 (1H, dd, J=7.8 and 13.7 Hz, H-8b'), as well as, signals 
at δ 73.5 (C-7'), and 48.1 (C-8') in the 13C NMR (DEPT) spectrum indicated the presence of a 
2-amino ethanoyl chain. In the HMBC spectrum, long-range correlations from the H-8’ protons 
to the carbonyl carbon and the methine carbon (δ 73.5, C-7') were observed, indicating the 
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presence of a 2-hydroxy-2-(4-hydroxyphenyl) ethyl amine group (octopamine) linked to C-9 of 
the ferulic unit. The structure of compound 36 was N-[2-hydroxy-2-(4-hydroxyphenyl)ethyl] 
ferulamide. The optical rotation of 36 was found to be -3.0°, establishing the S (-) absolute 
configuration at C-7′ chiral center.42 The R (+) isomer was previously isolated from root bark 
of Lycium chinense43 and it showed antifungal activity. This substance was synthesized in a 
combinatorial library of a small molecule that selectively induces apoptosis in cancer cells.44 
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Data analysis of compound 37 has led to identify it as N-feruloyl normetanephrine. It had 
molecular formula C19H21NO6 as deduced from the molecular ion peak [M]+ at m/z 359 in the 
EIMS spectrum. The UV spectrum revealed bands at 226, 298, and 320 nm. The 13C NMR 
spectrum showed the presence of seventeen signals. The DEPT experiment evidenced a 
methyl, a methylene, and nine methines. In the 1H NMR spectra, signals corresponding to two 
1,2,4-trisubstituted aromatic rings were present. The H-2, H-5, and H-6 of the ferulic moiety, 
in the 1H NMR spectrum, were at δ 7.13, 6.80, and 7.03, as a narrow doublet, a doublet, and a 
double doublet, respectively. The H-2', H-5', and H-6' of the normetanephrine moiety were at δ 
7.00, 6.77, and 6.83 as a narrow doublet, a doublet, and a double doublet, respectively. 
Furthermore, the spectrum showed the H-7 and H-8 trans olefinic protons at δ 7.45 and 6.47, 
the H-8' methylene as two double doublets at δ 3.54 and 3.44, and the H-7' as a double doublet 
at δ 4.73. In a NOE experiment the protons of the methoxyl group at δ 3.88 had relation with 
the proton doublet at δ 7.13  and the protons of the methoxyl at δ 3.86 had relation with the 
protons at δ 7.00. Finally, the HMBC experiment evidenced the following correlations: H-2' 
with C-4'; H-5' with C-1' and C-3'; H-6' with C-4' and C-7'; H-8' with C-9 and C-1'; H-2 with 
C-4; H-5 with C-1 and C-3; H-6 with C-4 and C-7; H-7 with C-9, and H-8 with C-1. This is the 
first report of N-feruloyl normetanephrine from plant extract. It was previously identified 
during the cloning and expression of a potato cDNA encoding hydroxycinnamoyl-
CoA:tyramine N-(hydroxycinnamoyl) trasferase.45
 56
  
OMe
HO
N
H
O
O
OH
1''
 
 
38 
 
Compound 38 had never been isolated before. It had the molecular formula C21H25NO5 as 
deduced from the molecular ion peak [M]+ at m/z 371 in the EIMS spectrum. The general 
features of its MS and NMR spectra closely resembled those of 36, except that for the presence 
of 42 mass unit more than 36, and three signals in the 1H NMR (δ 3.28, 1.58, and 0.92) and 13C 
NMR (δ 72.1, 24.5, and 11.5) spectra attributed to an n-propyl group. The long-range 
correlations, in the HMBC spectrum, from the H-7’ protons to the C-8’ carbon and the methine 
carbon (δ 72.1, C-1”) were observed, indicating that the n-propyl group was linked to the 
alcoholic hydroxyl.  
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39 
 
Compound 39 showed the pseudo-molecular ion peak [M-H]- at m/z 623 in the MALDI mass 
spectrum. Its molecular formula was deduced to be C36H36N2O8 from NMR spectral data. The 
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UV spectrum revealed bands at 246, 315, and 336 nm. The 1H and 13C resonances of 39 were 
assigned by combination of COSY, DEPT, HMQC, and HMBC experiments. Two doublets at 
δ 7.40 and 6.38 (J=16.0 Hz), in the 1H NMR spectrum, indicated the presence of a trans-
substituted double bond. Furthermore, an olefinic proton singlet at δ 7.59 was evident. Signals 
at δ 6.52 (1H, d, J=2.0 Hz, H-2), 6.65 (1H, d, J=8.0 Hz, H-5), and 6.74 (1H, dd, J=2.0 and 8.0 
Hz, H-6), in the 1H NMR spectrum, suggested the presence of a 1,2,4-trisubstituted aromatic 
ring, as did correlations with the signals at δ 113.6 (C-2), 116.4 (C-5), and 116.8 (C-6) in the 
HSQC spectrum. The 1H NMR spectrum showed two narrow doublets at δ 7.19 (1H, d, J=2.0 
Hz, H-2′), 6.83 (1H, d, J=2.0 Hz, H-6′), of a 1,3,4,5-tetrasubstituted aromatic ring, correlated in 
the HSQC experiment at δ 112.2 and 125.1 carbon signals, respectively. Furthermore, eight 
ortho-coupled protons of two disubstituted aromatic rings were present as doublets at δ 7.04 
(2H, d, J=8.0 Hz, H-2′′, H-6′′), 6.70 (2H, d, J=8.0 Hz, H-3′′, H-5′′), 6.91 (2H, d, J=8.0 Hz, H-
2′′′, H-6′′′), and 6.62 (2H, d, J=8.0 Hz, H-3′′′, H-5′′′), correlated in the HSQC experiment to 
the carbon signals at δ 131.2 and 116.8. Signals at δ 3.47 (2H, t, J=6.8 Hz, H-8′′), 2.75 (2H, t, 
J=6.8 Hz, H-7''), 3.43 (2H, t, J=6.8 Hz, H-8'''), 2.65 (2H, t, J=6.8 Hz, H-7'''), correlated in the 
HSQC experiment to the carbons at δ 43.0 (C-8'', C-8'''), 36.2 (C-7''), and 35.9 (C-7'''), 
indicated the presence of two 2-amino ethyl chains of a tyramine group. Long-range 
correlations between the H-7 olefinic proton and the carbonyl carbon (δ 170.4, C-9), the C-2 
and C-6 methine carbons, and the C-1 and C-5′ quaternary carbons in the HMBC spectrum 
indicate the presence of a 8-linked feruloyl group. Long-range correlations from the H-7’ 
proton to the carbonyl carbon (δ 169.5), the C-2′, C-6′, C-8′ methine carbons, and the C-1′ 
quaternary carbon, in the HMBC spectrum indicating the presence of a 5-linked feruloyl group. 
These correlations were consistent with a 8-5′ neolignan structure. The correlations from the 
H-8′′ protons to the C-9, and from the H-8′′′ protons to the C-9′ indicate the presence of two 
tyramine groups linked to C-9, and C-9′ carbons. The analysis of the NOESY spectrum 
evidenced NOEs between the H-7 proton with H-2 and H-6; the H-2 proton with 3-OMe; the 
H-2′ with H-8′ and 3′-OMe; the H-7′′ and H-8′′ with H-2′′ and H-6′′; the H-7′′′ and H-8′′′ with 
H-2′′′ and H-6′′′. These data confirmed the structure of compound 39 as depicted, it had never 
been isolated before.  
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40 
 
Compound 40 showed the pseudo-molecular ion peak [M-H]- at m/z 623 in the MALDI mass 
spectrum. Its molecular formula was deduced to be C36H36N2O8. The 1H and 13C resonances of 
40 were assigned by combination of COSY, DEPT, HMQC and HMBC experiments. The 1H 
NMR spectrum of 40 showed the presence of two tyramine moieties, six aromatic and/or 
olefinic protons, two methoxy signals and two methine protons signals, which were coupled 
with each other. The 1H and 13C NMR data of 40 were almost coincident with those reported 
by Sakakibara et al.46 for the dihydronaphthalene lignan, cannabisin D. The authors indicated a 
trans configuration of the phenyl group at C-7′ and the amide carbonyl at C-8' supported by the 
coupling constant between H-7′ and H-8′. Compound 40 showed, in the 1H NMR spectrum, the 
relative protons as two doublet at 4.36 and 3.70 (J=3.9 Hz). The coupling constant between H-
7′ and H-8′ indicates that the corresponding dihedral angle should be ca 45°. The minimized 
structure obtained by MM2 calculation47 was used to generate dihedral angles and an angle of 
52° was measured, which is compatible with a cis configuration (Fig. 2).48 Correspondingly, 
the NOESY spectrum of 40 showed NOE between H-7′ with H-5 and H-2′, so the quasi-
equatorial orientation of bond C-7′-H-7′ was supposed, and quasi-axial orientation of C-8′-H-
8′.  
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Fig. 2. Selected NOEs of minimized structure of compound 40. 
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Table 4. NMR Data (CD3OD, 500 MHz) for Compound 39 
Position 13C (ppm)a 1H δ (m, J/Hz) NOESY HMBCb
1 127.0    
2 113.6  6.52 (d, 2.0) 3-OMe 1, 3, 4,  7 
3 150.6    
4 149.3     
5 116.4  6.65 (d, 8.0)  4 
6 116.8 6.74 (dd, 8.0, 2.0)  2, 4, 7 
7 139.1 7.59 (s) 2, 6 1, 2, 9, 5’ 
8 129.4    
9 170.4    
3-OMe 56.2 3.38 (s) 2 3 
1’ 128.8    
2’ 112.2 7.19 (d, 2.0) 3’-OMe, 8’ 3’, 6’, 7’ 
3’ 149.9      
4’ 148.7     
5’ 129.7   1’, 4’ 
6’ 125.1  6.83 (d, 2.0) 8’ 1’, 2’, 4’, 7’ 
7’ 141.9 7.40 (d, 16.0)  1’, 2’, 6’, 8’, 9’ 
8’ 120.2 6.38 (d, 16.0)  1’, 9’ 
9’ 169.5    
3’-OMe 57.2 3.96 (s) 2’ 3’ 
1” 131.8     
2” 131.2  7.04 (d, 8.0) 7”, 8” 1”,  4” 
3” 116.8  6.70 (d, 8.0)  1”, 2”, 4”, 6” 
4” 157.3     
5” 116.8  6.70 (d, 8.0)  1”, 3”, 4” 
6” 131.2  7.04 (d, 8.0) 7”, 8” 2”, 4”, 7” 
7” 36.2  2.75 (t, 6.8) 2”, 6” 1”, 2”, 6”, 8” 
8” 43.0  3.47 (t, 6.8) 2”, 6” 1”, 7”, 9 
1”’ 131.6     
2”’ 131.2  6.91 (d, 8.0) 7”’, 8”’ 1”’, 3”’, 4” 
3”’ 116.8  6.62 (d, 8.0)  1”’, 2”’, 4”’ 
4”’ 157.3     
5”’ 116.8 6.62 (d, 8.0)  1”’, 3”’, 4”’ 
6”’ 131.2 6.91 (d, 8.0) 7”’, 8”’ 2”’, 4”’, 7”’ 
7”’ 35.9  2.65 (t, 6.8) 2”’, 6”’ 8”’ 
8”’ 43.0 3.43 (t, 6.8) 2”’, 6”’ 9’, 1”’, 7”’ 
                 a 13C NMR assignments are supported by a DEPT experiment. 
                b HMBC correlations from H to C. 
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          Table 5. NMR Data (CD3OD, 500 MHz) for Compound 40 
Position 13C (ppm)a 1H δ (m, J/Hz) NOESY HMBCb
1 125.3    
2 113.7 6.88 (s) 7, 3-OMe 3, 4, 6, 7 
3 148.7    
4 147.2     
5 117.7 6.52 (s) 7’ 1, 3, 7’ 
6 133.0    
7 135.1 7.21 (s) 2 2, 8, 9, 8’ 
8 128.0    
9 170.0    
3-OMe 57.1 3.90 (s) 2 3 
1’ 136.4    
2’ 113.0 6.69 (d, 1.0) 3’-OMe, 7’ 4’, 6’, 7’ 
3’ 150.1      
4’ 146.0    
5’ 116.2 6.66 (d,  8.0)  1’, 4’ 
6’ 121.9  6.41 (dd, 8.0, 2.0)  2’, 4’, 7’ 
7’ 48.1 4.36 (d, 3.9) 5, 2’ 1, 5, 6, 8, 1’, 2’, 
6’, 6’, 9’ 
8’ 50.3 3.70 (d, 3.9)  6, 7, 8, 9, 8’, 9’ 
9’ 175.0    
3’-OMe 56.8 3.75 (s) 2’ 3’ 
1” 131.9    
2” 131.3 6.97 (d, 8.5) 7” 1”,  3”, 4”, 7” 
3” 116.7  6.68 (d, 8.5)  1”, 4”, 5” 
4” 157.4     
5” 116.7  6.68 (d, 8.5)  1”, 3”, 4” 
6” 131.3  6.97 (d, 8.5) 7” 1”, 4”, 5”, 7” 
7” 36.2 2.65 (t, 6.8) 2”, 6” 2”, 6”, 8” 
8” 43.0 3.42 (t, 6.8)  9, 1”, 7” 
1”’ 131.6     
2”’ 131.2 6.82 (d, 8.5) 7”’ 1”’, 4”’, 7”’ 
3”’ 116.7  6.65 (d, 8.5)  1”’, 4”’, 5”’ 
4”’ 157.4     
5”’ 116.7  6.65 (d, 8.5)  1”’, 3”’, 4”’ 
6”’ 131.2  6.82 (d, 8.5) 7”’ 1”’, 4”’, 7”’ 
7”’ 35.9  2.50 (t, 6.8) 2”’, 6”’ 2”’, 6”’, 8”’ 
8”’ 42.9 3.23 (t, 6.8)  9’, 1”’ 
                a 13C NMR assignments are supported by a DEPT experiment. 
                b HMBC correlations from H to C. 
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3.2. Oxalis pes-caprae  
 
Oxalis pes-caprae, also known as ‘Bermuda buttercup’, is a native plant of South Africa, 
belonging to Oxalidaceae family. It is a perennial herb with a short, vertical stem that is mostly 
underground. It blooms in late winter or early spring with bright yellow flowers, its sour taste 
is due to oxalic acid present throughout the plant. It can form dense mats on the ground, 
outcompeting native plant species for light and space, and also works to inhibit the germination 
of native species. B. buttercup is most often associated with Mediterranean climates, but also 
occurs in subtropical and semi-arid regions. It is widely distributed in Italy and commonly 
found in cultivated lands. Additionally, it may cause oxalate poisoning in livestock if eaten in 
large quantities. 
 
 
 
 
 
 
 
 
 
 
Fig. 3- Oxalis pes-caprae 
 
 
Fresh leaves and twigs were infused with EtOAc and successively with CH3OH for 7 days at 
room temperature.  
The EtOAc extract was concentrated by evaporation and fractionated into acidic and neutral 
fractions with aqueous NaOH 2M. The neutral fraction, washed with H2O and concentrated 
under vacuum, was fractionated by silica gel column chromatography and the fractions were 
purified by preparative layer chromatography and HPLC yielding eight new cinnamic ester 
derivatives (44-51) and four flavons (56-59). 
The MeOH extract was concentrated and partitioned between EtOAc and H2O. The crude 
EtOAc residue was chromatographed on silica gel column and the fractions were purified by 
preparative layer chromatography and HPLC yielding six new cinnamic ester derivatives (41-
43, 52-54),49 one lignan (55), and a few phenols and cinnamic acids (60-66).  
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41 
 
Compound 41 was determined to have the molecular formula C19H20O6 by the molecular ion 
peak [M+] at m/z 344 in the EIMS spectrum. The 1H NMR and COSY spectra revealed two sets 
of 1,2,3,5-tetrasubstituted and 1,3-disubstituted benzene rings, a disubstituted trans double 
bond, and four methoxyls. The 13C NMR spectrum showed fifteen carbon signals. The DEPT 
spectrum showed three methyls, and seven methines that were correlated to the corresponding 
protons by the HSQC experiment. In a NOESY experiment the protons of the methoxyl groups 
at δ 3.91 had relation with the proton singlet at δ 6.82 and the protons of the methoxyl at δ 3.86 
had relation with the protons at δ 6.73 and 6.79. Finally, the HMBC experiment evidenced the 
following correlations: H-2/H-6 with C-3/C-5, C-4, and C-7; H-7 with C-2/C-6, C-8, and C-9; 
H-8 with C-1 and C-9; H-2' with C-3' and C-4'; H-4' and H-6' with C-1' and C-2'; H-5' with C-
1' and C-3'. Thus, the structure of (E)-3’-methoxyphenyl 3,4,5-trimethoxycinnamate was 
established for compound 41. 
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42 
 
Compound 42 was identified as (E)-3’-hydroxyphenyl 3,4,5-trimethoxycinnamate. It had 
molecular formula C18H18O6 as deduced from the molecular ion peak [M]+ at m/z 330 in the 
EIMS spectrum. In the 1H NMR spectrum, signals corresponding to two 1,2,3,5-
tetrasubstituted and 1,3-disubstituted benzene rings were present. The H-2 and H-6 of the 
3,4,5-trimethoxycinnamoyl moiety were at δ 6.82 as a singlet. In turn the H-5', H-4', H-6', and 
 64
H-2' of the 3-hydroxyphenyl moiety were at δ 7.25, 6.74, 6.72, and 6.68, respectively. 
Furthermore, the spectrum showed the H-7 and H-8 trans olefinic protons at δ 7.78 and 6.53, 
and three methoxyl groups at δ 3.91. In a NOESY experiment the protons of the methoxyl 
groups had relation with the proton singlet at δ 6.82. Finally, the HMBC experiment evidenced 
the following correlations: H-2/H-6 with C-3/C-5, C-4, and C-7; H-7 with C-1, C-2/C-6, and 
C-9; H-8 with C-1 and C-9; H-2' with C-3' and C-4'; H-4' and H-6' with C-1' and C-2'; H-5' 
with C-1' and C-3'. 
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43 
 
Spectra analysis of compound 43 defined it as 3’-hydroxyphenyl sinapate. It had molecular 
formula C17H16O6 as deduced from the molecular ion peak [M]+ at m/z 316.0943 in the 
HREIMS spectrum. The 13C NMR spectrum showed the presence of thirteen signals. In the 1H 
NMR spectrum the H-2 and H-6 signal of the sinapoyl moiety was at δ 6.82 as a singlet. The 
H-5', H-4'/H-6', and H-2', of the 3-hydroxyphenyl moiety were at δ 7.22, 6.70, and 6.66, 
respectively. Furthermore, the spectrum showed the H-7 and H-8 trans olefinic protons at δ 
7.77 and 6.47, and two methoxyl groups at δ 3.92. In a NOESY experiment the protons of the 
methoxyl groups had relation with the proton singlet at δ 6.82. In a HMBC study, the 
correlations were comparable to those of 42.  
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Compound 44 was determined to be (E)-3’-methoxyphenyl sinapate. The 13C NMR spectrum 
showed fourteen carbon signals. The DEPT spectrum showed two methyls, eight methines, and 
five quaternary carbons. The 1H NMR and 1H-1H COSY spectra revealed the presence of two 
1,2,3,5-tetrasubstituted and 1,3-disubstituted benzene rings. The H-2/H-6 of the sinapoyl 
moiety were at δ 6.83, in turn the H-6', H-5', H-4', and H-2' of the 3-methoxyphenyl moiety 
were at δ 6.82, 7.29, 6.68, and 6.63, respectively. Furthermore, the spectrum showed the H-7 
and H-8 trans olefinic protons at δ 7.79 and 6.52, and three methoxyl groups at δ 3.92 and 3.91. 
HMBC and NOESY experiments supported the hypothesized structure.  
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Compound 45 was identified as 2’-methoxyphenyl dihydrocinnamate. It had a molecular ion 
peak [M]+ at m/z 256 in the EI mass spectrum that according to the 13C NMR spectrum, 
suggested a molecular formula C16H16O3. The 13C NMR spectrum and a DEPT experiment 
indicated the presence of one methyl, two methylenes, seven methines, and four quaternary 
carbons. In the 1H NMR spectrum H-2, H-3, H-5, H-6 appeared as a multiplet at δ 7.29, H-4 
and H-6’ as a multiplet at δ 7.20, H-3’ as a doublet at δ 7.05, H-4’ and H-5’ as multiplet at δ 
6.92. Furthermore, the spectrum showed a methoxyl group at δ 3.76 and two triplets at δ 3.04 
and δ 2.92 mutually coupled of an ethylic chain. An HMBC showed correlations between the 
signal at δ 7.29 and C-1, C-4, C-7; H-3’ and H-6’ with C-1’, C-2’, C-4’, and C-5’. In a NOESY 
experiment the protons of the methoxyl group at δ 3.76 had relation with the proton at δ  7.05. 
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Compound 46 was identified as (E)-4’-acetylphenyl 4-hydroxycinnamate. It had a molecular 
ion peak [M]+ at m/z 282 in the EI mass spectrum that, according to the 13C NMR spectrum, 
suggested a molecular formula C17H14O4. The 1H NMR and 1H-1H COSY spectra revealed two 
sets of 1,4-disubstituted benzene rings: H-2/H-6 and H-3/H-5 of the cinnamoyl moiety were at 
δ  7.51 and 6.88 as doublets, H-3’/H-5' and H-2'/H-6’ of the acetylphenyl moiety were as 
doublets at δ  8.03 and 7.28, respectively. Furthermore, the 1H NMR spectrum showed the H-7 
and H-8 trans olefinic protons at δ 7.84 and  6.49 and one methyl group at δ 2.62 which had 
relation with H-3’ and H-5’ in a NOESY experiment. Finally, the HMBC experiment 
evidenced the following correlations: H-2/H-6 with C-3/C-5, C-4, C-1 and C-7; H-7 with C-1, 
C-2/C-6, and C-9; H-8 with C-1 and C-9; H3’/H5’ with C-1’, C-4’, C-7’; H-8’ with C-4’. 
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Spectral data of compound 47 and the molecular ion peak [M]+ at m/z 356 in the EI mass 
spectrum suggested a molecular formula C20H20O6. In the 13C NMR spectrum seventeen carbon 
signals were present and the DEPT experiment evidenced three methyls and seven methines.  
Pattern signals in the 1H NMR spectrum indicated the presence of  two 1,2,3,5-tetrasubstituted 
and 1,3-disubstituted aromatic rings. Two olefinic protons appeared at δ 7.80 and 6.54, three 
methoxyl groups at δ 3.90 and one methyl at δ 2.61. The 1H and 13C resonances were assigned 
by combination of 1H-1H COSY, DEPT, HMQC, and HMBC experiments. The HMBC 
spectrum evidenced the following correlations: H-2/H-6 with C-3/C-5, C-4, C-1, and C-7; H-7 
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with C-1, C-2/C-6, C-8 e C-9; H-2’ with C-1’, C-3’, C-4’, C-6’; H-8’ with C-3’ and C-7’. 
According to the structure, in a NOESY experiment the protons of the methoxyl groups had 
relation with H-2/H-6 and the protons of the methyl group at δ 2.62 had relation with H-2’ and 
H-4’. 
Based on these findings, compound 47 was concluded to be (E)-3’-acetylphenyl 3,4,5-
trimethoxycinnamate. 
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Compound 48 was determined to be (E)-4’-acetylphenyl sinapate. Spectral data and a 
molecular ion peak [M]+ at m/z 342 in the EI mass spectrum indicated a molecular formula 
C19H18O6. The 13C NMR spectrum showed fourteen carbon signals, which have been attributed 
by a DEPT experiment to two methyls, five methines and seven quaternary carbons. In 1H 
NMR spectrum two protons of a 1,2,3,5-tetrasubstituted aromatic ring resonated at δ 6.84 and 
protons of a 1,4 disubstituted aromatic ring resonated as two large doublets at δ 7.27 and 8.02. 
A singlet signal integrated for six protons appeared at δ 3.94 and a methyl group at δ 2.61. The 
connection of functional groups has been determined using HMBC correlations: H-2/H-6 gave 
cross peaks with C-3/C-5 and C-4; H-7 and H-8 with C-1 and C-9; H-2’/H-6’ with C-1’ and C-
4’; H-3’/H5’ and methyl protons with C-4’ and the carbonyl carbon (δ 196.9). According to the 
structure in the NOESY experiment the methoxyl groups had relation with H-2/H-6 protons 
at δ 6.84.   
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The molecular formula C20H20O6  of compound 49 was suggested by the molecular ion peak 
[M]+at m/z 356 in the EI mass spectrum and  the 13C NMR spectrum. The general features of 
its NMR spectra closely resembled those of 48, except for the presence of nine methoxyl 
protons in the 1H spectrum and a further methoxyl carbon in the 13C NMR spectrum. Analysis 
of spectral data allowed to defined compound 49 as (E)-4’-acethylphenyl 3,4,5-
trimethoxycinnamate. 
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Compound 50 was identified as (E)-3’-(1-hydroxyethyl)-phenyl 3,4,5-trimethoxycinnamate. 
The molecular ion peak [M]+ at m/z 358 in the EI mass spectrum and the 13C NMR spectrum 
suggested the molecular formula C20H22O6. The 13C NMR (DEPT) spectra showed seventeen 
signals defined as three methyls, eight methines, six quaternary carbons. The 1H NMR 
spectrum showed a singlet at δ 7.00 integrated for two protons attributed to H-2/H-6; a doublet 
at δ 7.25 and a double doublet at δ 7.03 attributed to H-4’ and H-6’ respectively, and two 
triplets at δ 7.37 and 7.18 relative to H-5’ and H-2’. Furthermore, the spectrum showed H-7 
and H-8 trans olefinic protons as two doublets at δ 7.81 and 6.69, a doublet and a quartet at δ 
4.85 and δ 1.44 correlated in the 1H-1H COSY experiment and attributed to H-7’ and H-8’, 
respectively. A HMQC experiment allowed to assign the protons to the corresponding carbons. 
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In the HMBC spectrum protons H-2/H-6 were correlated to C-4 and C-7; H-2’ and H-5’ to C-
1’, C-4’.  
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Compound 51 was identified as (E)-2-hydroxyethyl 3,4,5-trimethoxycinnamate. It had 
molecular formula C14H18O6 as deduced from the molecular ion peak [M]+ at m/z 282 in the 
EIMS spectrum. The 13C NMR spectrum showed the presence of eleven signals. The DEPT 
experiment evidenced two methyls, two methylenes and three methines. In the 1H NMR 
spectrum, signals corresponding to a 1,2,3,5-tetrasubstituted benzene ring were present. The H-
2 and H-6 of the 3,4,5-trimethoxycinnamoyl moiety were at δ 6.75 as a singlet. The H-2' and 
H-3' of the hydroxyethyl chain were at δ 4.35, and 3.90, respectively. Furthermore, the H-7 and 
H-8 trans olefinic protons occurred at δ 7.63 and 6.38, and three methoxyl groups were 
observed at δ 3.88. In a NOESY experiment the protons of the methoxyl groups had relation 
with the proton singlet at δ 6.75. Finally, the HMBC experiment evidenced the following 
correlations: H-2/H-6 with C-3/C-5, C-4, and C-7; H-7 with C-1, C-2/C-6, and C-9; H-8 with 
C-1 and C-9; H-1' with C-9 and C-2'; H-2' with C-1'.    
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Compound 52 was defined to be 2-hydroxyethyl sinapate. It had molecular formula C13H16O6 
as deduced from the molecular ion peak [M]+ at m/z 268 in the EIMS spectrum. The 13C NMR 
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spectrum showed the presence of ten signals, assigned by DEPT experiment as a methyl, two 
methylenes, and three methines. In the 1H NMR spectrum, signals corresponding to a 1,3,4,5-
tetrasubstituted benzene ring were present. The H-2 and H-6 of the sinapoyl moiety, in the 1H 
NMR spectrum, were at δ 6.77 as a singlet. The H-1' and H-2' of the 2-hydroxyethyl moiety 
were at δ 4.35 and 3.87, respectively. Furthermore, the spectrum showed the H-7 and H-8 trans 
olefinic protons at δ 7.64 and 6.38, and two methoxyl groups at δ 3.91. In a NOESY 
experiment the protons of the methoxyl groups had relation with the protons at δ 6.77. Finally, 
the HMBC experiment evidenced the following correlations: H-2/H-6 with C-3/C-5, C-4, and 
C-7; H-7 with C-1, C-2/C-6, and C-9; H-8 with C-1 and C-9; H-1' with C-9 and C-2'; H-2' with 
C-1'.  
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Compound 53 was identified as acetyl derivative of compound 44. Its 1H NMR spectrum 
showed the presence of  a additional methyl at δ 2.11 and the 13C NMR spectrum showed a 
methyl and carbonyl at δ 20.9 and 170.8, respectively. This hypothesis was confirmed by the 
EIMS spectrum that showed a molecular ion peak [M+] at m/z 324 according to the molecular 
formula C16H20O7.  
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Compound 54 had molecular formula C11H12O5 as deduced from the molecular ion peak [M]+  
at m/z 224 in the EIMS spectrum. The 13C NMR spectrum showed the presence of eleven 
signals, assigned by DEPT experiment as two methylenes and five methines. In the 1H NMR 
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spectrum, signals corresponding to a 1,2,5-trisubstituted benzene ring were present. The H-2, 
H-5, and H-6 of the caffeoyl moiety, in the 1H NMR spectrum, were at δ 7.04, 6.77, and 6.95, 
as a narrow doublet, a doublet, and a double doublet, respectively. The H-1' and H-2' of the 2-
hydroxyethyl moiety were at δ 4.24 and 3.79, respectively. Furthermore, the spectrum showed 
the H-7 and H-8 trans olefinic protons at δ 7.58 and 6.29. Finally, the HMBC experiment 
evidenced the following correlations: H-2 with C-3, C-4, and C-7; H-6 with C-2, C-4, and C-5; 
H-7 with C-1, C-2, C-6, and C-9; H-8 with C-1 and C-9; H-1' with C-9 and C-2'; H-2' with C-
1'. All these features allowed to define compound 54 as 2-hydroxyethyl caffeate. 
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Compound 55 showed a pseudo-molecular ion peak [M+H]+ in a MALDI mass spectrum at m/z 
285 that, along with spectral data, indicated a molecular formula C16H12O5. The 1H NMR 
spectrum showed the presence of protons coupled in a AA’XX’ system of two 1,4-
disubstituted aromatic rings and two trans olefinic protons at δ 7.45 and 6.30. The 13C NMR 
spectrum and a DEPT experiment showed five methines and six quaternary carbons, two of 
them at δ 170.6 and 171.3 relative to two carboxyl groups. The HMQC experiment allowed to 
attribute the protons to the corresponding carbons. The HMBC spectrum showed cross-peaks 
of H-7 and H-8 with C-9 and C-1; H-2/H-6 with C-4 and C-7; H-2’/H-6’ with C-4’ and C-7’. 
These data have led to identify compound 55 as (E)-4-[4-(2-carboxyvinyl)phenoxy] benzoic 
acid. 
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Compound 56 was determined to be 5,6,7,8,4’-pentamethoxyflavone. It had a molecular ion 
peak [M]+ at m/z 372 in the EI mass spectrum that, along with the 13C NMR spectrum, 
suggested a molecular formula C20H20O7. 13C NMR spectrum showed eighteen carbons defined 
by a DEPT experiment as five methoxyls, three methines, and seven quaternary carbons. 1H 
NMR spectrum showed a pair of doublets at δ 7.88 and 7.02 attributed to H-2’/H-6’ and H-
3’/H-5’, a singlet at δ 6.60 attributed to H-3, three singlets at δ 4.10, 4.02, and 3.89 each 
integrated for three protons, and a singlet at δ 3.95 integrated for six protons. These data were 
in agreement with those previously reported.50
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1H NMR spectrum of compound 57 evidenced the presence of a 1,2,4-trisubstituted aromatic 
ring, a singlet at δ 6.62, and six methoxyl groups. 13C NMR spectrum and a molecular ion peak 
[M]+ at m/z 402 in the EI mass spectrum defined the molecular formula C21H22O8. By 
comparing the spectral data with those previously reported, compound 57 was identified as 
5,6,7,8,3’,4’-esamethoxyflavone.50
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NMR data of compound 58 were similar to that of compound 57. The 1H NMR spectrum 
showed two doublets and a double doublet of a 1,2,4-trisubstituted aromatic ring, one singlet at 
δ 6.60, and five methoxyls. 13C NMR spectrum showed twenty carbons defined as five 
methoxyls, four methines, and eleven quaternary carbons through a DEPT experiment. All 
spectroscopic data agreed with those reported for 5-hydroxy-6,7,8,3’,4’-
pentamethoxyflavone.50
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Compound 59 was identified as 4’-hydroxy-5,6,7,8,3’-pentamethoxyflavone on the basis of its 
spectroscopic data and by comparing them to data reported in the literature.50 The 1H NMR 
spectrum showed two doublets and a double doublet in the aromatic region, one singlet at 
δ 6.60, and five methoxyls. The 13C NMR and DEPT spectrum showed the presence of five 
methoxyls, four methines and eleven quaternary carbons. The cross peak between a methoxyl 
group and H-2’ in the NOESY experiment confirmed  the hydroxyl position. 
By comparison with authentic samples metabolites 60-66 were identified as 1,3-
dihydroxybenzene, 4-hydroxybenzyl alcohol, 3-methoxy-4-hydroxybenzoic acid, 4-
hydroxycinnamic acid, methyl 4-hydroxycinnamate, sinapic acid and caffeic acid, respectively. 
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3.3. Swinglea glutinosa
 
Swinglea glutinosa is a small tropical tree from the Rutaceae family. Brought to South America 
from South East Asia, it is used as ornamental plant in Colombia and as a natural barrier in 
rural area and gardens. S. glutinosa possesses fruits, which are not edible, but have an 
extraordinary pleasant smell. Essential oil from S. glutinosa fruit peel was obtained by 
microwave-assisted hydro-distillation. The complex odour bouquet exhibited by the essential 
oil depends upon its chemical composition, but not only on the presence of compounds at 
higher concentrations.
Extracts of the stem bark of this plant have been previously assessed for antiplasmodial activity 
showing promising activity in vitro against Plasmodium falciparum.51
We investigated the roots extract to define its metabolites composition. 
 
 
 
Fig. 4- Swinglea glutinosa 
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Dried root of Swinlea glutinosa was extracted at room temperature with EtOAc twice for 12 h. 
After evaporation under reduced pressure at 40 oC the extract was fractionated by silica gel 
flash column chromatography  eluting with hexane and EtOAc. Fractions with similar TLC 
profiles were combined to yield 16 fractions, these were purified by column chromatography, 
TLC, and HPLC yielding three coumarins (67-69) and nine acridone alkaloids (70-78). 
Coumarins constitute a class of widely distributed heterocyclic natural products exhibiting a 
broad pharmacological profile, including cytotoxic, antiviral or antibacterial activities.52
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Compound 67 was isolated as colorless needles. The EI mass spectrum showed a molecular ion 
peak [M]+ at m/z 228. The 1H NMR spectrum showed two doublets at δ 7.54 and 6.15 (J=9.6 
Hz) characteristic of H-4 and H-3 of a coumarin nucleus,53 two doublets  at δ 5.67 and 6.81 
(J=9.6 Hz), and the singlet at 1.41 (6H) typical for the dimethylchromene ring. The remaining 
pair of doublets at δ 7.15 and 6.65 (J=8.4 Hz) was attributed to H-5 and H-6. These data were 
in agreement with those reported for seselin.54 It has been reported to act as potential anticancer 
agent. 55
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Spectral data of compound 68 identified it as 5-methoxyseselin. The 1H NMR spectrum 
showed two doublets at δ 7.91 and 6.09 (J=9.4 Hz) attributed to the coumarin nucleus, the 
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characteristic signals of a dimethylchromene ring at δ 6.75 (1H, d, J=10.0 Hz), δ 5.54 (1H, d, 
J=10.0Hz), and δ 1.42 (6H, s), one singlet at δ 6.20, and one methoxyl group at δ 3.84. 
Comparison with literature data56 confirmed the structure. Compound 68 has already been 
isolated from Rutaceae and it has been reported to have antibacterial activity. 57
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Compound 69 showed a pseudo-molecular ion peak [M+H]+ at m/z 297.1491 in the HRESI 
mass spectrum suggesting the molecular formula C19H20O3. The 13C NMR and DEPT spectra 
indicated the presence of four methyls, one methylene, six methines, and seven quaternary 
carbons. The 1H NMR spectrum showed two doublets at δ 7.54 and 6.16 (J=9.6 Hz) attributed 
to H-4 and H-3 of the coumarin nucleus, the characteristic signals of a dimethylchromene ring 
at δ 6.84 and δ 5.68 (d, J=10.2 Hz) and two methyls at δ 1.43 (6H, s). Furthermore, the 
spectrum showed a singlet at δ 7.02 and a prenyl group at δ 5.22 (1H, t, J=7.2 Hz), 3.24 (2H, d, 
J=7.2 Hz), 1.72 and 1.70 (each 3H). In a HMBC spectrum H-1’’ had correlation with C-3’’, 
and C-8a; H-2’’ with C-1’’ and C-8; H-5 with C-1’, C-4, C-7, and C-8a. These data allowed to 
identified compound 69 as 6-(3,3-dimethylallyl) seselin. It has never been isolated before. 
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The molecular formula C20H21NO6 of compound 70 was deduced on the basis of an HRESI 
mass experiment, which showed a pseudo-molecular ion peak [M-H]- at m/z 370.1291. The 13C 
NMR spectrum showed twenty signals that were attributed by a DEPT experiment to four 
methyls, one methylenes, four methines, and eleven quaternary carbons. The presence of signal 
at δ 13.78, in the 1H NMR spectrum, indicated a chelated phenolic hydroxyl group.  
Signals relative to three aromatic protons in the 1H NMR spectrum resonated in an ABX 
system in acetone-d6 at δ 7.79 (1H, dd, J=1.6 and 8.0 Hz), δ 7.27 (1H, dd, J=1.6 and 8.0 Hz) 
and δ 7.15 (1H, t, J=8.0 Hz). They were attributed to H-8, H-6, and H-7, respectively, where 
the lower field proton at δ 7.79 was deshielded by the 9-carbonyl group. In the aliphatic region, 
protons at δ 3.20 (2H, m) and δ 4.87 (1Η, dd, J=8.0 and 9.2 Hz), two methyl groups at 
δ 1.33 and δ 1.29, and a quaternary carbon, in the 13C-NMR spectrum, at δ 72.0 were 
consistent with a hydroxyisopropyldihydrofuran moiety. 
Two singlet signals at δ 3.87 and 3.70 (each 3H) correlated in the HSQC spectrum with 13C 
signals at δ 60.6 and δ 46.5 were assigned to methoxyl and N-methyl groups, respectively.  
Further support of the supposed structure was provided by an HMBC experiment. Proton at δ 
7.79 (H-8) gave correlation with C-6, C-9, and C-10a; protons at δ 3.16 attributed to H-1’a,b 
gave heterocorrelation with C-1, C-3, and C-3’; protons at δ 1.26 and 1.40 relative to H-4’ and 
H-5’ methyls gave a cross peak with C-2’ at δ 92.4. Based on literature58 data, the structure of 
compound 70 was assigned as depicted. 
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71 R = CH2CH-C(CH3)2 R1 = OH  R2 = OMe
72 R = H R1 = OH R2 = OMe
73 R = R1= R2 = OMe
74 R = CH2CH-C(CH3)2 R1= OH R2= H
75 R = H R1 = OH R2 = CH2CH-C(CH3)2
76 R = H R1 = R2 = OMe  
 
Compounds 71-78 contained a 1-hydroxy-9-acridone nucleus as common structural unit as 
suggested the 1H and 13C NMR spectra. The 1H NMR spectrum of compound 71 showed three 
aromatic protons in an ABX system, a methoxyl and a N-methyl at δ 3.79 and 3.78, and a 
prenyl moiety at δ 5.30 (1H, m), 3.40 (2H, d, J=7.3 Hz), 1.80 and 1.68 (each 3H, s). The 
substitution on acridone nucleus  were deduced by C-H long range correlations observed in the 
HMBC spectrum. Comparison with literature data59 allowed to define compound 71 as 
glycocitrine IV. 
Compound 72 was identified as citrusinine II. Its 1H NMR spectrum showed three ABC type 
protons and one singlet in the aromatic region, besides a methoxyl and a  N-methyl groups. 
The combination of COSY, HMQC and HMBC spectra and comparison with data previously 
reported60 confirmed the structure. 
The 1H NMR spectrum of compound 73 showed three protons coupled in an ABC system in 
the aromatic region, and four singlets each integrated for three protons at δ 4.12, 3.94, 3.83, 
and 3.80. Its spectral data were in agreement with those previously reported61 for citrusinine I. 
Compounds 74 and 75 were identified as junosine and oriciacridone. Their 1H NMR spectra 
showed the presence of ABC-type aromatic protons, one isolated aromatic proton, a prenyl 
group, and a N-methyl group. HMQC and HMBC correlations allowed to locate the prenyl 
group at the C-2 position for compound 74 and at the C-4 position for 75. Comparison with 
literature data62 confirmed the structures. 
Compound 76 had showed the same signal pattern as 72 but with two methoxyl groups. It was 
determined to be citrusinine I by comparing its data with those reported in the literature61. 
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The 1H NMR spectrum (acetone-d6) of compound 77 showed the signals corresponding to four 
protons in the aromatic region. The ABX protons resonated at δ 7.78 (1H, d, J=7.6 Hz), 7.32 
(1H, d, J=7.6 Hz), and 7.19 (1H, t, J=7.6 Hz) and were assigned to H-8, H-6 and H-7; one 
singlet at δ 6.11 was attributed to H-2 proton. The existence of a 2,2-dimethylpyran moiety was 
suggested by the coupled signals at δ 6.75 and 5.66 (2H, d, J=9.6 Hz), and two methyls at δ 
1.50 (6H, s). N-methyl group was at δ 3.83. According to literature data62 compound 77 was 
identified as atalaphyllidine. 
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Pattern signals in the 1H NMR spectrum of 78 resembled that of 77 except for the presence of a 
methoxyl group at δ 3.85 instead of an aromatic proton at δ 6.11. H-1’, H-2’, and H-4’/H-5’ of 
the dimethylpyran system were at δ 6.72, 5.71 and 1.52. Comparison with literature data62 
identified compound 78 as pyranofoline. 
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3.4.  Amyris madrensis 
 
Amyris madrensis, a densely-branched shrub, belongs to Rutaceae family. It is found only in 
Texas. The glossy evergreen leaves are dark green and leathery. The white flowers, 
inconspicuous but fragrant, appear during spring to fall, and the fruit is a small, attractive, 
reddish-brown drupe, greatly valued by birds. The aromatic leaves are used in making tea and 
as a tonic.  
Only one publication is reported in literature about the chemical study of this plant. 
 
 
 
 
Fig. 5- Amyris madrensis 
 
 
Dried leaves of A. madrensis were ground in a blender. Ground plant material was extracted at 
room temperature with hexane, EtOAc, and subsequently with CH3OH. Preliminary bio-
autography of the extracts on TLC plates revealed antifungal activity of the EtOAc extract. The 
occurrence  of antifungal compounds was evidenced by the presence of clear zones on a dark 
background on the plate. That prompted us to investigate further. The EtOAc extract was 
fractionated by silica gel column chromatography and crystallization providing seven 
coumarins (79-85) and methyl eugenol (86). 
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Compound 79 showed a pseudo-molecular ion peak [M+H]+ at m/z 305.1009 in the HRESI 
mass spectrum suggesting the molecular formula C16H16O6. The 13C NMR spectrum showed 
sixteen carbons identified by a DEPT experiment as three methyls, one methylene, four 
methines, and eight quaternary carbons. In the aromatic region of the 1H NMR spectrum two 
doublets characteristic for a coumarin nucleus were present at δ 7.59 and 6.20 and a singlet at δ 
6.82, these signals were attributed to H-4, H-3, and H-7, respectively. Furthermore, the 
spectrum showed a triplet at δ 5.12, integrated for one proton (H-2’), correlated in a H-H 
COSY spectrum to a multiplet at δ 3.25 integrated for two protons (H-1’a,b). Three singlets, 
each integrated for three protons, were at δ 1.96, 1.57, and 1.52. The position of the 
substituents was determined by analyzing the HMBC spectrum, which revealed heteronuclear 
couplings of H-5 with C-8a, C-7, C-4, and C-1’; H-1’ with C-7, C-6 and C-3’. These data 
defined the structure of compound 79 as depicted, it has been isolated for the first time. 
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Compound 80 had a molecular formula C15H14O4 suggested by the pseudo-molecular ion peak 
[M+H]+ at m/z 259.0937 in the HRESI mass spectrum. 1H and 13C NMR spectra showed a 
pattern of signals typical of a coumarin nucleus and a 1-oxoprenyl chain with a carbonyl 
carbon at δ 190.7. Spectral data and comparison with literature data identified compound 80 as 
dehydrogeijerin.63
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Compound 81 was determined to be hopeyhopin. The molecular formula C15H14O5 was 
indicated by the pseudo-molecular ion peak [M+H]+ at m/z 275.0915 in the HRESI mass 
spectrum. Signals at δ 4.01 in 1H NMR spectrum (H-2’) and δ 68.1 (C-2’) and 62.1 (C-3’) in 
the 13C NMR spectrum suggested the presence of an oxirane ring. Literature data confirmed the 
assigned structure.64
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Compound 82 had molecular formula C17H18O6 according to the pseudo molecular ion peak 
[M+H]+ at m/z 319.0835 in the HRESI mass spectrum. The 1H NMR spectrum showed two 
doublets at δ 7.62 and 6.21 (J=9.6 Hz) attributed to H-4 and H-3,  two singlets a δ 7.43 and 
6.77 relative at H-5 and H-8 respectively, and two doublets  at δ 5.92 and 3.07 (J=8.8 Hz) 
attributed to H-1’ and H-2’. Furthermore, the spectra showed a methoxyl group at δ 3.87 and 
three methyls at δ 2.07, 1.34, and 1.22. Comparison with literature data confirmed the 
structure.65
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Compound 83 molecular formula C15H14O4 according to the molecular ion peak [M+H]+ at m/z 
259.1025 in the HRESI mass spectrum.The 1H NMR spectrum showed two doublets at δ 7.54 
and 6.20 (J=9.4 Hz) attributed to the coumarin nucleus, the characteristic signals of a 
dimethylchromene ring at δ 6.80 (1H, d, J=10.0 Hz), δ 5.68 (1H, d, J=10.0 Hz), ad δ 1.46 (6H, 
s), one singlet at δ 6.72 and a methoxyl group at δ 3.84. These data were in agreement with 
those reported for braylin.66
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Compound 84 was determined to be heraclenin. The molecular formula C16H14O5 was deduced 
by the molecular ion peak [M+H]+ at m/z 287.0841 in the HRESI mass spectrum. In the 1H 
NMR spectrum signals of the coumarin nucleus were at δ 7.76 (1H, d, J=9.6 Hz, H-4), 7.38 
(1H, s, H-5), and 6.35 (1H, d, J=9.6 Hz, H-3); the furano protons appeared as doublets at δ 7.67 
and 6.80 (J=2.4 Hz). Signals at δ 4.56 (2H, m), 3.29 (1H, m), 1.31 (3H, s) and 1.25 (3H, s) 
were attributed to H-1’’, H-2’’, H-4’’, and H-5’’, respectively. HMQC and HMBC experiments 
allowed to assigned the position of the substituents and the structure was confirmed by 
literature data.67
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The EI mass spectrum of compound 85 showed a molecular ion peak [M]+ at m/z 214 in the EI 
mass spectrum. The 1H NMR spectrum accounted for three aromatic protons at δ 7.59 (d, J=9.6 
Hz), 6.64 (s), and 6.24 (d, J=9.6 Hz), and three methoxyl groups at δ 3.99, 3.93, and 3.89. On 
the basis of this evidence, the compound was characterized as 6,7,8-trimethoxycoumarin and 
this was confirmed by literature data.68
 
 
OMe
MeO
 
 
86 
 
The EI mass spectrum of compound 86 showed a molecular ion peak [M]+ at m/z 178. The 1H 
NMR spectrum showed signals of an ABX system attributed to a 1,2,4 trisubstituted aromatic 
ring, two multiplets at δ 5.95 and 5.05, and a doublet at δ 3.31 (J=6.7 Hz) of an allyl side chain. 
These data defined compound 86 as methyleugenol. 
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3.5. Bioassay 
 
3.5.1 Phytotoxic activity of compounds isolated from A. cordifolia 
 
The compounds isolated from A. cordifolia were tested for their phytotoxicity on the seeds of 
Lactuca sativa.19 This species was selected as representative of main dicotyledon commercial 
crops.19 It has been used extensively as a test organism because of its fast germination and high 
sensitivity, and allows comparison of bioassay results for many different compounds.69 
Aqueous solution of the isolated compounds, ranging between 10–4 and 10–7 M, were tested on 
germination, root length, and shoot length of treated lettuce seeds.  
Figures 6A, B, C show the activity of the compounds 1, 3, 4, 6, 7, 9, 10, 13-15, 17-19, 26-29 
and 32-35. 3,4-Dimethoxy-dihydrocinnamic acid 13 and methyl 3-(1H-indol-3-yl) propanoate 
28 were found to be the most active, reducing the germination by 90%, and the radical and 
shoot growth by 100% at 10–4 and 10–5 M, respectively. The other compounds showed slight 
inhibition of germination, with an activity of 10–30% at the highest concentration tested, with 
the exception of compounds 29 and 35, which reduced the germination by 80 and 45% at 10–4 
M, respectively. Exceptional was also compound 15, which gave rise to a stimulation of 
germination at all concentrations tested (Fig. 6A). Further, the dilignan 18 showed a 
stimulation of root length at all concentrations tested, while compounds 29, 32, 33, and 35 
inhibited root growth of about 50% at the highest concentration tested (Fig. 6B). Dilignan 18 
showed a stimulation of shoot length as well at all concentrations tested, compounds 32 and 33 
reduced the shoot length by 60 and 80% at 10–4 M, respectively (Fig. 6C). 
The activities of the above compounds isolated from A. cordifolia were compared with that of 
4-hydroxybenzoic acid (HBA), a well-known and effective germination inhibitor.70 The 
inhibition value for many compounds isolated from A. cordifolia were, at a concentration of 
10–4 M, comparable to that of HBA. The bioactivities of the compounds tested showed a 
variable response on lettuce, and for some compounds, no dose-dependence effects were 
observed. The reason for this response could be due to differences in seed size, seed-coat 
permeability, differential uptake, and metabolism.71
                    
 
 
 86
 
 
 
 
 
 
Fig. 6A- Effect on germination of Lactuca sativa L. Value presented as percentage differences from control. 
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Fig. 6B- Effect on root length of Lactuca sativa L. Value presented as percentage differences from control 
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Fig. 6C- Effect on shoot lenght of Lactuca sativa L. Value presented as percentage differences from control 
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The activity of the oxyneolignans 20-25 are reported in Fig. 7. All compounds reduced the 
 
 
 
germination by 18-25% at 10-4 M, and dose dependence effects were observed. They reduced 
the root elongation by 20% at 10-4 M, but compound 20 was the most active (40%) when 
compared to the control and compound 22 was almost completely inactive. Amongst 
compounds 20-25, only oxyneolignan 23 reduced shoot elongation by 15% at the highest 
concentration and no important effects were observed for compounds 20, 22, and 25, while 
compounds 21 and 24 showed a stimulatory effects within 20-50%.  
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Fig. 7- Effect of compounds 20-25 on shoot lenght (A), root elongation (B), shoot elongation (C) of Lactuca 
sativa L.Value presented as percentage differences from control. 
 
 
Cinnamic acid amides 37 and 38 (Fig. 8) reduced the germination by 20% compared to the 
control at 10-4 M, and dose dependence effects were observed. Compounds 36 and 39 were 
inactive, and compound 40 reduced the germination by 10 % at highest concentration tested. 
The root elongation of L. sativa was not affected by compounds tested, with exception of  
lignanamide 39 that showed 25% of inhibition at 10-4 M. Amongst compounds 36-40, only 
amide 37 stimulated shoot elongation at all concentration tested and no important effects were 
observed for compounds 36, 38, 39, and 40. 
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Fig. 8- Effect of compounds 36-40 on shoot lenght (A), root elongation (B), shoot elongation (C) of Lactuca 
sativa L.Value presented as percentage differences from control 
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3.5.2 Phytotoxic activity of compounds isolated from Oxalis pes-caprae 
ome of the isolated compounds from O. pes-caprae were tested against on Lactuca sativa  to 
pounds on the inhibition of germination of L. sativa seeds (Fig. 
 
 
S
evaluate the inhibitory or stimulatory effects on germination, root length, and shoot length of 
the tested seeds. The results are reported as percentage differences from the control in Fig. 9A, 
B, and C. The activities of  the compounds were compared with that of pendimethalin (P), a 
commercial pre-emergence herbicide used widely in agriculture. Aqueous solutions of the 
compounds, ranging from 10-4 to 10-7 M, were investigated in accordance with the procedures 
optimized by Macias et al.19 
The effects of the tested com
9A) showed a variable behaviour within 10-20% at higher concentrations except for 47 and 49 
that showed an inhibition of germination by 60-80% at the highest concentration tested. 
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Fig. 9A- Effect on germination of Lactuca sativa L. Value presented as percentage differences from control. 
 
 
 
The results reported in Fig. 9B show greater phytotoxic activities on lettuce root length by 
compounds 42, 43, 53, and 54, with respect to this standard herbicide. The tested compounds 
revealed ≥80% inhibition at 10-4 M concentration and compound 54 was found to be 
completely active up to 10-7 M. Compound 54 showed a radical and shoot inhibition of 100% 
at all concentration tested (Fig. 9B, C). This compound was tested at lower concentrations (10-8 
and 10-9 M) and it showed no relevant effects on germination and shoot length, while slight 
stimulatory effects were observed on root length (results not shown). 
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Fig. 9B- Effect on root length of Lactuca sativa L. Value presented as percentage differences from control. 
 
 
Finally, compounds 41-43, 53 reduced shoot length by 60-80% at the highest concentration 
tested (Fig. 9C). Compounds 47 and 49 had a good activity as well, they reduced the shoot 
elongation by 50% at 10-4 M; compounds 51 and 52 were moderately active only at higher 
concentration. 
Flavons 56-59 affected lightly the germination and the shoot length at all concentration tested, 
while at lower concentration they showed a slight stimolatory effect on the root length. 
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Fig. 9C- Effect on shoot lenght of Lactuca sativa L. Value presented as percentage differences from control. 
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3.5.3 Antialgal activity of compounds from Swinglea glutinosa extract 
 
Pure compounds from S. glutinosa extract were evaluated for antialgal activity toward 
Oscillatoria perornata (Table 6). The most toxic of the isolated compounds was found to be 
compound 73 with a LCIC of 10 µM. It showed a selective toxicity toward Oscillatoria 
perornata when compared to Selenastrum capricornutum. Compounds 67-69, 75 and 76 
showed a moderate toxicity with a LCIC of 100 µM. 
 
 
                Table 6. Evaluation of pure compounds from S. glutinosa antialgal activity 
 
 
 
  
 Oscillatoria 
perornata 
Selenastrum 
capricornutum 
Compound LOEC
μM 
LCIC
μM 
LOEC
μM 
 
LCIC 
μM 
 
67 10 100 10 100 
68 10 100 0.1 >100 
69 10 100 >100 >100 
71 100 >100 >100 >100 
72 >100 >100 >100 >100 
73 10 10 100 >100 
74 >100 >100 >100 >100 
75 100 100 >100 >100 
76 100 100 100 >100 
77 >100 >100 >100 >100 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 97
3.5.4 Antifungal activity of compounds isolated from Amyris madrensis 
 
Bioutography of the ethyl acetate extract of Amyris madrensis leaves revealed the presence of 
active constituents against the crop pathogen Colletotrichum fragariae. Fractionation of the 
extract led to the isolation of  compounds 79-86. The antifungal activity of pure compounds 
was evaluated by bioautography according to the Wedge method20 and evidenced by the 
presence of clear zones with a dark background on the TLC plate. The most active compounds 
that gave the most well-defined inhibitory zones are reported in Fig. 10. 
 
 
  80                  81  82 84 85 
Fig. 10- Bioautography of pure compounds from Amyris madrensis. The plates were sprayed with Colletotrichum 
fragariae. 
                                                                                                    
 
 
3.5.5 Acetylcholinesterase inhibitory activity 
 
Alzheimer’s diseas is the most common cause of senile dementia in later life. Inhibitors of 
acetylcholinesterase currently form the basis of the newest drugs available for the management 
of this disease. They function by correcting a deficiency of the neurotransimitter acetylcholine 
in the synapses of the cerebral cortex. Galanthamine, isolated from plants of the 
Amaryllidaceae family, is the most recent addition to drugs used for the treatmentof 
Alzhermer’s disease.22 In view of the potential of plants for the discovery of new 
acetylcholinesterase inhibitors, a TLC bioautography was used for the screening of pure 
compounds. This method is rapid and simple to use and gives quick access to information 
concerning the activity. The test relies on the cleavage by acetylcholinesterase of 1-naphthyl 
acetate to form 1-naphthol, wich in turn reacts with Fast Blue B salt to give a purple-coloured 
diazonium dye (Fig. 11). Regions of TLC plate which contain acetylcholinesterase inhibitors 
show up as white spots against the purple background. Pure compounds from S. glutinosa and 
galanthamine were applied onto the TLC plates and the bioautography was carried out. 
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Compounds that exhibited inhibitory activity are reported in Fig. 12. It shows areas of 
inhibition of the enzyme with white spots on the plate. 
 
 
 
 
                    AchE 
 +   CH3COOH 
 
                
OCOCH3 OH
                     Naphthyl                       α-Naphtol 
                   acetate 
  
 
 
 
  
                                                                                                       Fast Blue Salt B 
 
 
  
  
 
                                               Azo dye (purple) 
 
Fig. 11- Reaction of acetylcholinesterase with naphtyl acetate and the subsequent formation of the purple dye in 
the TLC bioassay 
 
 
 
 
G 67 69 70    72 74 75 76 
Fig. 12- Bioautograph showing the inhibition of AchE activity by galanthamine and compounds from S. glutinosa  
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3.6. Photo-oxidation of propenyl phenols 
 
Isoeugenol 87a was subjected to methylene blue–sensitized photooxygenation under 
various conditions (solvent, concentration).72 More dilute solutions allowed reaction time 
to be reduced avoiding secondary oxygenation, mainly of the double bond. Moreover, the 
reaction mixture resulted less complex and product separation more easy. 1H NMR analysis 
and preparative TLC and HPLC were used to identify and quantify the isolated products. 
 
 
HO
OCH3
R
        
a R= CH3
b R = CH2OH
c R = COOH
             87  
 
Compound 88a was identified as dehydroisoeugenol by comparison with its spectral data 
with those reported in literature.73 Compound 89 was identified as vanillin by comparison 
with commercial sample. Compound 90, which was obtained as a 2:1 diastereoisomeric 
erythro/threo mixture, was identified as guaiacylpropan-1,2-diol-β-O-4'-isoeugenylether by 
comparison with literature spectroscopic data.74
             
 
OH
CHO
OCH3O
R OCH3
OH
OCH3
R
88a R = CH3
88b R= CH2OH
89
 
 
O
OCH3 OH
OH
OCH32
7
2'
57' 6'
 
 
90 (erythro and threo)  
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Compound 91 was a 9:1 diastereoisomeric threo/erythro mixture as observed in its 1H 
NMR spectrum. The molecular formula C20H24O5 was deduced by the HREIMS spectrum 
which showed the molecular ion peak [M]+ at m/z 344.1620. Signals (major isomer) at δ 
6.29 (1H, d, J=15.5 Hz, H-7'), and 6.08 (1H, dt, J=6.5 and 15.5Hz, H-8'), in the 1H NMR 
spectrum, indicated the presence of a trans-substituted double bond. Six aromatic signals in 
δ 6.95-6.58 range in the 1H NMR spectrum suggested the presence of two 1,2,4-
trisubstituted aromatic rings, as did six methine signals at δ 109.3-120.9 range  in the 13C 
NMR (DEPT) spectrum. In the HMBC spectrum, long-range correlations from the H-7' 
olefinic proton to the methyl carbon C-9' at δ 18.9, the methine carbons C-2' at δ 109.8, and 
C-6' at δ 119.1 were observed. In the 1H NMR spectrum, the signals at δ 4.43 (1H, d, J=7.8 
Hz, H-7), 4.07 (1H, m, H-8), and 1.01 (3H, d, J=6.0 Hz, H-9), as well as signals at δ 91.0, 
71.3, and 18.0 in the 13C NMR (DEPT) spectrum attributed to C-7, C-8, C-9, respectively, 
indicated the presence of a propane 1,2-diol chain. In the HMBC spectrum, long-range 
correlations from the H-7 proton to the methyl (C-9), the methine carbons at δ 71.3, 109.3, 
120.9, 131.0, and 145.1 assigned to C-8, C-2, C-6, C-1, and C-4', respectively were 
observed, indicating the presence of a 1-(4-hydroxy-3-methoxyphenyl)propane-1,2-diol 
linked to C-4 of the isoeugenol unit that involve a 4'-O-7 linkage. Compound 91 was 
previously reported as an oxidatively dimerized isoeugenol. 75   
 
 
 
O
OCH3
HO
OH
OCH3
 
 
91  (erythro and threo)  
 
Compound 92 was isolated from the irradiation mixture in water (2%). It had molecular 
formula C16H14O6 as the HREIMS spectrum showed the molecular ion peak [M]+ at m/z 
302.0785. The 1H NMR spectrum showed a singlet at δ 9.98 attributed to aldeidic group, as 
confirmed by a signal at δ 192.2 in the 13C NMR spectrum. Six aromatic signals in δ 7.02-
7.84 range, in the 1H NMR spectrum and 1H-1H COSY suggested the presence of two 
1,2,4-trisubstituted aromatic rings, as did six methine signals at δ 111.2-125.8 range  in the 
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13C NMR (DEPT) spectrum. These data, along with HSQC and HMBC spectra, confirmed 
the structure of compound 92 as depicted. 
 
 
O
OCH3
OHC
OCH3
OH
O
 
 
92 
 
Appreciable amount of lignan 88a was obtained both in organic solvents and in H2O-
CH3CN. Compound 90 was found in 20 and 8% amount in H2O and H2O-CH3CN as 
solvents. Compound 91 was present in small amount under all the conditions used.  
A rationalization of the results is reported in Scheme 1. In the formation of compounds 
88a, 90, 91 the key intermediate should be radical 94a deriving from electron-transfer 
reaction between 87a and singlet oxygen followed by hydrogen abstraction.76 Radical 
couplings and nucleophilic additions should lead to the final products 88a, 90, 91 (Scheme 
1). As reported,77 88a is formed by 5-8’ coupling followed by an intramolecular 
cycloaddition 4-O-8’. Coupling and water addition to the resulting quinone methide 
appears to lead to compound 90. The low yield can be explained on the basis of previous 
data,4b which evidenced the scarce competition of water addition respect to that of other 
nucleophiles such as methanol or ethanol, even in the presence of excess of water. 
Oxygenated species as OOH radical (or O2)75 may be involved in the formation of 
compound 91, followed by the nucleophilic addition of 87a.  
Vanillin 89 is the cleavage product of the intermediate dioxetane deriving from addition of 
singlet oxygen to the double bond. According to Kuo,77 it should be the precursor of 
compound 92 via abstraction of the phenolic hydrogen by oxygenated species and addition 
of the so formed radical to 89.  
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Scheme 1 
 
 
To minimize oxygen addition we used typical conditions for generating phenoxy radicals 
by different approaches (Scheme 2).77,78 When isoeugenol 87a was irradiated at λ > 310 nm 
in the presence of di-tert-butyl peroxide in dry CH3CN in inert atmosphere,77 the reaction 
mixture, analysed by 1H NMR after 14 h, evidenced 60% conversion and the presence of 
compound 88a (20%) in addition to trace amounts of 89 and 91. Irradiation was also 
carried out in the presence of chloranil, a well-known electron-transfer sensitizer77 able to 
abstract hydrogen,78 in dry CH3CN, in inert atmosphere. After 8 h, the reaction mixture, 
analysed by 1H NMR, evidenced 40% conversion and the presence of only compound 88a 
in 20% amount.  
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Scheme 2 
 
 
The mild conditions (MB-sensitized photooxygenation in H2O/CH3CN and peroxide-
promoted photo-oxidation) were also used for coniferyl alcohol 87b and ferulic acid 87c. 
The results are depicted in Scheme 3. The photooxygenation of 87b in H2O/CH3CN and 
methylene blue as sensitizer led, after 20 h, only to vanillin 89, evidently due to the 
activated double bond.79 More satisfying was irradiation in the presence of the peroxide. 
The reaction mixture, analysed after 14 h by 1H NMR, evidenced 90% conversion. HPLC 
separation gave compounds 88b (30%) and 7 (10%), identified by comparison with 
literature spectroscopic data as dihydrodiconiferyl alcohol80 and pinoresinol,81 respectively.  
Radical 94b, formed as above 94a, partly gives the β-5 dimer 88b and partly dimerizes to 
furofuran lignan 93 through initial 8-8’ coupling followed by intramolecular 7-O-9’ and 7’-
O-9 cyclizations of alcoholic functions.  
All attempts to oxidate ferulic acid 87c under both conditions failed. No lignan derivatives 
were observed even after prolonged irradiation (30 h). Cis-trans-isomerization and 
formation of vanillin (trace) under MB-sensitized photooxygenation were the only events 
observed. 
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4. CONCLUSIONS  
 
During the three years of my PhD studies four plants have been analysed, Aptenia cordifolia, 
Oxalis pes-caprae (two spontaneous plants of the Mediterranean area), Swinglea glutinosa, and 
Amyris madrensis. The plants have been treated by infusion procedure with an hydroalcoholic 
solution (10% MeOH-H2O) and/or organic solvent. The extracts obtained have been 
concentrated and fractionated by different chromatographic techniques (CC, TLC, HLPC), 
while the structural characterisation of pure compounds has been performed by spectroscopic 
and spectrometric techniques (1H and 13C NMR, UV, IR, EI MS, ESI MS, MALDI MS). The 
investigation of these plants has led to the identification of: three lignans (16, 17, 19), one 
dilignan (18), six neolignans (20-25, 55), three cinnamic acid amides (36-38), two 
lignanamides (39, 40), fourteen aromatic esters (41-54), fourteen cinnamic acid derivatives (6-
15, 63-66), five C-13 nor-terpenes (29-34), methylinositol (35), two tryptophan derivatives 
(27-28), eight phenol derivatives (1-5, 60-62), four flavons (56-59), ten coumarins (67-69, 79-
85), nine acridone alkaloids (70-78), and methyleugenol (86). The dilignan 18, the lignan 19, 
the six neolignans 20-25 and 55, the cinnamic acid amide 38, the lignanamide 39, the aromatic 
esters 41-54, and the two coumarins 69 and 79 have been isolated for the first time.  
Some of the isolated compounds have been tested on seeds of a standard plant (Lactuca sativa 
L) to evaluate phytotoxic activity. The assays have been run in accordance with the procedures 
optimized by Macias et al.19 The results reported have shown a strong inhibiting effect of many 
compounds like 13, 28, 42, 43, and  in particular ester 54 which inhibits growth of the standard 
specie by 100% at all concentrations tested. Such a potent bioactivity for very diluted solution 
of compound 54 suggests further investigations of phytotoxic activity to fully understand the 
ecological role of this ester and to evaluate its potential use as a herbicide.  
Some of the isolated compounds have been evaluated for antifungal activity against the plant       
pathogen Colletotrichum fragariae, and antialgal activity toward Oscillatoria perornata. The 
most active of the tested compounds were coumarins 80, 81, 82, 84, and 85 as showed clear 
zones of growth inhibition on the TL plates, while acridone alkaloid 73 showed a selective 
toxicity toward Oscillatoria perornata when compared to Selenastrum capricornutum. 
Further studies with these compounds with in vivo systems are needed to further determine 
their potential as commercial fungicides or algicides. 
The data presented enlighten the role covered by plant-originated compounds in the research of 
new eco-compatible agrochemicals. Natural substances still represent a fruitful field of 
investigation to detect unknown molecules having new structures and functionalities that 
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evolution has refined for highly specific biological roles. This thesis has also led to the 
identification and structural characterisation of some molecules having a new interesting 
carbon skeleton, that might contribute to the complicated process of discovery and definition of 
natural substances.  
Finally, this work has showed the interesting possibility to obtain lignans using 
environmentally friendly photo-induced methods. 
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